Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013742	s-prealb	mg/l (g/l)	15506	36880	0.00%
3013742	s-prealb	g/l (g/l)	13047	33017	0.00%
3013742	p-prealb	g/l (g/l)	10004	17748	0.25%
3013742	s-prealb	— (—)	4093	6872	100.00%	Distribution not available
3013742	p-prealb	— (—)	1602	2235	100.00%	Distribution not available
3013742	prealb	g/l (g/l)	1513	1747	0.00%
3013742	p-prealbumiini	g/l (g/l)	833	1157	0.00%
3013742	s-prealb	mg/l______ (g/l)	574	1188	0.00%
3013742	s-prealbumiini	g/l (g/l)	387	498	0.00%
3013742	prealbumiini,seerumista	g/l (g/l)	162	194	0.00%
3013742	p-prealb	mg/l (g/l)	155	179	0.00%
3013742	prealb	— (—)	95	98	100.00%	Distribution not available
3013742	prealbumiini	g/l (g/l)	72	85	0.00%
3013742	prealbumiini,plasma	g/l (g/l)	69	103	0.00%
3013742	prealb	g/l_______ (g/l)	39	40	0.00%
3013742	p-prealbumiini	g/l_______ (g/l)	35	46	0.00%
3013742	s-prealbumiini	— (—)	31	38	100.00%	Distribution not available
3013742	p-prealbumiini	— (—)	20	20	100.00%	Distribution not available
3013742	s-prealbl	mg/l (g/l)	7	9	0.00%	Distribution not available
3013742	prealbumiini,seerumista	— (—)	5	9	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Use of hypnotics and sedatives

8271

30024

1.65

322.83

2.5

2.3

0.22

0.21

g/l

2.99

7673

28073

Cardiac arrhythmias

4277

14531

2.00

321.51

2.4

0.21

0.22

g/l

20.26

4006

13753

Asthma

5628

16514

1.85

321.15

2.3

0.22

g/l

0.69

5294

15460

Polyarthropathies

5447

20101

1.85

319.80

2.5

2.4

0.21

g/l

0.82

5084

18824

Benign neoplasm of other and ill-defined parts of digestive system

1876

7650

2.89

316.48

2.9

2.2

0.22

0.20

g/l

12.97

1780

7127

Hypothyroidism, drug reimbursement

848

1315

4.90

316.26

2.3

2.2

0.21

0.23

g/l

5.41

800

1257

Intracranial trauma

4550

16799

1.94

315.83

2.5

0.21

g/l

4.06

4166

15802

Crohn disease

1347

4614

3.45

314.36

4.0

2.3

0.23

0.22

g/l

8.52

1286

4330

Mucosal proctocolitis

1325

4499

3.48

313.95

3.6

2.3

0.23

0.22

g/l

9.52

1260

4219

Diseases of arteries, arterioles and capillaries

5584

24125

1.82

312.83

2.3

0.20

0.21

g/l

9.00

5134

22437

Gastroduodenal ulcer

2400

10807

2.47

312.68

3.1

2.0

0.19

0.20

g/l

11.91

2214

10000

Artificial opening status

795

1999

5.58

311.00

3.5

2.2

0.21

g/l

0.15

759

1880

Other eating disorders

610

1197

6.50

310.83

3.3

2.9

0.23

0.22

g/l

0.30

559

1126

Convulsions, not elsewhere classified

1993

8165

2.66

310.00

2.7

2.3

0.21

0.22

g/l

6.96

1804

7643

Atrial fibrillation and flutter with reimbursement

2128

5479

2.71

309.20

2.4

2.2

0.20

0.22

g/l

25.85

1988

5159

Constipation

7704

30250

1.84

307.65

2.7

2.3

0.21

g/l

5.61

7132

28246

Malaise and fatigue

5369

16972

2.79

307.65

2.5

2.2

0.20

0.21

g/l

34.15

4904

15877

Cholecystectomy

6090

28978

1.92

307.65

2.6

2.2

0.21

g/l

0.00

5786

26877

All kidney diseases

9512

30060

2.32

307.65

2.7

2.3

0.21

0.22

g/l

30.68

8893

28103

Codeine or tramadol medication

8676

29760

1.66

307.65

2.2

2.3

0.22

0.21

g/l

8.19

8097

27740

Non-invasive ventilation

2027

6405

3.01

307.65

2.6

2.3

0.20

0.22

g/l

24.78

1935

6098

Other disorders of fluid, electrolyte and acid-base balance

3855

13092

3.30

307.65

2.8

2.2

0.19

0.20

g/l

15.62

3517

12193

Acute renal failure

2909

9503

3.81

307.65

3.1

2.2

0.19

0.20

g/l

10.75

2685

8803

Mood [affective] disorders

8192

31957

1.73

307.65

2.5

2.3

0.22

0.21

g/l

12.57

7504

29997

Any mental disorder

8719

25293

1.82

307.65

2.5

2.3

0.21

g/l

0.57

8023

23849

Condition for Implicit Sepsis (Organ dysfunction codes)

8490

26531

2.45

307.65

2.9

2.2

0.20

0.22

g/l

72.85

7848

24856

Bacterial Sepsis

5688

17316

3.17

307.65

3.0

2.1

0.19

0.21

g/l

71.22

5219

16149

Renal failure

5362

19077

2.76

307.65

2.9

2.2

0.20

g/l

2.21

4948

17672

Hypertension, essential

6040

18236

2.00

307.65

2.4

2.3

0.22

g/l

0.66

5652

17131

Certain infectious and parasitic diseases

7955

20254

2.10

307.65

2.7

2.1

0.21

0.22

g/l

34.29

7419

18976

Heart failure, strict

5569

19518

2.19

307.65

2.3

0.18

0.21

g/l

87.55

5098

18178

All pneumoniae

9251

30948

2.10

307.65

2.5

2.4

0.20

0.22

g/l

49.41

8616

28995

Erysipelas

5105

21198

2.27

307.65

2.4

2.1

0.20

0.22

g/l

57.03

4706

19766

Erysipelas, including avohilmo

6608

23931

2.23

307.65

2.4

2.1

0.20

0.22

g/l

70.24

6109

22367

Diarrhoea and gastroenteritis of presumed infectious origin

5826

29604

1.87

307.65

2.8

2.3

0.21

g/l

1.84

5422

27634

Atrial fibrillation and flutter

2564

6731

2.70

307.65

2.4

2.2

0.20

0.22

g/l

33.99

2395

6334

Bacterial infection, other or unspecified, including avohilmo

6772

21167

3.02

307.65

2.9

2.1

0.19

0.21

g/l

85.12

6248

19736

Septicaemia

5252

16593

3.42

307.65

3.1

2.2

0.19

0.21

g/l

84.69

4826

15476

Other viral hepatitis, including avohilmo

984

2051

6.73

307.65

3.0

2.4

0.20

0.23

g/l

29.28

906

1937

Malignant neoplasm of liver and intrahepatic bile ducts

561

847

10.87

307.65

6.0

2.1

0.17

0.19

g/l

6.80

534

770

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

8623

26831

2.38

307.65

2.9

2.2

0.20

0.22

g/l

70.38

7989

25180

Eating disorder

942

2239

5.10

307.65

3.2

2.6

0.23

g/l

0.68

868

2110

Explicit Sepsis

5383

17379

3.32

307.65

3.1

2.1

0.19

0.21

g/l

85.51

4949

16225

Nutritional anaemias

5457

22006

2.69

307.65

2.9

2.2

0.19

0.21

g/l

28.61

5047

20442

Other viral hepatitis

937

1904

6.97

307.65

3.1

2.4

0.20

0.23

g/l

27.80

863

1798

Complications of surgical and medical care, not elsewhere classified

9911

31104

2.33

307.65

2.7

2.2

0.21

g/l

10.74

9315

28918

Pneumonias (Asthma/COPD co-morbidities)

9213

30901

2.10

307.65

2.5

2.3

0.20

0.22

g/l

50.67

8579

28943

Anaemias

2882

2015

11.29

307.65

3.6

2.4

0.21

0.23

g/l

27.49

2715

1916

Implicit viral Sepsis

2210

8253

3.11

307.65

3.2

2.1

0.20

0.21

g/l

3.67

2034

7701

Explicit Sepsis, including avohilmo

5487

17691

3.30

307.65

3.1

2.1

0.19

0.21

g/l

87.38

5050

16521

Noninfective enteritis and colitis

4477

20669

2.40

307.65

3.3

2.3

0.22

0.21

g/l

11.76

4221

19300

Type 2 diabetes, strict (exclude DM1)

7522

26065

1.77

307.65

2.4

2.2

0.22

0.21

g/l

1.58

6982

24391

Implicit bacterial Sepsis, including avohilmo

5454

16834

3.15

307.65

2.9

2.1

0.19

0.21

g/l

59.03

5005

15688

Viral Sepsis

2211

8276

3.10

307.65

3.2

2.1

0.20

0.21

g/l

3.75

2035

7724

Implicit viral Sepsis, including avohilmo

3081

12618

2.77

307.65

3.0

2.1

0.20

0.21

g/l

4.97

2846

11785

Any event in cancer register

8615

20626

2.69

307.65

2.5

2.3

0.22

0.21

g/l

2.49

8217

19017

Malignant neoplasm of breast

3257

9114

2.53

307.65

1.8

2.1

0.23

0.22

g/l

12.64

3125

8379

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

11004

29606

2.83

307.65

2.9

2.2

0.20

0.22

g/l

61.92

10264

27648

Hypertensive diseases (excluding secondary)

4119

10059

2.59

307.65

2.5

2.3

0.22

0.23

g/l

1.58

3873

9505

Implicit Sepsis

8112

25104

2.68

307.65

2.9

2.2

0.20

0.22

g/l

71.17

7461

23496

Medical observation and evaluation for suspected diseases and conditions

5269

13502

2.13

307.65

2.8

2.0

0.21

g/l

0.89

4883

12562

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5474

27056

2.23

307.65

2.8

2.2

0.21

g/l

2.50

5153

25159

Obesity

5605

27178

2.11

307.65

2.3

2.4

0.22

g/l

0.28

5242

25496

Malignant neoplasm of digestive organs

6569

10848

6.28

307.65

3.1

2.1

0.20

g/l

8.17

6314

9872

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4576

18991

2.71

307.65

2.6

2.4

0.20

0.21

g/l

28.44

4119

17826

Other bacterial diseases, including avohilmo

10670

27808

2.67

307.65

2.8

2.2

0.20

0.22

g/l

119.45

9949

26039

Malignant neoplasm of colon

1935

4912

4.99

307.65

2.5

2.0

0.20

g/l

0.87

1867

4457

Hepatocellular carcinoma

433

603

12.71

307.65

6.3

2.0

0.17

0.19

g/l

6.12

416

543

Malignant neoplasm of breast, HER2-negative

3254

9107

2.53

307.65

1.8

2.1

0.23

0.22

g/l

12.60

3122

8373

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

9066

31114

2.10

307.65

2.5

2.4

0.20

0.22

g/l

53.72

8437

29153

Fever of other and unknown origin

6269

19831

3.11

307.65

3.1

2.2

0.20

0.22

g/l

56.24

5880

18565

Viral hepatitis

994

2327

5.76

307.65

3.0

2.4

0.20

0.23

g/l

23.01

914

2194

6333

22456

2.87

307.65

2.9

2.3

0.19

0.22

g/l

68.06

5737

21046

Renal tubulo-interstitial diseases

8878

29407

2.45

307.65

2.7

2.3

0.20

0.21

g/l

44.98

8261

27478

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1164

1907

9.58

307.65

5.4

2.0

0.17

0.20

g/l

18.79

1103

1729

Gastro-oesophageal reflux disease

5549

26772

1.86

307.65

2.4

2.2

0.22

0.21

g/l

4.37

5179

24997

Viral hepatitis, including avohilmo

1047

2463

5.71

307.65

3.0

2.4

0.20

0.23

g/l

25.87

961

2324

Malignant neoplasm of breast, HER2-negative, including Hilmo

3289

9184

2.51

307.65

1.8

2.1

0.23

0.22

g/l

13.09

3155

8446

Other heart diseases, wide

6989

25200

1.77

307.65

2.5

2.4

0.21

0.22

g/l

34.58

6528

23697

IBD patients in KELA-register

2228

8676

2.93

307.65

3.7

2.3

0.23

0.22

g/l

19.25

2127

8127

Certain infectious and parasitic diseases, including avohilmo

5248

14554

1.90

307.65

2.5

2.2

0.21

0.22

g/l

14.49

4898

13641

Autoimmune diseases excluding thyroid diseases, strict definition

8698

25560

1.97

307.65

2.9

2.2

0.21

g/l

0.70

8164

23842

Inflammatory bowel disease

3014

13009

2.61

307.65

3.6

2.3

0.23

0.21

g/l

16.10

2858

12183

Abnormal findings on examination of blood, without diagnosis

4477

20539

2.18

307.65

2.7

2.3

0.21

g/l

1.00

4187

19096

Any reimbursement code in KELA

4298

7565

3.07

307.65

2.8

1.9

0.22

0.23

g/l

2.71

4062

7023

Malignant neoplasm of breast, HER-positive

2583

8130

2.62

307.65

1.8

2.1

0.23

0.21

g/l

13.73

2473

7456

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6116

28547

2.03

307.65

2.6

2.3

0.21

g/l

1.77

5714

26534

Chronic viral hepatitis

789

1534

7.37

307.65

2.8

2.5

0.20

0.23

g/l

22.78

719

1451

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

894

1449

9.63

307.65

5.5

2.0

0.17

0.19

g/l

15.54

847

1312

Implicit bacterial Sepsis

5070

15665

3.27

307.65

3.0

2.1

0.19

0.21

g/l

55.40

4646

14593

Other heart diseases

3760

10360

2.56

307.65

2.7

2.4

0.21

0.23

g/l

28.60

3528

9788

Persons encountering health services for specific procedures and health care

10412

28031

2.40

307.65

2.7

2.3

0.21

0.22

g/l

42.55

9741

26156

Infections of the skin and subcutaneous tissue

4861

27135

1.89

307.65

2.7

2.4

0.21

g/l

12.62

4537

25392

Symptoms and signs involving the digestive system and abdomen

8518

21272

2.15

307.65

2.8

2.1

0.21

0.22

g/l

14.66

7988

19783

Intestinal infectious diseases, including avohilmo, including avohilmo

9023

32250

1.63

307.65

2.6

2.3

0.21

g/l

0.48

8404

30078

Solid cancers

8305

18566

2.93

307.65

2.5

2.2

0.22

0.21

g/l

1.63

7939

17068

Metabolic disorders

8462

26353

2.08

307.65

2.5

2.3

0.21

g/l

0.67

7848

24675

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3453

9280

2.54

307.65

3.4

2.2

0.20

0.23

g/l

52.79

3241

8759

Other bacterial diseases

10484

27895

2.81

307.65

2.8

2.2

0.20

0.22

g/l

138.19

9744

26098

Substance use, excluding alcohol

1830

7018

2.96

307.65

2.5

2.4

0.21

0.22

g/l

6.56

1668

6625

Other diseases of intestines

9129

26564

2.05

307.65

2.7

2.3

0.22

0.21

g/l

1.22

8567

24772

Influenza and pneumonia

9410

30425

2.05

307.65

2.6

2.3

0.20

0.22

g/l

45.94

8763

28508

Complications of medical and surgical care

7355

31284

2.34

307.65

2.8

2.2

0.21

g/l

6.91

6928

29079

Neoplasms

5782

13288

2.44

307.65

2.7

2.3

0.22

g/l

2.55

5506

12209

Autoimmune diseases

8895

26469

1.80

307.65

2.8

2.2

0.21

g/l

0.40

8311

24710

6554

22964

2.82

307.65

2.9

2.3

0.20

0.22

g/l

63.48

5946

21539

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2758

6159

6.07

307.65

2.8

2.1

0.19

0.20

g/l

11.33

2644

5621

Malignant neoplasm, wide definition

8621

19264

2.91

307.65

2.5

2.2

0.22

g/l

0.91

8241

17724

Implicit Sepsis, including avohilmo

8465

26394

2.55

307.65

2.9

2.2

0.20

0.22

g/l

69.88

7804

24727

Autoimmune diseases excluding thyroid diseases

8945

26338

1.96

307.65

2.9

2.2

0.21

g/l

0.75

8391

24585

Bacterial infection, other or unspecified

6298

19925

3.09

307.65

2.9

2.1

0.19

0.21

g/l

79.12

5806

18569

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

8611

28969

2.01

307.65

2.9

2.3

0.21

g/l

0.24

8117

26985

Malignant neoplasm of pancreas

1032

2085

6.89

307.65

3.5

1.9

0.18

0.20

g/l

3.71

981

1892

Malignant neoplasm of oral cavity, including Hilmo

769

1245

9.94

307.65

2.6

2.0

0.23

0.20

g/l

11.61

748

1129

Malignant neoplasm, including Hilmo

8597

19219

2.91

307.65

2.6

2.2

0.22

g/l

0.77

8218

17684

Diseases of oesophagus, stomach and duodenum

9739

29268

2.12

307.65

2.8

2.2

0.21

g/l

5.59

9078

27329

Malignant neoplasm of head and neck

1239

2383

7.39

307.65

2.5

2.0

0.22

0.20

g/l

17.86

1205

2181

Cardiovascular diseases (excluding rheumatic etc)

4705

12287

2.34

307.65

2.8

2.4

0.22

0.23

g/l

6.41

4453

11612

Osteopathies and chondropathies

4879

24894

1.93

307.65

2.6

2.3

0.20

0.21

g/l

11.43

4516

23238

Heart failure, not strict

7902

22479

2.68

307.65

2.8

2.2

0.19

0.22

g/l

103.52

7346

21067

Malignant neoplasm of oral cavity

655

953

12.20

307.65

2.5

2.0

0.23

0.20

g/l

11.36

635

871

Mental and behavioural disorders due to alcohol

5090

21187

2.56

307.65

2.6

2.4

0.20

0.21

g/l

28.42

4593

19884

Diabetes mellitus

8225

27537

1.83

307.65

2.5

2.3

0.21

g/l

1.67

7608

25793

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2608

8000

3.78

307.65

2.5

2.1

0.19

0.20

g/l

6.67

2494

7304

Malignant neoplasm

8398

18922

2.90

307.65

2.5

2.2

0.22

0.21

g/l

1.17

8031

17402

Cholangitis (primary sclerosing, PSC), with reimbursement 202

506

598

24.74

307.65

7.5

2.5

0.21

0.22

g/l

2.68

497

563

Disorders of gallbladder, biliary tract and pancreas

10883

27559

2.77

307.65

3.1

2.0

0.20

0.21

g/l

27.05

10325

25516

Asthma, excluding more controls

5411

15032

1.95

307.65

2.4

2.3

0.22

g/l

2.94

5095

14110

Hepatocellular carcinoma, including Hilmo

584

796

13.40

307.65

6.1

2.1

0.17

0.19

g/l

9.01

556

714

Anxiety disorders, excluding more controls

6367

23106

1.86

307.65

2.6

2.3

0.22

g/l

8.50

5900

21841

Viral hepatitis, IBD co-morbidity

917

1216

10.75

307.65

2.9

2.4

0.20

0.22

g/l

16.45

841

1162

Diseases of the digestive system

4762

21133

2.52

307.65

3.4

2.2

0.20

0.21

g/l

21.73

4413

19621

Cerebrovascular diseases (FINNGEN)

2408

7206

2.55

307.65

2.5

2.2

0.21

0.22

g/l

12.51

2250

6799

Intestinal infectious diseases

7691

34622

1.74

307.65

2.8

2.3

0.21

g/l

2.56

7152

32304

8097

23701

2.16

307.65

2.5

2.3

0.20

0.22

g/l

36.46

7525

22166

Any death

6840

21005

2.61

307.65

2.6

2.2

0.18

0.22

g/l

245.20

6243

19748

Malignant neoplasm of stomach

775

1446

7.53

307.65

3.3

2.0

0.20

0.19

g/l

1.35

748

1308

Type 2 diabetes

7926

26407

1.84

307.65

2.4

2.2

0.21

g/l

0.08

7336

24714

Other septicaemia, including avohilmo

4827

15449

3.49

307.65

3.1

2.1

0.19

0.21

g/l

74.03

4446

14388

Colorectal adenocarcinoma

2895

6670

5.63

307.65

2.4

2.0

0.21

0.20

g/l

8.10

2813

6052

Colorectal cancer

3437

7874

5.45

307.65

2.4

2.0

0.21

0.20

g/l

4.22

3331

7143

Malignant neoplasm of colon, including Hilmo

2355

5995

4.95

307.65

2.5

2.0

0.20

g/l

1.42

2272

5437

Cholelithiasis

7408

25463

2.15

307.65

2.6

2.0

0.21

g/l

9.74

7020

23546

Other functional intestinal disorders

3927

18441

2.09

307.65

2.6

2.2

0.21

g/l

0.62

3644

17124

Colon adenocarcinoma

1517

3836

5.03

307.65

2.6

2.0

0.20

g/l

1.07

1466

3478

Malignant neoplasm of breast, including Hilmo

3290

9184

2.51

307.65

1.8

2.1

0.23

0.22

g/l

13.13

3156

8446

Malignant neoplasm of digestive organs, including Hilmo

7303

11551

6.31

307.65

3.2

2.1

0.20

0.21

g/l

12.74

7015

10523

Depression medications

1965

2164

4.95

307.65

2.5

2.4

0.23

g/l

2.44

1835

2060

Malignant neoplasm of rectum

1429

2964

6.65

307.65

2.3

2.0

0.21

0.20

g/l

10.30

1392

2700

First line medication for Crohn's disease

10243

26223

2.28

307.65

3.0

2.1

0.22

0.21

g/l

4.12

9689

24324

Hypothyroidism and >3 levothyroxin purchases

1573

2018

4.72

307.65

2.6

2.3

0.22

0.23

g/l

3.84

1466

1918

General symptoms and signs

9306

22469

2.23

307.65

2.7

2.2

0.21

0.22

g/l

17.83

8675

21058

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3285

5815

10.29

307.65

4.9

2.1

0.16

0.21

g/l

167.18

2983

5448

Cholangitis (primary sclerosing, PSC)

1241

2125

9.83

307.65

6.3

2.0

0.19

0.21

g/l

7.62

1205

1956

Hypertensive diseases

6048

18674

1.94

307.65

2.4

0.22

g/l

1.61

5685

17551

Malignant neoplasm of breast, ER-positive, including Hilmo

2591

8145

2.62

307.65

1.8

2.1

0.23

0.21

g/l

14.02

2481

7470

General examination and investigation of persons without complaint and reported diagnosis

5000

13485

2.05

307.65

2.7

2.0

0.21

g/l

1.19

4721

12550

Abnormalities of breathing

7097

23214

1.85

307.65

2.4

0.21

g/l

1.39

6580

21742

Depression or dysthymia

5152

15508

1.92

307.65

2.5

2.4

0.21

g/l

3.73

4731

14656

Malignant neoplasm

8433

18962

2.91

307.65

2.5

2.2

0.22

0.21

g/l

1.28

8065

17440

Colorectal cancer, including Hilmo

3841

8596

5.41

307.65

2.4

2.0

0.21

0.20

g/l

4.33

3709

7803

malignant neoplasm of female genital organs, including Hilmo

1586

5279

3.32

307.65

1.9

2.0

0.21

g/l

1.76

1511

4813

Liquid cancers, including Hilmo

3031

11135

2.67

307.65

2.4

2.1

0.20

0.21

g/l

5.51

2818

10145

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

873

1400

9.91

307.65

5.4

2.0

0.17

0.19

g/l

16.64

822

1264

Cholelithiasis, broad definition with cholecystitis

7814

25821

2.19

307.65

2.7

2.0

0.20

0.21

g/l

15.88

7404

23884

Iron deficiency anaemia

4764

19171

2.80

307.65

2.9

2.2

0.19

0.21

g/l

25.32

4406

17835

Other and unspecified anaemias

4761

18697

2.75

307.65

2.8

2.2

0.19

0.20

g/l

19.18

4370

17339

Dialysis, with operation codes

1567

4830

4.13

307.65

4.6

2.3

0.21

g/l

0.12

1492

4502

Other septicaemia

4734

15131

3.52

307.65

3.1

2.1

0.19

0.21

g/l

73.21

4355

14091

Aplastic and other anaemias

5162

19838

2.73

307.65

2.9

2.2

0.19

0.20

g/l

21.34

4739

18405

Diabetes medication

8142

29248

1.71

307.65

2.5

2.3

0.21

g/l

1.31

7549

27374

Bleeding

7434

28420

1.98

307.65

2.8

2.3

0.20

0.21

g/l

44.12

6877

26511

Dyspnoea

7627

31966

1.83

307.65

2.3

0.21

g/l

6.41

7081

29839

Diabetes, varying definitions

8209

27522

1.83

307.65

2.5

2.3

0.21

g/l

1.66

7592

25781

Hernia of abdominal wall, postoperative

2205

3439

7.88

307.65

3.3

1.4

0.21

0.22

g/l

7.50

2116

3101

Heart failure,strict

5180

16281

2.50

307.65

2.3

2.2

0.19

0.21

g/l

98.68

4768

15200

Mood disorders, excluding more controls

7612

24821

1.92

307.65

2.5

2.3

0.22

0.21

g/l

5.66

6966

23417

Other nutritional deficiencies

6080

28103

2.15

307.65

2.4

0.21

0.22

g/l

0.30

5676

26355

Alcohol use disorder, Swedish definition

6143

21422

3.00

307.65

3.0

2.3

0.19

0.22

g/l

64.55

5569

20082

Other anaemias

4789

18817

2.73

307.65

2.8

2.2

0.19

0.20

g/l

19.29

4395

17452

Persons encountering health services for other counselling and medical advice, not elsewhere classified

9602

27615

1.97

307.65

2.6

2.3

0.21

g/l

0.24

9050

25711

Persons encountering health services in other circumstances, wide

9945

27712

1.97

307.65

2.6

2.3

0.21

g/l

0.19

9308

25785

Autoimmune hepatitis, wide definition

830

1543

8.53

307.65

5.4

2.1

0.20

0.22

g/l

7.99

792

1469

Asthma, unspecified (mode)

4410

15845

2.16

307.65

2.3

2.2

0.21

0.22

g/l

6.48

4131

14824

Nonalcoholic fatty liver disease

1851

3837

7.48

307.65

2.7

2.4

0.23

0.22

g/l

18.20

1737

3611

Alcohol use disorder, ICD-based

4246

17764

2.71

307.65

2.6

2.4

0.20

0.21

g/l

23.45

3830

16650

Endocrine, nutritional and metabolic diseases

5962

15154

2.10

307.65

2.6

2.4

0.22

g/l

0.38

5574

14275

Persons encountering health services in other circumstances

3381

16863

2.14

307.65

2.7

2.3

0.21

g/l

2.03

3116

15750

Hypokalaemia

1395

4740

3.56

307.65

3.1

2.2

0.20

g/l

3.17

1270

4446

Examination and observation for other reasons

5209

13434

2.37

307.65

3.0

2.0

0.22

0.21

g/l

1.91

4898

12509

Diseases of arteries, arterioles and capillaries (FINNGEN)

2287

5462

3.29

307.65

2.5

2.2

0.21

0.22

g/l

16.43

2121

5138

Other medical care

6178

17948

3.43

307.65

2.6

2.2

0.19

0.21

g/l

116.12

5785

16632

Any gastric operation

7607

8402

5.09

307.65

2.8

1.6

0.21

0.23

g/l

46.24

7179

7613

Other disorders of skin and subcutaneous tissue

6383

30383

1.91

307.65

2.5

2.3

0.20

0.21

g/l

15.07

5907

28298

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5981

27971

2.32

307.65

2.8

2.2

0.21

g/l

3.18

5642

25994

Exposure to unspecified factor

8245

34590

1.71

307.65

2.5

2.4

0.21

g/l

0.11

7588

32378

Obesity and other hyperalimentation

5626

27283

2.10

307.65

2.3

2.4

0.22

g/l

0.33

5259

25594

Type 2 diabetes, wide definition

6897

22715

2.07

307.65

2.4

2.2

0.21

g/l

2.54

6368

21184

Fall on same level

8860

29645

1.67

307.65

2.5

2.4

0.21

0.22

g/l

12.02

8158

27879

Benign neoplasm of colon, rectum, anus and anal canal

5595

26977

1.89

307.65

2.7

2.2

0.21

g/l

11.18

5261

25000

Adenocarcinoma and ductal carcinoma of pancreas

577

1039

8.45

307.65

4.0

2.0

0.18

0.20

g/l

3.30

555

953

Transplanted organ and tissue status

1330

3519

5.03

307.65

6.7

2.4

0.22

0.21

g/l

2.40

1292

3304

Malignant neoplasm of pancreas, including Hilmo

1314

2571

7.21

307.65

3.6

2.0

0.19

0.20

g/l

3.79

1252

2337

Adenocarcinoma and papilloma adenocarcinoma of rectum

1422

2914

6.76

307.65

2.3

2.0

0.21

0.20

g/l

10.36

1391

2655

Used for control exclusion in common control thyroid runs

8354

24557

1.81

307.65

2.8

2.2

0.21

g/l

0.35

7816

22890

Psychiatric diseases

7377

22446

1.73

307.65

2.4

2.3

0.21

g/l

0.41

6813

21166

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1481

3042

6.75

307.65

2.3

2.0

0.21

0.20

g/l

9.08

1447

2771

Type 2 diabetes, definitions combined, including avohilmo

7426

25754

1.76

307.65

2.4

2.2

0.22

0.21

g/l

1.98

6885

24105

Mental and behavioural disorders due to psychoactive substance use

5975

24244

2.51

307.65

2.6

2.4

0.20

0.22

g/l

26.68

5412

22757

Asthma, unspecified (mode), excluding more controls

4249

14416

2.27

307.65

2.3

0.21

0.22

g/l

10.83

3986

13527

Solid cancers, including Hilmo

8466

18925

2.91

307.65

2.5

2.2

0.22

0.21

g/l

1.41

8101

17405

Malignant neoplasm of stomach, including Hilmo

866

1663

7.21

307.65

3.3

2.0

0.20

0.19

g/l

1.27

835

1501

Hypo-osmolality and hyponatraemia

1997

7319

3.21

307.65

2.8

2.2

0.19

0.20

g/l

12.08

1827

6812

Obesity due to excess calories

4336

20616

2.32

307.65

2.3

2.4

0.22

g/l

0.19

4044

19350

Obesity, other/unspecified

3043

13521

2.50

307.65

2.4

0.21

0.22

g/l

2.32

2869

12697

Alcohol dependence

2617

10741

2.78

307.65

2.6

2.4

0.20

0.21

g/l

15.09

2353

10092

Complications of procedures, not elsewhere classified

8025

30280

2.35

307.65

2.7

2.2

0.21

g/l

5.55

7560

28154

GASTRO-related operations

7607

8402

5.09

307.65

2.8

1.6

0.21

0.23

g/l

46.24

7179

7613

Depression

7640

30808

1.75

307.65

2.5

2.3

0.22

0.21

g/l

9.84

7011

28958

Cirrhosis of liver, NAS

1466

2066

19.35

307.65

5.3

2.1

0.16

0.21

g/l

100.71

1346

1933

Primary biliary cholangitis (PBC)

549

703

19.68

307.65

5.5

2.0

0.20

0.22

g/l

3.46

528

669

Other and unspecified iron deficiency

3735

15042

2.85

307.65

2.9

2.2

0.20

0.21

g/l

11.98

3443

13995

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2406

4657

2.75

307.65

2.5

2.0

0.22

0.23

g/l

5.11

2265

4364

Unspecified jaundice

781

1570

7.14

307.65

4.8

1.9

0.17

0.21

g/l

29.19

715

1457

Ascites

1518

2612

9.83

307.65

4.4

2.0

0.15

0.21

g/l

121.94

1371

2430

Nausea and vomiting

2870

10020

3.20

307.65

3.0

2.1

0.20

0.21

g/l

5.53

2659

9275

Abdominal and pelvic pain

8034

21266

2.02

307.65

2.7

2.1

0.21

0.22

g/l

3.78

7548

19777

L04AD Calcineurin inhibitors

1484

4088

4.84

307.65

6.3

2.4

0.22

g/l

2.76

1445

3833

Oxycodone

5345

13940

3.99

307.65

2.8

2.1

0.20

0.21

g/l

24.76

5031

12904

L04AA Selective immunosuppressants

2169

9220

2.69

307.65

4.6

2.3

0.22

0.21

g/l

3.74

2091

8650

Other diseases of liver

3340

6702

7.45

307.65

3.5

2.0

0.22

g/l

1.07

3102

6303

Budesonide

1581

5157

3.66

307.65

4.3

2.2

0.23

0.21

g/l

14.14

1499

4818

Azathioprine

1665

5248

3.82

307.65

4.5

2.2

0.23

0.21

g/l

16.11

1601

4908

Parasetamol

5292

14196

1.98

307.65

2.4

2.6

0.22

0.21

g/l

1.55

4954

13186

Tramadol

7654

19001

2.67

307.65

2.8

2.1

0.21

g/l

0.70

7148

17684

Codeine

7191

20064

2.06

307.65

2.2

0.22

g/l

1.20

6727

18685

Insulin, intermediate and long-acting

4723

25318

1.95

307.65

2.8

2.3

0.19

0.21

g/l

40.85

4368

23577

Oral corticosteroids

9316

29125

2.01

307.65

2.7

2.2

0.21

g/l

1.62

8763

27084

Hypothyroidism (congenital or acquired)

1594

2033

4.74

307.65

2.6

2.3

0.23

g/l

3.52

1486

1933

Covid-19 confirmed case

3511

17076

2.28

307.65

2.6

2.2

0.20

0.21

g/l

3.12

3269

15870

Oedema, not elsewhere classified

3336

12798

2.89

307.65

2.6

2.1

0.20

0.21

g/l

21.93

3069

11965

Personality disorders, excluding more controls

2000

7931

2.76

307.65

2.4

0.22

g/l

0.11

1829

7544

Type 2 diabetes, definitions combined

7482

25784

1.78

307.65

2.4

2.2

0.22

0.21

g/l

1.43

6944

24124

Benzodiazepine use

8489

33202

1.83

307.65

2.4

2.3

0.21

g/l

0.39

7811

31060

5-aminosalicylic acid

2019

7807

2.93

307.65

3.7

2.2

0.23

0.22

g/l

14.97

1919

7291

Chronic pancreatitis

2013

4428

6.57

307.65

4.0

2.1

0.19

0.21

g/l

19.49

1911

4104

Chronic hepatitis, not elsewhere classified

757

1034

15.00

307.65

6.0

2.0

0.21

0.22

g/l

2.14

718

974

Alcoholic liver disease

1969

3472

9.51

307.65

4.6

2.0

0.16

0.21

g/l

119.07

1761

3247

Hypertension

6042

18666

1.94

307.65

2.4

0.22

g/l

1.67

5678

17543

Fibrosis and cirrhosis of liver

2074

2795

18.61

307.65

5.3

2.0

0.17

0.21

g/l

78.56

1929

2616

Hepatic failure, not elsewhere classified

786

1219

12.43

307.65

5.9

2.0

0.16

0.21

g/l

47.08

709

1134

Acute pancreatitis (for exclusion)

2293

8430

3.26

307.65

3.7

2.2

0.19

0.21

g/l

12.04

2190

7839

Inflammatory bowel disease, strict (require KELA)

2228

8949

2.83

307.65

3.7

2.4

0.23

0.22

g/l

19.36

2127

8375

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8097

23701

2.16

307.65

2.5

2.3

0.20

0.22

g/l

36.46

7525

22166

Other diseases of biliary tract

1487

3144

7.02

307.65

5.4

1.9

0.19

0.21

g/l

19.39

1421

2895

Substance abuse, excluding more controls

5809

19303

2.83

307.65

2.6

2.3

0.20

0.21

g/l

19.86

5260

18216

Paralytic ileus and intestinal obstruction

2879

10763

3.11

307.65

3.0

2.1

0.20

g/l

3.03

2705

9954

Diseases of liver

7278

14113

8.02

307.65

4.0

2.0

0.20

0.21

g/l

60.35

6711

13225

Oesophageal varices

1020

1496

16.30

307.65

6.6

2.2

0.15

0.21

g/l

90.46

935

1406

Other antidepressants

8289

24223

1.85

307.65

2.3

0.22

0.21

g/l

10.27

7598

22776

Primary biliary cholangitis, wide definition

627

740

24.69

307.65

6.8

2.1

0.20

0.21

g/l

5.39

604

703

Colectomy operation

2187

7100

3.92

307.65

2.8

2.2

0.21

0.20

g/l

3.30

2109

6591

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

7583

26329

1.81

307.65

2.5

2.3

0.21

g/l

3.96

7026

24660

Hypothyroidism, levothyroxine purchases

1573

2018

4.72

307.65

2.6

2.3

0.22

0.23

g/l

3.84

1466

1918

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2194

8641

2.75

307.65

2.5

2.4

0.22

g/l

1.83

2018

8209

KRA_PSY_EATING, excluding more controls

934

1567

7.27

307.65

3.1

2.6

0.23

g/l

0.65

861

1498

Opioids

8040

20357

2.18

307.65

2.5

2.2

0.21

0.22

g/l

1.86

7542

18958

Nephropathy related operations

1483

4818

3.90

307.65

4.7

2.4

0.21

g/l

0.59

1413

4497

ILD medications: immunosuppressive drugs

6146

25792

2.37

307.65

3.6

2.1

0.22

0.21

g/l

12.21

5864

24059

Ulcer of lower limb, not elsewhere classified

1857

6067

3.85

307.65

2.3

2.2

0.19

0.20

g/l

8.20

1711

5642

Colon adenocarcinoma, helper endpoint

1517

5404

3.46

307.65

2.6

2.2

0.20

g/l

0.65

1466

5001

Infections, IBD-co-morbidities

1613

3254

4.01

307.65

3.5

2.4

0.21

g/l

2.76

1511

3086

ILD medications: azathioprine

1665

5127

3.91

307.65

4.5

2.1

0.23

0.21

g/l

15.98

1601

4792

Cardiovascular diseases

4141

10648

2.18

307.65

2.8

2.4

0.22

0.23

g/l

3.79

3916

10072

All-cause Heart Failure

5440

19218

2.18

307.65

2.3

0.18

0.21

g/l

84.55

4977

17901

Insulin, combination of fast acting with intermediate-acting or long-acting

5184

26886

1.88

307.65

2.9

2.3

0.19

0.21

g/l

42.37

4800

25012

Acute pancreatitis

2293

7319

3.80

307.65

3.7

2.0

0.19

0.21

g/l

14.37

2190

6757

All chronic kidney diseases

5492

19834

2.46

307.65

2.7

2.2

0.21

g/l

3.41

5093

18467

Acute tubulo-interstitial nephritis

5455

24089

2.07

307.65

2.5

2.2

0.20

0.21

g/l

30.74

5063

22480

Inflammatory bowel disease treatment related agents

10139

29738

2.03

307.65

2.9

2.2

0.22

0.21

g/l

4.60

9565

27659

Heart failure and antihypertensive medication

2613

5492

3.61

307.65

2.6

2.3

0.19

0.21

g/l

34.29

2423

5149

Malignant neoplasm of head and neck, including Hilmo

1412

2915

6.63

307.65

2.5

2.0

0.22

0.20

g/l

19.58

1373

2659

Other diseases of pancreas

1319

3014

6.32

307.65

3.5

2.0

0.22

0.21

g/l

3.52

1272

2799

ILD medications: prednisolone, methylprednisolone, prednisone

9735

27742

2.10

307.65

3.0

2.1

0.22

0.21

g/l

4.69

9182

25779

Substance abuse

5809

23854

2.52

307.65

2.6

2.4

0.20

0.22

g/l

26.45

5260

22392

Malignant neoplasm of rectum, including Hilmo

1755

3686

6.53

307.65

2.3

2.0

0.21

0.20

g/l

11.73

1701

3357

Pneumonia, organism unspecified

8543

29313

2.17

307.65

2.5

2.3

0.20

0.22

g/l

56.01

7937

27463

Other diseases of the digestive system

3378

14260

2.71

307.65

3.3

2.1

0.19

0.20

g/l

21.24

3113

13215

Autoimmune diseases related-to ILD

7400

33796

1.96

307.65

2.9

2.2

0.22

0.21

g/l

8.67

6965

31474

GI-bleeding

3313

14261

2.64

307.65

3.3

2.1

0.19

0.20

g/l

22.66

3047

13210

Dental caries

3013

9536

3.53

307.65

3.9

2.3

0.21

g/l

0.08

2851

8936

Insulin medication

5182

23122

2.01

307.65

2.9

2.3

0.19

0.21

g/l

39.28

4798

21577

Caries of dentine

2700

8502

3.65

307.65

3.8

2.3

0.21

g/l

0.35

2559

7965

ILD medications

10011

28087

2.06

307.65

3.0

2.1

0.22

0.21

g/l

6.84

9462

26098

Chronic kidney disease

3210

13651

2.56

307.65

2.7

2.1

0.21

0.20

g/l

6.21

2958

12600

Colitis, primary sclerosing

395

417

30.79

307.65

7.2

2.3

0.21

0.23

g/l

2.73

390

392

Other inflammatory liver diseases

1074

2207

7.32

307.65

5.1

1.9

0.20

0.22

g/l

13.47

1026

2070

Gastrointestinal diseases

4518

7915

3.08

307.65

2.8

1.6

0.22

g/l

5.49

4252

7326

Diabetes, insulin treatment (Kela reimbursement)

8063

29421

1.72

307.65

2.5

2.3

0.21

g/l

4.30

7472

27510

Ulcerative colitis

2286

9674

2.66

307.65

3.7

2.3

0.23

0.21

g/l

11.91

2164

9047

Other or unspecified ileus, impaction or obstruction

2091

7344

3.37

307.65

3.1

2.1

0.20

g/l

2.15

1965

6782

Primary Sclerosing Cholangitis, IBD and UDCA required

647

572

38.88

307.65

8.1

2.1

0.21

0.22

g/l

2.16

638

537

Intestinal stricture

3497

13928

2.94

307.65

3.1

2.2

0.20

0.21

g/l

3.63

3293

12921

Mood disorders

8198

31985

1.73

307.65

2.5

2.3

0.22

0.21

g/l

12.39

7509

30024

Injuries to the head

8643

33364

1.61

305.11

2.4

0.21

g/l

9.25

7908

31293

Anxiety (asthma-related co-morbidities)

4467

18820

1.91

303.51

2.6

2.4

0.22

g/l

2.91

4131

17821

Codes for special purposes

4416

24669

1.90

302.41

2.5

2.3

0.21

g/l

1.82

4113

22982

malignant neoplasm of female genital organs

1379

4748

3.29

302.25

1.9

2.0

0.21

g/l

2.86

1311

4324

Other (not insulin) diabetes medications

7484

27710

1.66

301.88

2.4

2.2

0.21

g/l

1.28

6945

25901

Other soft tissue disorders, not elsewhere classified

7256

25793

1.68

301.74

2.4

0.22

0.21

g/l

5.04

6743

24090

Provisional assignment of new diseases of uncertain etiology

4409

24650

1.90

301.20

2.5

2.3

0.21

g/l

1.82

4107

22963

Eating disorders

1021

3009

3.97

300.98

3.1

2.5

0.23

0.22

g/l

1.11

940

2826

Malignant neoplasm of tongue, including Hilmo

450

709

10.52

300.84

2.5

2.0

0.23

0.20

g/l

7.53

437

651

Personal history of malignant neoplasm

1024

3103

4.14

298.41

1.7

2.2

0.24

0.21

g/l

39.64

1011

2914

Pain in limb

6510

25394

1.72

298.18

2.3

2.4

0.21

g/l

1.99

6032

23712

COPD/asthma/ILD related infections

7537

23701

1.67

297.89

2.5

2.3

0.21

0.22

g/l

16.36

7022

22166

COPD/asthma related infections

7537

23701

1.67

297.89

2.5

2.3

0.21

0.22

g/l

16.36

7022

22166

Heart failure and bmi 25plus

3140

10427

2.23

296.53

2.3

0.19

0.21

g/l

53.70

2885

9723

Non-ischemic cardiomyopathy

2923

11421

2.26

294.97

2.3

0.18

0.21

g/l

50.36

2672

10640

Other pulmonary diagnosis

5687

16659

1.79

293.17

2.5

2.3

0.21

0.22

g/l

8.83

5317

15596

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

7483

30180

1.65

292.81

2.9

2.2

0.20

0.21

g/l

50.98

6947

28178

Excluding asthma or asthma-COPD overlap

5680

16659

1.79

291.53

2.5

2.3

0.21

0.22

g/l

8.33

5312

15596

Benign neoplasm: Colon

4690

25559

1.86

290.59

2.7

2.2

0.21

0.20

g/l

10.23

4414

23686

Diverticular disease of intestine

5598

20708

1.78

290.48

2.4

2.2

0.21

g/l

2.99

5207

19253

Syncope and collapse

3537

15545

2.03

289.02

2.4

2.2

0.20

0.21

g/l

9.86

3240

14511

Pain, not elsewhere classified

2312

10553

2.39

288.98

2.6

2.2

0.22

g/l

0.27

2158

9908

Antihypertensive medication - note that there are other indications

4003

11032

1.99

287.98

2.7

2.5

0.22

g/l

0.94

3771

10414

Iron deficiency anaemia secondary to blood loss (chronic)

1639

6526

2.91

287.38

3.2

2.1

0.19

0.20

g/l

15.19

1523

6062

Second line medication for Crohn's disease

4683

27250

1.84

286.35

3.1

2.3

0.22

0.21

g/l

11.90

4446

25492

Other diseases of pleura

3910

18727

1.97

285.52

2.6

2.2

0.19

0.20

g/l

31.93

3611

17361

Poisoning by drugs, medicaments and biological substances

2033

8881

2.54

285.00

2.6

2.4

0.21

0.22

g/l

2.49

1860

8343

Dysphagia

2166

9748

2.46

282.87

2.4

2.0

0.21

g/l

0.62

2006

9053

Alcohol abuse, main dg, excluding more controls

1359

4933

3.15

281.38

2.5

0.20

0.22

g/l

5.85

1241

4658

Asthma (only as main-diagnosis), excluding more controls

4797

15032

1.85

281.11

2.3

0.22

g/l

1.85

4512

14110

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4648

21116

1.86

281.06

2.5

2.2

0.20

0.21

g/l

0.34

4282

19641

Malignant neoplasm of tongue

376

533

12.85

279.42

2.5

2.0

0.23

0.20

g/l

6.90

363

489

Care involving use of rehabilitation procedures

4786

25193

1.81

278.98

2.5

2.3

0.22

g/l

0.62

4469

23472

Other gastritis (incl. Duodenitis)

2052

9134

2.53

278.29

3.1

2.1

0.20

0.21

g/l

1.77

1916

8499

COPD differential diagnosis

5629

16708

1.77

276.90

2.5

2.3

0.21

0.22

g/l

8.86

5260

15642

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

7784

32544

1.60

276.65

2.6

2.3

0.21

g/l

2.66

7272

30344

ILD differential diagnosis

5625

16705

1.77

276.10

2.5

2.3

0.21

0.22

g/l

8.92

5256

15639

Continuous positive airway pressure

1557

4976

2.90

275.36

2.5

2.4

0.21

0.22

g/l

4.86

1444

4725

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1340

4891

3.14

275.34

2.5

2.1

0.20

g/l

1.99

1270

4474

Liquid cancers

2220

9589

2.40

275.03

2.4

2.1

0.20

g/l

4.37

2048

8734

Asthma (mode)

5401

16705

1.78

274.63

2.3

0.22

g/l

0.15

5089

15639

Diseases of the skin and subcutaneous tissue

7288

23211

1.64

274.62

2.5

2.3

0.21

g/l

3.21

6802

21632

Anxiety disorders

6784

29717

1.64

268.04

2.6

2.3

0.22

0.21

g/l

13.68

6282

27892

Neurotic, stress-related and somatoform disorders

6718

29488

1.65

268.02

2.6

2.3

0.22

0.21

g/l

13.30

6225

27679

COPD (mode)

2603

9850

2.26

267.96

2.2

0.20

0.21

g/l

13.36

2375

9189

Volume depletion

1082

3598

3.61

267.50

3.0

2.2

0.19

0.20

g/l

1.81

989

3349

Selective serotonin reuptake inhibitors

7321

24402

1.63

266.79

2.4

0.22

0.21

g/l

7.93

6724

22954

Autoimmune hepatitis

264

267

34.59

266.46

7.1

2.1

0.20

0.22

g/l

1.88

256

253

Osteoporosis

2498

11218

2.29

265.35

2.8

2.1

0.20

g/l

6.32

2297

10421

Ulcerative colitis, NAS

1352

5078

3.08

265.08

4.2

2.3

0.22

0.21

g/l

4.23

1285

4757

Pain in throat and chest

6214

22872

1.68

264.55

2.4

0.22

0.21

g/l

0.19

5784

21418

Other CVD (FINNGEN)

1127

2809

3.56

264.13

2.3

0.19

0.21

g/l

10.65

1031

2648

Symptoms and signs concerning food and fluid intake

1123

3818

3.46

264.11

2.6

2.2

0.21

g/l

1.73

1028

3592

Missing teeth due to accident, extraction or parodontitis

5138

27933

1.76

263.75

2.5

2.3

0.21

g/l

0.46

4771

26043

Other reaction to severe stress, and adjustment disorders

2771

14025

2.12

261.90

2.9

2.4

0.22

g/l

0.06

2588

13236

Poisoning by medicine

1840

8024

2.55

259.28

2.5

2.4

0.21

0.22

g/l

2.29

1685

7548

Malignant neoplasm of oesophagus, including Hilmo

500

990

7.15

259.17

2.9

2.0

0.19

0.20

g/l

0.86

480

902

Total colectomy operation

608

1436

6.05

258.43

3.6

2.4

0.23

0.22

g/l

2.23

586

1347

Total colectomy

608

1436

6.05

258.43

3.6

2.4

0.23

0.22

g/l

2.23

586

1347

Headache

4595

20816

1.79

256.75

2.4

2.2

0.22

g/l

2.57

4271

19543

Decubitus ulcer and pressure area

813

2370

4.45

254.08

2.5

2.1

0.17

0.20

g/l

15.59

746

2194

Biguanides

7211

28390

1.60

253.69

2.3

0.21

g/l

2.73

6680

26518

Other noninfective gastroenteritis and colitis

2181

10325

2.34

252.10

3.2

2.3

0.21

g/l

1.44

2044

9613

Recurrent or chronic depression

2929

10375

2.09

250.67

2.5

2.4

0.22

g/l

5.10

2691

9879

Gastric ulcer

1661

7101

2.65

247.66

3.1

2.0

0.19

0.20

g/l

9.01

1537

6565

Other anxiety disorders

3434

16032

1.93

246.66

2.5

2.4

0.23

0.22

g/l

4.42

3186

15091

Other Crohn's disease

767

2170

4.37

245.87

4.2

2.3

0.24

0.22

g/l

5.47

735

2036

Concussion

3810

16674

1.87

244.54

2.4

2.5

0.21

g/l

3.17

3491

15681

Asthma (only as main-diagnosis)

4956

16514

1.76

244.36

2.3

0.22

g/l

0.41

4660

15460

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1482

6064

2.78

242.97

3.6

2.4

0.23

0.22

g/l

9.93

1409

5690

Other disorders of urethra and urinary system

5344

23014

1.70

241.21

2.4

2.3

0.21

g/l

1.60

4941

21506

L04AX Other immunosuppressants

4428

26616

1.77

240.51

3.1

2.3

0.22

0.21

g/l

8.69

4200

24901

All anxiety disorders

4548

21063

1.76

240.20

2.6

2.4

0.22

g/l

5.48

4206

19815

Other diseases of intestine

1497

6209

2.76

239.63

3.3

2.1

0.21

g/l

0.05

1409

5780

Gout

2489

10740

2.19

239.22

2.4

2.3

0.20

g/l

1.79

2293

9961

Ulcerative colitis (strict definition, require KELA)

1507

6259

2.73

238.99

3.6

2.4

0.23

0.22

g/l

10.57

1428

5870

Heart failure and coronary heart disease

3670

14537

1.92

237.81

2.2

2.3

0.19

0.20

g/l

29.00

3360

13445

Symptoms and signs involving cognition, perception, emotional state and behaviour

7273

32360

1.57

236.56

2.3

2.4

0.21

g/l

4.95

6691

30297

Explicit bacterial Sepsis, including avohilmo

1085

3865

3.28

235.32

3.1

2.1

0.18

0.21

g/l

22.86

1009

3612

Disorders of lipoprotein metabolism and other lipidaemias

6121

23843

1.64

233.28

2.1

2.3

0.22

0.21

g/l

9.73

5676

22290

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1582

6803

2.62

231.90

3.6

2.4

0.23

0.22

g/l

12.99

1501

6381

Pain (limb, back, neck, head abdominally)

5126

15568

1.72

231.20

2.5

2.3

0.21

g/l

0.97

4785

14514

Other special examinations and investigations of persons without complaint or reported diagnosis

4536

13503

1.78

229.59

2.6

2.0

0.21

g/l

0.11

4253

12563

Factors influencing health status and contact with health services

1985

4334

2.43

229.35

2.4

1.9

0.21

0.22

g/l

2.05

1843

4000

Benign neoplasms

7004

25095

1.58

228.76

2.6

2.3

0.22

0.21

g/l

11.19

6596

23290

Other symptoms and signs involving the digestive system and abdomen

1468

6138

2.67

227.45

2.7

1.9

0.21

g/l

1.67

1378

5730

Low back pain

5853

25317

1.63

226.84

2.4

0.21

g/l

1.53

5437

23668

Acute alcohol intoxication, ICD10

1766

8033

2.45

226.78

2.5

0.20

0.22

g/l

9.53

1604

7556

Falls/tendency to fall

7615

25533

1.55

226.13

2.5

2.4

0.21

0.22

g/l

8.69

7051

24032

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1408

5806

2.73

225.58

2.6

2.4

0.21

0.22

g/l

4.35

1289

5457

Exclusions for E4_PCOS_CONSORTIUM

5185

20117

1.69

225.16

2.5

2.3

0.22

g/l

0.94

4853

18819

Haemorrhage from respiratory passages

2930

14047

1.99

224.77

2.6

2.3

0.20

0.21

g/l

5.52

2677

13084

Persons encountering health services for specific procedures, not carried out

881

2864

3.64

224.56

2.9

2.3

0.21

0.22

g/l

2.36

803

2701

Insulin, fast-acting

2912

15861

1.99

224.26

3.0

2.3

0.19

0.21

g/l

49.43

2695

14823

Streptococcal septicaemia, including avohilmo

953

3262

3.48

223.88

3.0

2.2

0.18

0.21

g/l

23.16

883

3050

Explicit bacterial Sepsis

1050

3775

3.24

223.80

3.0

2.1

0.18

0.21

g/l

22.14

975

3524

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

347

571

9.81

222.11

2.3

2.0

0.23

0.20

g/l

6.55

338

528

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

348

573

9.63

221.95

5.4

2.0

0.17

0.20

g/l

6.91

331

526

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2194

10900

2.18

220.06

2.5

2.4

0.22

g/l

1.99

2018

10248

Care involving dialysis

830

2660

3.80

219.42

3.0

2.3

0.22

0.21

g/l

1.06

783

2498

Suicide or other Intentional self-harm

1956

9353

2.29

219.31

2.5

2.4

0.21

0.22

g/l

2.36

1791

8769

Pure hypercholesterolaemia

5608

22740

1.64

219.15

2.1

2.3

0.22

0.21

g/l

6.57

5214

21236

Cutaneous abscess, furuncle and carbuncle

2179

10865

2.19

218.73

2.8

2.4

0.20

0.22

g/l

8.59

2028

10176

Crohn's disease NAS

711

2078

4.23

217.63

4.6

2.3

0.23

0.22

g/l

4.80

675

1949

Fentanyl

1007

3579

3.24

217.11

3.2

2.0

0.19

0.20

g/l

2.47

951

3301

Abnormal findings on diagnostic imaging of lung

3932

22303

1.79

217.00

2.4

2.2

0.20

0.21

g/l

1.35

3673

20689

Symptoms and signs involving the urinary system

5861

28837

1.61

215.90

2.5

2.3

0.21

g/l

3.95

5388

26916

Adenocarcinoma and papillary adenocarcinoma of stomach

393

734

7.38

215.45

3.4

2.0

0.20

0.19

g/l

0.59

382

663

Chronic apical periodontitis

8106

31303

1.51

215.28

2.4

2.3

0.21

g/l

0.04

7552

29214

Hernia

6905

30821

1.55

215.28

2.6

2.3

0.21

g/l

0.15

6475

28722

Acute alcohol intoxication

2076

10230

2.22

214.92

2.5

2.4

0.20

0.21

g/l

6.54

1887

9601

Adenocarcinoma of pancreas

414

825

7.15

213.55

3.8

1.9

0.18

0.20

g/l

3.27

396

757

Streptococcal septicaemia

921

3184

3.44

212.49

3.0

2.1

0.18

0.21

g/l

22.48

852

2982

Malignant neoplasm of oesophagus

385

723

7.75

212.36

3.1

2.1

0.19

0.20

g/l

1.25

368

661

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

980

2308

3.39

212.05

2.4

2.3

0.21

g/l

0.21

917

2182

Intestinal adhesions without obstruction

912

3152

3.47

211.44

3.2

2.1

0.20

0.21

g/l

1.92

864

2927

Peripheral artery disease

3529

16199

1.85

211.44

2.2

0.19

0.20

g/l

5.44

3230

14987

Abnormal results of function studies

950

3362

3.39

211.38

3.1

2.4

0.21

g/l

0.06

867

3144

Ventral hernia

2095

10495

2.21

209.86

3.0

2.2

0.21

g/l

2.00

1998

9768

Early onset COPD, excluding more controls

1637

7418

2.43

209.57

2.4

2.2

0.21

g/l

2.46

1501

6944

Secondary uncertain malignant neoplasm

1083

4075

3.00

208.73

2.2

2.1

0.18

0.20

g/l

14.53

1014

3698

Implicit fungal Sepsis, including avohilmo

793

2560

3.80

207.91

3.1

2.0

0.20

0.21

g/l

1.91

732

2404

Symptoms and signs involving the circulatory and respiratory systems

6934

23245

1.55

205.96

2.5

2.4

0.22

0.21

g/l

0.16

6459

21772

Hernia of abdominal wall

3632

21641

1.80

205.87

2.9

2.3

0.21

g/l

0.84

3432

20170

Pulmonary heart disease, diseases of pulmonary circulation

2667

14578

1.99

204.90

2.5

2.2

0.20

g/l

4.46

2484

13512

Problems related to lifestyle

950

3378

3.22

204.57

2.5

2.3

0.21

0.22

g/l

3.88

852

3169

Gout, FINNGEN

2489

13252

2.04

203.90

2.4

2.2

0.20

g/l

2.25

2293

12249

Malignant neoplasm of other and unspecified parts of tongue

274

388

12.79

203.77

2.4

2.1

0.23

0.20

g/l

5.23

265

353

Asthma, hospital admission 2, infections

4540

27839

1.67

203.53

2.5

2.4

0.21

g/l

0.10

4247

25916

Asthma-related infections

4540

27839

1.67

203.53

2.5

2.4

0.21

g/l

0.10

4247

25916

Disorders of adult personality and behaviour

2101

10582

2.14

202.82

2.5

2.4

0.22

g/l

0.21

1917

9964

Other diseases of urinary system

7161

27339

1.53

202.71

2.4

0.21

g/l

1.06

6642

25572

Cholecystitis

1240

5084

2.76

201.88

3.1

1.9

0.18

0.20

g/l

20.34

1167

4661

Chronic gastritis

2224

11521

2.11

201.13

2.8

2.0

0.20

g/l

0.16

2015

10694

Personality disorders

2000

9948

2.18

200.19

2.4

0.22

g/l

0.45

1829

9363

Other bacterial intestinal infections

1614

7452

2.42

200.15

3.1

2.2

0.20

g/l

0.74

1493

6930

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1347

5790

2.66

199.84

2.8

2.2

0.20

0.21

g/l

5.49

1258

5407

Other diseases of blood and blood-forming organs, wide

1927

9553

2.25

199.76

2.8

2.3

0.20

0.21

g/l

3.23

1805

8918

Asthma, hospital admissions 3, pneumonia

2972

16808

1.89

199.73

2.4

2.3

0.21

g/l

0.05

2769

15573

Asthma-related pneumonia or sepsis

2972

16808

1.89

199.73

2.4

2.3

0.21

g/l

0.05

2769

15573

Asthma-related pneumonia

2967

16780

1.89

199.42

2.4

2.3

0.21

g/l

0.04

2766

15547

Disorders of mineral metabolism

902

3215

3.36

198.04

3.3

2.3

0.20

0.21

g/l

0.30

844

3022

Insulin, fast-acting or short human

2925

16567

1.90

197.98

3.0

2.4

0.19

0.21

g/l

46.53

2706

15481

External causes of morbidity and mortality

4427

13477

1.72

197.65

2.4

2.3

0.21

0.22

g/l

3.93

4121

12685

Coagulation defects, purpura and other haemorrhagic conditions

1698

8053

2.35

197.09

3.1

2.3

0.20

0.21

g/l

6.57

1598

7525

Sequelae of external causes of morbidity and mortality

2207

11518

2.11

196.52

2.6

2.3

0.20

0.21

g/l

1.03

2081

10741

Vocal cord dysfunction

1016

3279

2.99

196.38

2.4

2.2

0.21

0.22

g/l

3.43

966

3127

Anorexia (incl.atypical)

585

1588

4.40

196.22

3.7

2.7

0.23

0.22

g/l

1.88

541

1483

Reimbursement for rheumatic diseases

4304

26867

1.68

195.94

3.3

2.2

0.21

g/l

0.98

4070

25046

Abnormal serum enzyme levels

2579

13686

1.99

194.83

2.8

2.4

0.21

0.20

g/l

10.59

2433

12717

Chronic ulcer of skin, not elsewhere classified

788

2646

3.69

194.62

2.7

2.1

0.19

0.21

g/l

4.55

738

2464

Venous thromboembolism

4205

25390

1.69

192.78

2.5

2.2

0.20

0.21

g/l

4.82

3910

23556

Open wound of head

4239

24983

1.68

191.42

2.4

0.20

0.21

g/l

13.19

3852

23364

Amputation

1024

3968

3.03

191.00

2.3

2.2

0.18

0.20

g/l

9.60

935

3676

Alcohol-induced chronic pancreatitis

721

2335

3.90

190.35

3.3

2.4

0.19

0.21

g/l

12.25

672

2182

Intracranial injury

4427

26200

1.65

188.97

2.4

0.21

g/l

3.78

4042

24509

Hard cardiovascular diseases

6127

24303

1.56

188.74

2.5

2.4

0.21

g/l

5.71

5709

22762

Gout, idiopatic and unspecified

2149

11299

2.10

188.27

2.4

2.2

0.21

0.20

g/l

2.64

1981

10475

Alcohol withdrawal state with delirium

759

2550

3.71

187.78

2.8

2.4

0.18

0.21

g/l

16.45

672

2393

Periodontitis

7268

32259

1.49

187.50

2.4

2.3

0.21

g/l

0.91

6781

30096

Alcohol abuse, main dg

1359

6011

2.54

187.21

2.5

0.20

0.22

g/l

6.45

1241

5647

Persons encountering health services for examination and investigation

4380

13504

1.69

186.78

2.5

2.0

0.21

g/l

0.16

4109

12564

Chronic periodontitis, including avohilmo

7256

32260

1.49

186.69

2.4

2.3

0.21

g/l

0.86

6773

30096

Pain in joint

4036

15128

1.71

186.37

2.5

2.3

0.22

0.21

g/l

15.36

3759

14143

Valvular heart disease excluding rheumatic fever

3554

15192

1.78

185.65

2.4

0.19

0.21

g/l

46.08

3283

14230

Finngen Rheumatological endpoints

6698

26001

1.52

183.90

2.5

2.4

0.22

0.21

g/l

0.43

6246

24310

Other bacterial intestinal infections, including avohilmo

1945

9954

2.13

181.81

2.9

2.2

0.20

0.21

g/l

0.85

1796

9267

Obesity related asthma

2759

15769

1.88

181.79

2.2

2.4

0.22

0.21

g/l

3.47

2581

14774

Asthma (diagnoses ohter than nonallergic)

6380

35463

1.51

181.74

2.3

2.4

0.21

g/l

0.97

5989

33027

Non-rheumatic valve diseases

3515

15080

1.77

180.55

2.4

0.19

0.21

g/l

46.15

3247

14122

Crohn's disease of small intestine

697

2253

3.71

180.53

3.8

2.2

0.23

0.22

g/l

4.65

676

2109

1133

4680

2.69

179.62

2.9

2.2

0.22

g/l

0.69

1053

4376

Malignant neoplasm of tonsil and base of tongue, including Hilmo

338

659

7.51

179.61

3.0

2.1

0.23

0.20

g/l

8.77

328

606

Mental and behavioural disorders due to opioids

428

997

5.44

179.10

2.6

2.5

0.20

0.23

g/l

12.42

380

935

Cellulitis

1862

9453

2.16

178.71

2.6

2.4

0.20

0.21

g/l

4.93

1725

8840

Unspecified kidney failure

1029

4124

2.90

178.57

2.8

2.1

0.20

g/l

0.85

953

3796

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

647

2001

3.79

178.06

2.2

2.5

0.21

0.23

g/l

7.82

590

1883

Lower back pain or/and sciatica

7740

34165

1.46

177.54

2.3

0.21

g/l

2.10

7174

31894

Atherosclerosis, excluding cerebral and coronary sclerosis

3229

15116

1.80

176.28

2.2

0.19

0.20

g/l

3.16

2951

13964

DVT of lower extremities and pulmonary embolism

3274

19683

1.77

176.26

2.4

2.2

0.20

0.21

g/l

2.90

3041

18260

Hyperkalaemia

667

2147

3.82

175.95

3.0

2.2

0.19

0.20

g/l

2.53

609

2000

Gout, unspecified

1791

9066

2.20

175.81

2.4

2.2

0.21

0.20

g/l

1.90

1644

8404

Disorders of other endocrine glands

3332

19876

1.75

174.86

2.7

2.4

0.22

0.21

g/l

6.33

3110

18571

Neurological diseases, wide definition

1899

4578

2.19

174.31

2.4

2.7

0.22

g/l

1.62

1771

4342

Bacterial intestinal infections, IBD co-morbidities

1600

7792

2.28

173.31

3.1

2.2

0.20

g/l

0.99

1480

7251

STROKE

3976

16710

1.69

173.16

2.4

2.3

0.21

0.22

g/l

6.61

3714

15658

Specific personality disorders

1714

8507

2.18

172.72

2.5

2.4

0.22

g/l

0.02

1568

8009

Other diseases of anus and rectum

2343

12871

1.95

172.62

2.5

2.1

0.21

g/l

2.76

2167

11931

Other external causes of accidental injury

5515

18288

1.57

172.31

2.4

0.21

g/l

3.78

5091

17240

8092

29305

1.45

171.93

2.5

2.3

0.21

g/l

1.06

7518

27295

Chronic lower respiratory diseases

8523

32413

1.43

171.42

2.4

0.21

g/l

0.56

7959

30260

Noninfectious colitis NAS

1208

5280

2.58

171.25

3.4

2.2

0.21

g/l

0.37

1129

4927

Pulmonary embolism

2386

13317

1.94

171.25

2.4

2.2

0.20

g/l

2.59

2222

12347

Cystitis

5982

24213

1.53

170.86

2.4

2.3

0.21

g/l

0.19

5537

22629

Fungal Sepsis

519

1462

4.60

170.60

3.6

2.0

0.20

0.21

g/l

1.45

491

1384

Purpura and other haemorrhagic conditions

1229

5447

2.57

170.02

3.3

2.3

0.19

0.21

g/l

10.97

1154

5078

Invasive ventilation

775

2779

3.38

169.65

3.0

2.4

0.20

0.21

g/l

2.11

705

2592

Polyneuropathies and other disorders of the peripheral nervous system

1849

9573

2.14

169.51

2.8

2.3

0.20

g/l

0.14

1733

8912

Injuries to the abdomen, lower back, lumbar spine and pelvis

3143

18676

1.76

168.69

2.4

2.3

0.20

0.21

g/l

3.78

2869

17375

Pulmonary heart disease

2386

13384

1.93

168.46

2.4

2.2

0.20

g/l

2.39

2222

12404

Malignant neoplasm of small intestine, including Hilmo

372

825

6.08

168.09

3.3

2.1

0.21

0.20

g/l

1.68

360

762

Dorsalgia

6957

25802

1.48

166.96

2.4

0.22

0.21

g/l

4.80

6466

24116

Attention to artificial openings

493

1361

4.66

166.27

3.0

2.2

0.20

0.21

g/l

0.43

468

1271

Accidents

5477

18288

1.55

165.65

2.4

0.21

g/l

3.69

5064

17240

Diaphragmatic hernia

2834

16774

1.82

165.46

2.5

2.2

0.21

g/l

4.86

2642

15601

Sequelae with surgical and medical care as external cause

1734

8854

2.17

165.41

2.6

2.2

0.20

0.21

g/l

0.42

1629

8248

Other CVD

1740

8888

2.16

165.33

2.3

2.1

0.19

0.20

g/l

1.74

1575

8210

Medicines for HER+ breast cancer

2749

14986

1.84

165.14

1.8

2.2

0.22

0.21

g/l

26.33

2627

13938

Malnutrition

353

786

6.95

164.21

3.6

2.8

0.17

0.21

g/l

12.34

333

736

Malignant neoplasm of other and unspecified parts of biliary tract

250

401

9.86

163.40

5.3

1.9

0.17

0.20

g/l

6.58

237

367

Malignant neoplasm of tonsil and base of tongue

292

550

7.88

161.38

2.8

2.1

0.23

0.21

g/l

7.58

282

508

Crohn disease (strict definition, require KELA)

636

2085

3.64

160.94

4.0

2.4

0.24

0.22

g/l

4.12

618

1959

Crohn disease (strict definition, require KELA, min 2 HDR)

629

2053

3.67

160.40

4.1

2.4

0.24

0.22

g/l

4.04

611

1931

Malignant neoplasm of skin, including Hilmo

3271

13234

1.74

160.30

2.3

2.1

0.21

g/l

0.22

3043

12075

COPD

3504

17782

1.70

159.79

2.2

2.3

0.20

g/l

2.96

3204

16508

Emotionally unstable personality disorder

929

3716

2.77

157.34

2.5

0.23

g/l

0.16

856

3512

Gout, strict definition

1580

7977

2.21

156.59

2.3

2.2

0.21

0.20

g/l

2.66

1444

7397

Dermatitis

4627

30327

1.56

156.11

2.6

2.3

0.21

g/l

0.31

4331

28306

Immunodeficiencies

539

1648

4.15

156.08

4.3

2.5

0.23

0.21

g/l

4.93

514

1539

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

661

2254

3.47

156.06

4.0

2.4

0.24

0.22

g/l

4.45

643

2115

Misadventures to patients during surgical and medical care

1226

5611

2.45

155.88

3.1

2.2

0.20

0.21

g/l

1.09

1152

5219

Laparoscopic right hemicolectomy

672

2366

3.63

155.77

2.2

0.21

0.20

g/l

2.71

658

2199

Bipolar affective disorders

1341

6316

2.30

154.99

2.5

2.4

0.23

0.22

g/l

3.04

1241

5976

Enterocolitis due to Clostridium difficile

1009

4275

2.70

154.96

3.2

2.1

0.19

0.20

g/l

2.66

919

3950

All influenza

1979

10738

1.98

153.68

2.8

2.3

0.21

g/l

3.64

1832

10029

Crohn's disease of large intestine

528

1593

4.05

153.67

4.5

2.3

0.24

0.22

g/l

4.10

500

1497

Schizophrenia or delusion, excluding more controls

1977

10534

1.97

153.66

2.2

2.3

0.22

g/l

0.11

1807

9969

Benign neoplasm: Pancreas

409

1075

5.60

153.61

3.0

2.2

0.22

0.21

g/l

5.43

396

1002

Sleep apnoea

6761

30413

1.45

152.23

2.2

2.4

0.22

0.21

g/l

14.95

6294

28438

Chronic hepatitis NAS

240

409

10.64

151.69

5.4

2.6

0.20

0.22

g/l

1.88

220

387

Thrombocytopenia, unspecified

745

2775

3.22

151.62

3.3

2.3

0.19

0.21

g/l

10.36

698

2585

Hypotension

1520

7643

2.20

151.29

2.2

2.1

0.19

0.20

g/l

1.93

1373

7036

L02BG Aromatase inhibitors

2307

13071

1.89

151.14

1.8

2.2

0.22

0.21

g/l

27.79

2207

12148

Immunodeficiency with predominantly antibody defects

360

858

5.91

151.10

4.5

2.7

0.23

0.22

g/l

3.09

347

810

Diseases of the respiratory system

4310

13936

1.61

151.10

2.4

2.3

0.21

0.22

g/l

5.65

4036

13046

Unspecified fall

3865

24671

1.62

150.82

2.4

0.20

0.21

g/l

5.37

3521

23025

Peripheral artery operations in Hilmo

1123

5030

2.51

150.40

2.3

2.2

0.19

0.20

g/l

7.34

1031

4657

Malignant neoplasm of skin

3093

12681

1.73

150.37

2.3

2.1

0.21

g/l

0.20

2871

11557

Pleural effusion

1339

6450

2.32

150.12

2.6

2.2

0.18

0.20

g/l

26.78

1234

5962

Bronchitis

7690

33621

1.42

150.00

2.5

2.3

0.21

g/l

0.72

7158

31339

Follow-up examination after treatment for conditions other than malignant neoplasms

2936

11679

1.75

149.60

2.6

2.0

0.21

g/l

1.32

2757

10888

Neurological diseases

5777

19962

1.50

149.40

2.4

2.5

0.22

0.21

g/l

3.78

5409

18711

Implicit fungal Sepsis

469

1352

4.47

148.96

3.4

2.1

0.20

0.21

g/l

1.13

442

1281

Portal vein thrombosis

271

525

8.30

147.91

5.4

2.2

0.17

0.22

g/l

12.21

254

493

Secondary hypertension

657

2242

3.28

147.42

2.9

2.3

0.23

0.22

g/l

1.78

627

2107

6-mercaptopurine

380

936

5.03

147.34

3.5

2.3

0.24

0.22

g/l

5.62

366

866

Dermatitis and eczema

7907

34373

1.40

147.22

2.5

2.3

0.21

g/l

1.84

7357

32063

Intestinal malabsorption

525

1639

4.01

146.53

4.2

2.2

0.20

0.22

g/l

3.60

486

1525

Hypothyroidism, strict autoimmune

4874

21613

1.53

146.29

2.4

2.1

0.21

g/l

0.51

4513

20138

Hyperkinetic disorders, excluding more controls

719

2396

3.00

145.99

2.8

3.0

0.23

g/l

0.91

672

2303

Ischemic heart diseases

5956

24905

1.48

145.82

2.4

0.21

g/l

4.77

5541

23297

Other chronic obstructive pulmonary disease

3325

17186

1.68

145.23

2.2

2.3

0.20

g/l

3.07

3035

15949

Postprocedural disorders of digestive system, not elsewhere classified

421

1156

4.86

144.85

4.7

2.2

0.22

0.21

g/l

0.98

410

1076

Toxic liver disease

245

438

8.77

144.31

3.7

2.1

0.20

0.22

g/l

3.94

228

420

Other and unspecified polyneuropathies, also in other diseases

1597

8317

2.12

144.12

2.7

2.2

0.21

0.20

g/l

0.40

1497

7739

Ulcerative ileocolitis

435

1210

4.51

144.02

3.8

2.3

0.23

0.22

g/l

0.97

419

1130

3220

20130

1.67

143.69

2.6

2.4

0.22

0.21

g/l

1.06

3016

18804

Injuries to the hip and thigh

3663

21287

1.62

143.36

2.2

2.3

0.20

0.21

g/l

17.52

3355

19757

Malignant neoplasm of corpus uteri, including Hilmo

735

2765

3.05

143.23

1.7

2.0

0.22

0.20

g/l

8.94

707

2512

Nonalcoholic steatohepatitis

195

290

13.74

141.50

3.9

2.5

0.22

0.23

g/l

0.12

183

272

Other chronic obstructive pulmonary disease, including avohilmo

4043

22032

1.59

141.35

2.2

2.3

0.20

g/l

3.82

3700

20496

Malignant neoplasm of breast, ER-negative, including Hilmo

1392

6416

2.19

141.18

1.9

2.0

0.22

0.21

g/l

6.26

1331

5857

Ulcerative colitis (strict definition, all Crohn cases excluded)

1137

5244

2.40

140.70

3.4

2.4

0.23

0.22

g/l

8.82

1077

4917

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2920

11972

1.72

140.34

2.3

2.1

0.21

g/l

0.10

2699

10907

Other diseases of the respiratory system

1660

8811

2.06

140.33

2.9

2.2

0.20

g/l

1.77

1553

8130

Other respiratory disorders and diseases

1660

8811

2.06

140.33

2.9

2.2

0.20

g/l

1.77

1553

8130

Chronic periodontitis, complicated

4185

27433

1.56

140.16

2.5

2.3

0.21

g/l

0.07

3903

25629

Glomerular diseases

1463

7459

2.17

139.93

2.5

2.4

0.21

g/l

1.20

1374

6959

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2824

11561

1.74

139.87

2.3

2.1

0.21

0.20

g/l

0.06

2607

10531

Percutaneous Coronary Intervention

5674

24236

1.48

139.72

2.4

0.21

g/l

5.04

5290

22654

Malignant neoplasm of breast, HER-negative

1305

6069

2.24

139.55

1.8

2.0

0.22

0.21

g/l

6.61

1248

5542

Acute peritonitis

648

2354

3.31

138.15

3.7

2.2

0.19

0.21

g/l

8.26

610

2181

Malignant neoplasm of small intestine

292

627

6.46

138.03

3.4

2.1

0.21

0.20

g/l

1.38

280

577

Malignant neoplasm of ovary, including Hilmo

538

1747

3.62

137.43

1.9

2.1

0.19

0.21

g/l

2.88

507

1598

Candidiasis, including avohilmo

2243

13079

1.83

137.04

2.7

2.3

0.21

g/l

0.14

2090

12228

Peripheral arterial reconstruction

1413

7179

2.18

136.86

2.1

2.2

0.19

0.20

g/l

0.93

1300

6626

Adjustment and management of implanted device

1365

6836

2.18

135.52

2.2

2.1

0.20

g/l

2.17

1253

6308

Retention of urine

2599

12700

1.76

134.61

2.3

0.20

g/l

2.31

2360

11794

Extracorporeal dialysis

631

2307

3.34

134.19

3.1

2.4

0.22

0.21

g/l

1.12

596

2152

Abnormal findings on diagnostic imaging of other body structures

1228

5976

2.29

134.02

2.6

2.2

0.21

g/l

0.29

1171

5577

Injuries to the thorax

3425

22287

1.62

133.70

2.5

2.3

0.20

0.21

g/l

8.41

3118

20770

Collagenous colitis

841

3520

2.75

133.12

3.0

2.2

0.21

g/l

0.18

793

3296

Mental and behavioural disorders due to sedatives or hypnotics

619

2221

3.25

132.89

2.5

2.4

0.21

0.22

g/l

3.83

546

2084

Fracture of femur

2141

11164

1.85

132.78

2.2

2.1

0.18

0.20

g/l

19.70

1934

10268

Weight loss

950

4208

2.59

132.77

2.5

2.3

0.21

g/l

0.24

859

3936

Other and unspecified dermatitis

3807

25375

1.57

132.64

2.6

2.3

0.21

g/l

0.14

3577

23726

Enlarged lymph nodes

1168

5550

2.29

132.51

2.6

2.2

0.21

0.22

g/l

3.17

1106

5205

Other acute lower respiratory infections

3845

24426

1.57

131.84

2.7

2.3

0.21

g/l

1.89

3575

22729

Right hemicolectomy

613

2228

3.36

131.67

2.8

2.1

0.20

g/l

0.91

589

2063

Sleep disorders (combined)

7530

29060

1.39

131.41

2.2

2.4

0.22

0.21

g/l

21.01

7028

27127

Coronary revascularization (ANGIO or CABG)

5630

24250

1.47

131.40

2.4

0.21

g/l

4.56

5255

22667

Emergency coronary revascularization (for ACS)

6110

26520

1.44

131.36

2.4

0.21

g/l

4.87

5693

24711

Bacterial pneumoniae

2895

15901

1.68

131.02

2.4

2.3

0.20

0.21

g/l

5.36

2667

14836

Paroxysmal tachycardia

1455

6157

2.09

130.41

2.4

2.3

0.21

0.22

g/l

9.76

1377

5814

Cardiomyopathy

1342

6780

2.16

130.13

2.3

0.20

0.21

g/l

11.06

1246

6351

Injury, poisoning and certain other consequences of external causes

3460

11005

1.63

129.81

2.4

2.3

0.21

0.22

g/l

2.13

3229

10347

Any operation in hilmo

195

12.54

129.42

2.7

1.4

0.23

0.25

g/l

1.33

180

Genitourinary diseases

3740

12142

1.60

129.17

2.7

2.5

0.22

g/l

0.03

3512

11360

Malignant neoplasm of oropharynx, including Hilmo

264

552

6.69

128.90

2.9

2.1

0.23

0.21

g/l

5.03

256

508

Diseases of peritoneum

894

3906

2.61

128.28

3.5

2.2

0.19

0.21

g/l

5.85

838

3643

Episodal and paroxysmal disorders

7421

27819

1.39

128.18

2.3

2.4

0.22

0.21

g/l

9.49

6922

25966

Glucagon-like peptide-1 (GLP-1) analogues

2253

13448

1.79

126.79

2.3

2.4

0.22

0.21

g/l

5.54

2106

12674

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2253

13448

1.79

126.79

2.3

2.4

0.22

0.21

g/l

5.54

2106

12674

Basal cell carcinoma, including Hilmo

2783

11629

1.70

125.99

2.3

2.1

0.21

0.20

g/l

0.16

2576

10591

Malignant neoplasm of corpus uteri

661

2519

3.00

125.67

1.7

2.0

0.22

0.20

g/l

7.87

637

2290

Amputation of toe

700

2777

2.98

125.64

2.2

0.18

0.20

g/l

7.01

647

2571

Major coronary heart disease event

5963

25733

1.44

125.55

2.4

0.21

g/l

5.06

5548

24034

Mental and behavioural disorders due to use of other stimulants, including caffeine

303

711

5.32

125.32

2.4

2.6

0.20

0.24

g/l

10.95

270

666

Presence of cardiac and vascular implants and grafts

3186

15086

1.64

125.02

2.2

0.19

0.20

g/l

9.79

2936

13934

Other dorsopathies, not elsewhere classified

6800

25867

1.41

124.97

2.4

0.22

0.21

g/l

5.58

6332

24178

Sleep apnoea, including avohilmo

6903

30828

1.40

124.91

2.2

2.4

0.22

0.21

g/l

17.04

6430

28820

Non-selective monoamine reuptake inhibitors

2598

15430

1.71

124.81

2.2

2.3

0.21

g/l

1.04

2407

14527

Non-Hodgkin lymphoma, all, including Hilmo

906

3987

2.50

124.67

2.3

2.1

0.19

0.20

g/l

3.44

844

3636

Delirium, not induced by alcohol and other psychoactive substances

1095

5235

2.33

124.50

2.3

2.1

0.18

0.20

g/l

5.68

977

4857

Spondylopathies

5492

23134

1.45

123.16

2.3

0.21

g/l

1.96

5083

21608

COPD, early/later onset

3350

18513

1.60

122.23

2.2

2.3

0.20

g/l

3.08

3058

17194

Mycoses

2101

12451

1.81

121.75

2.8

2.3

0.21

g/l

1.56

1958

11644

Disorders of thyroid, IBD co-morbidities

1109

3513

2.29

121.69

2.3

0.22

g/l

0.39

1049

3330

Cerebrovascular diseases

5293

26247

1.46

120.95

2.2

2.3

0.20

0.21

g/l

5.89

4870

24444

Bacterial pneumonia, not elsewhere classified

2720

15008

1.67

120.92

2.4

2.2

0.20

0.21

g/l

4.24

2506

13994

Alcohol-induced acute pancreatitis

418

1287

4.18

120.60

3.8

2.4

0.19

0.22

g/l

6.12

394

1199

Abnormal weight loss

870

3875

2.58

120.28

2.4

2.3

0.21

g/l

0.20

793

3616

Later onset COPD, excluding more controls

1588

6549

2.00

119.97

2.1

0.19

0.20

g/l

8.44

1454

6078

ILD, hospital admission 2, with pulmonary infections

850

3734

2.57

119.76

2.4

2.1

0.21

0.20

g/l

0.20

789

3470

Disorders of lens

4707

20422

1.49

118.86

2.5

2.3

0.21

g/l

7.21

4360

19105

COPD related to multimorbidity

2939

16014

1.64

118.40

2.2

0.20

g/l

2.34

2674

14837

COPD, hospital admissions

3302

18389

1.60

118.30

2.2

2.3

0.20

g/l

2.55

3016

17074

Presence of other functional implants

4181

19680

1.52

117.75

2.2

0.20

0.21

g/l

5.04

3838

18228

Other ulcerative colitis

528

1862

3.33

117.31

4.3

2.2

0.23

0.22

g/l

1.98

504

1740

Glomerular disorders in diseases classified elsewhere

968

4531

2.40

117.25

2.5

2.3

0.21

g/l

0.04

905

4222

Urinary track infection

3749

12443

1.57

117.17

2.4

2.3

0.22

g/l

0.63

3521

11707

Systemic connective tissue disorders

2557

16102

1.68

116.44

2.5

2.2

0.21

g/l

0.76

2380

15022

Acute bronchitis

2921

18535

1.62

116.37

2.6

2.3

0.21

g/l

0.74

2711

17206

Other symptoms and signs involving cognitive functions and awareness

3481

20700

1.56

116.26

2.3

0.20

0.21

g/l

2.33

3172

19275

Other diseases of stomach and duodenum

616

2380

3.03

115.75

3.5

2.0

0.20

0.21

g/l

1.69

578

2218

Unspecified haematuria

3079

16360

1.61

115.71

2.5

2.3

0.20

g/l

1.80

2820

15220

Agranulocytosis

959

4506

2.41

115.64

3.0

2.3

0.20

0.21

g/l

5.36

899

4226

Use of disulfiram, acamprosate or naltrexone

751

3178

2.70

115.59

2.5

2.4

0.22

g/l

0.17

684

2989

Certain disorders involving the immune mechanism

1453

7873

2.01

115.44

3.2

2.4

0.22

0.21

g/l

4.93

1376

7380

Fracture of lumbar spine and pelvis

1750

9990

1.88

115.38

2.4

2.1

0.19

0.20

g/l

7.11

1594

9262

Basal cell carcinoma

2651

11273

1.68

115.20

2.3

2.1

0.20

g/l

0.03

2453

10257

Fibrosis of liver

162

252

14.01

114.07

6.2

2.5

0.19

0.22

g/l

6.56

157

239

Respiratory insufficiency

681

2763

2.76

112.62

2.5

2.1

0.19

0.20

g/l

2.18

631

2567

Symptoms and signs involving the skin and subcutaneous tissue

5013

34163

1.44

112.54

2.4

2.3

0.22

0.21

g/l

10.59

4726

31824

Dizziness and giddiness

5182

29104

1.43

112.50

2.3

0.21

g/l

0.66

4788

27210

Other specific joint derangements/joint disorders

4864

21493

1.46

112.30

2.5

2.4

0.22

0.21

g/l

11.66

4547

20162

Emotional disorders starting during childhood or adolecense, excluding more controls

315

779

4.40

111.81

3.3

3.8

0.22

0.23

g/l

0.75

296

740

Other diseases of lip and oral mucosa

3017

19889

1.60

111.71

2.5

2.3

0.22

0.21

g/l

3.27

2844

18596

Malignant neoplasm of urinary organs, including Hilmo

790

3450

2.52

110.74

2.1

2.0

0.21

0.20

g/l

4.10

731

3133

Diseases of pulp and periapical tissues, including avohilmo

7012

27198

1.37

110.69

2.4

2.3

0.21

g/l

0.21

6531

25337

Fracture of rib(s), sternum and thoracic spine

2299

14310

1.71

110.06

2.6

2.3

0.20

0.21

g/l

4.52

2088

13330

Soft tissue disorders

6788

25963

1.37

109.64

2.4

0.21

g/l

2.90

6317

24247

Candidiasis

1119

5653

2.17

109.36

3.0

2.2

0.21

g/l

1.56

1056

5301

Nonorganic sleeping disorders, excluding more controls

1286

6761

2.02

108.60

2.4

0.23

0.22

g/l

4.02

1188

6406

Other complications of surgical and medical care, not elsewhere classified

790

3499

2.52

108.51

2.9

2.2

0.21

g/l

0.64

741

3267

Irritable bowel syndrome

1818

10642

1.81

108.35

2.3

2.2

0.23

0.21

g/l

13.11

1690

9939

Kidney transplant status

515

1891

3.28

108.01

4.1

2.6

0.23

0.22

g/l

4.28

493

1775

Nerve, nerve root and plexus disorders

7224

32963

1.35

107.53

2.3

0.21

g/l

0.86

6726

30728

Pacemaker

2672

16066

1.64

107.49

2.2

0.19

0.20

g/l

9.31

2460

14822

Abnormalities of heart beat

2483

15275

1.65

107.23

2.4

2.3

0.21

g/l

0.13

2293

14267

Mycoses, including avohilmo

6286

35862

1.37

107.12

2.4

0.22

0.21

g/l

2.72

5832

33511

Hydronephrosis

911

4310

2.34

106.29

2.5

2.2

0.20

0.21

g/l

3.45

852

4017

Crohn disease (strict definition, all UC cases excluded)

464

1613

3.38

105.84

3.7

2.3

0.23

0.22

g/l

2.92

449

1518

Viral pneumonia

1003

4920

2.23

105.80

2.6

2.3

0.21

g/l

0.54

929

4594

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1253

5690

2.02

105.47

2.9

0.23

g/l

1.18

1165

5373

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2248

14044

1.69

105.36

2.6

2.4

0.20

0.21

g/l

7.27

2070

13113

Malignant neoplasm of oropharynx

213

442

6.78

105.12

2.8

2.2

0.23

0.21

g/l

4.53

206

407

Malignant neoplasm of bladder, including Hilmo

784

3442

2.45

104.43

2.4

1.9

0.20

0.19

g/l

3.88

723

3118

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

837

3883

2.44

104.09

3.2

2.2

0.21

g/l

0.23

800

3624

Osteoporosis with pathological fracture (FG)

684

2927

2.71

103.89

2.6

2.0

0.19

0.20

g/l

1.81

616

2703

Bulimia nervosa (incl. atypical)

282

713

4.62

103.87

2.8

2.5

0.23

g/l

0.85

263

676

Vascular disorders of the intestines

611

2471

2.83

103.57

2.8

2.0

0.19

0.20

g/l

2.00

561

2287

Other pleural conditions

871

4115

2.38

103.18

2.5

2.1

0.17

0.20

g/l

19.93

803

3793

Biological medication for rheuma

1260

6748

2.01

102.49

3.3

2.5

0.23

0.22

g/l

5.35

1213

6354

Early onset COPD

1637

9525

1.85

102.35

2.4

0.21

g/l

0.20

1501

8923

Other systemic involvement of connective tissue (FG)

1856

10924

1.77

102.06

2.4

2.2

0.21

g/l

0.11

1718

10197

Benign neoplasm: Colon, unspecified

1916

11649

1.77

101.99

2.8

2.2

0.21

0.20

g/l

4.98

1779

10839

Other disorders of glucose regulation and pancreatic internal secretion

711

3100

2.59

101.94

2.8

2.4

0.19

0.21

g/l

11.04

644

2895

Gingivitis and periodontal diseases

6724

26218

1.36

101.74

2.4

2.3

0.21

g/l

2.37

6251

24418

Superficial injury of head

1761

10414

1.80

101.72

2.2

2.3

0.21

g/l

1.03

1605

9752

Malignant neoplasm of tonsil, including Hilmo

213

455

6.48

101.40

3.0

2.1

0.24

0.21

g/l

6.03

207

419

Gastrointestinal stromal tumor and sarcoma

179

333

8.29

101.14

2.2

2.0

0.22

0.20

g/l

3.40

172

299

Osteomyelitis

594

2416

2.86

100.62

2.7

2.3

0.19

0.21

g/l

7.31

552

2260

Diseases of oral cavity, salivary glands and jaws

3857

13689

1.50

100.47

2.3

2.2

0.21

0.20

g/l

0.84

3566

12691

Disorders of calcium metabolism

585

2364

2.86

99.98

3.0

2.3

0.20

0.21

g/l

1.99

541

2228

Panic disorder

952

4646

2.19

99.76

2.4

0.23

0.22

g/l

0.70

865

4374

In situ neoplasms

2804

18679

1.58

98.89

2.3

2.2

0.22

0.20

g/l

12.93

2644

17345

Elevated blood glucose level

725

3238

2.54

98.73

2.9

2.3

0.20

0.21

g/l

3.09

675

3026

COPD, hospital admission 2, with asthma infections

2327

12775

1.66

98.41

2.2

0.20

g/l

2.75

2132

11833

Undetermined asthma, excluding more controls

911

4409

2.23

98.03

2.4

2.2

0.22

g/l

0.12

849

4130

Diseases of the musculoskeletal system and connective tissue

3413

11550

1.53

96.95

2.5

0.22

0.21

g/l

2.77

3173

10869

Exposure to other specified factors

5429

34780

1.38

96.95

2.4

0.22

0.21

g/l

2.88

5026

32591

Conduction disorders

2067

10250

1.71

96.86

2.2

2.3

0.20

0.21

g/l

12.62

1907

9582

Cardiomyopathy (excluding other)

942

4674

2.21

96.63

2.2

2.4

0.19

0.21

g/l

11.09

869

4378

Bacterial pneumonia (organism specified)

3096

19070

1.53

96.31

2.5

2.2

0.20

0.21

g/l

0.89

2854

17691

Phobic anxiety disorders

848

4001

2.27

96.29

2.8

2.6

0.22

0.23

g/l

0.86

781

3769

Hypertensive heart and/or renal disease

1819

7938

1.77

96.22

2.2

0.20

g/l

1.21

1656

7385

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

833

3888

2.30

96.11

2.3

1.9

0.20

0.19

g/l

3.86

773

3495

Acute upper respiratory infections of multiple and unspecified sites

5125

27577

1.40

96.09

2.7

2.3

0.22

0.21

g/l

0.91

4804

25731

Other/unspecified dorsalgia

2576

16717

1.59

95.62

2.4

2.3

0.22

0.21

g/l

3.96

2368

15637

Other arthritis (FG)

2160

13677

1.66

95.40

2.4

2.3

0.21

g/l

0.07

2041

12791

Assault

926

4571

2.19

95.13

2.5

0.22

0.23

g/l

4.04

858

4301

Diseases of the myoneural junction and muscle

988

5037

2.17

95.00

2.5

2.3

0.19

0.21

g/l

4.82

895

4702

Complications of internal orthopaedic prosthetic devices, implants and grafts

1626

9640

1.81

94.45

2.1

0.20

g/l

3.13

1505

8938

Malignant neoplasm of rectosigmoid junction, including Hilmo

283

783

4.47

94.17

2.4

1.9

0.20

g/l

1.03

274

710

748

3455

2.44

94.04

3.6

2.3

0.14

0.21

g/l

69.72

634

3209

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

718

3255

2.46

93.50

2.7

2.2

0.21

g/l

0.93

671

3044

ILD, hospital admissions 3, with pneumonia sepsis

719

3274

2.48

93.36

2.4

2.1

0.20

g/l

0.06

662

3039

Post-traumatic stress disorder

555

2218

2.72

93.33

2.7

2.5

0.23

g/l

0.62

507

2096

Other acute viral hepatitis

183

373

7.18

92.99

3.4

2.8

0.18

0.23

g/l

9.92

170

351

Other disorders of veins

2823

18754

1.55

92.77

2.3

2.1

0.21

g/l

6.81

2592

17571

Senile cataract

4265

18643

1.44

92.29

2.5

2.3

0.20

0.21

g/l

7.87

3948

17420

Hypothyroidism, other/unspecified

5826

28913

1.36

92.28

2.4

2.3

0.21

g/l

2.53

5420

26962

Disorders of the thyroid gland

6245

30870

1.35

92.22

2.3

0.21

g/l

2.73

5811

28783

Injuries to the knee and lower leg

7970

33761

1.31

92.13

2.4

0.21

g/l

0.03

7419

31510

Dorsopathies

6720

26021

1.34

92.04

2.4

0.22

0.21

g/l

6.16

6268

24328

Hypoglycaemia, other or unspecified

583

2439

2.73

92.04

2.8

2.5

0.19

0.21

g/l

9.09

526

2277

Other arrhythmias

4054

21670

1.44

91.64

2.3

2.4

0.21

0.22

g/l

14.34

3765

20347

Cardiomyopathies, Primary/intrinsic

907

4527

2.20

91.60

2.2

2.4

0.19

0.21

g/l

10.64

839

4244

Other specified/unspecified arthritis

1908

11858

1.70

91.25

2.4

0.21

g/l

0.06

1807

11142

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1414

6596

1.86

91.17

2.2

2.0

0.20

g/l

0.39

1325

5978

Other respiratory diseases principally affecting the interstitium

1370

7849

1.89

90.82

2.4

2.2

0.20

g/l

1.30

1269

7278

Fracture of shoulder and upper arm

2581

17184

1.57

90.55

2.4

0.20

0.21

g/l

6.02

2358

16018

Nonhereditary hypogammaglobulinemia

168

330

7.91

89.96

5.6

2.4

0.23

0.22

g/l

0.83

162

309

COPD-related respiratory insufficiency

936

4781

2.16

89.55

2.4

2.2

0.19

0.20

g/l

1.00

867

4432

Hypothyreosis and Thyroxine purchase for inclusion criteria

6022

30078

1.35

88.78

2.4

2.3

0.21

g/l

2.20

5598

28060

Squamous cell neoplasms and carcinomas of the skin

682

3074

2.42

88.42

2.3

1.9

0.20

0.19

g/l

4.44

636

2764

Other and unspecified nonorganic psychotic disorders

1244

6933

1.91

88.30

2.3

2.4

0.22

g/l

0.66

1140

6529

Functional dyspepsia

1795

11078

1.71

88.07

2.5

2.1

0.22

0.21

g/l

3.84

1677

10350

Malignant neoplasm of tonsil

188

408

6.40

88.03

2.8

2.2

0.24

0.21

g/l

5.17

182

376

Diseases of pulp and periapical tissues and dental caries

4382

16230

1.43

87.97

2.3

2.2

0.21

g/l

0.70

4043

15092

Symptoms and signs involving the nervous and musculoskeletal systems

3958

28680

1.43

87.91

2.2

2.4

0.21

g/l

3.64

3684

26719

Malignant neoplasm of ovary

377

1292

3.38

87.68

1.9

2.1

0.19

0.21

g/l

2.41

351

1189

Caries of dentine, including avohilmo

5219

19833

1.38

87.48

2.4

2.3

0.21

g/l

1.01

4826

18470

Viral and other specified intestinal infections, including avohilmo

1724

10101

1.72

87.27

2.9

2.4

0.22

g/l

0.32

1626

9446

Generalized anxiety disorder

994

5152

2.04

87.18

2.7

2.4

0.23

0.22

g/l

1.78

928

4849

Neuroendocrine tumor and carcinoma of small intestine

178

373

6.66

86.83

2.6

2.1

0.22

0.20

g/l

2.12

169

340

Diagnoses used for exclusion with ILD

1790

11107

1.71

86.78

2.7

2.2

0.20

0.21

g/l

1.56

1644

10314

Type of accident

2035

13005

1.65

86.72

2.7

2.3

0.20

0.21

g/l

8.16

1877

12142

Protein-energy malnutrition of moderate and mild degree

162

324

8.37

86.38

3.2

2.8

0.17

0.21

g/l

7.88

151

305

Other embolism and thrombosis

961

5005

2.10

86.10

2.8

2.1

0.20

0.21

g/l

1.76

889

4675

Undetermined asthma

911

4628

2.12

85.98

2.4

2.2

0.22

0.21

g/l

0.27

849

4346

Type 1 diabetes

1582

9482

1.75

85.94

2.5

0.19

0.22

g/l

38.81

1439

8904

Vitamin B12 deficiency anaemia

801

3916

2.25

85.84

3.2

2.1

0.19

0.20

g/l

2.46

747

3614

Exclusions for E4_PCOS_BROAD

1241

7004

1.90

85.50

2.7

2.6

0.22

0.21

g/l

0.89

1164

6586

Asthma/COPD (KELA code 203)

6283

32364

1.33

85.48

2.3

2.4

0.21

g/l

0.25

5858

30214

Cough

2763

17569

1.53

85.20

2.5

2.4

0.22

0.21

g/l

4.31

2582

16449

Dental operations

4064

15023

1.44

84.09

2.3

2.2

0.21

g/l

0.66

3767

13898

Other and unspecified myopathies

735

3532

2.34

83.64

2.5

2.2

0.19

0.20

g/l

6.81

658

3283

Injuries to the shoulder and upper arm

5819

34491

1.34

83.58

2.4

0.21

g/l

4.03

5351

32201

Pneumonitis due to solids and liquids

679

3162

2.39

83.02

2.9

2.2

0.18

0.20

g/l

8.50

607

2923

Hypertensive Heart Disease

1628

7468

1.75

82.87

2.2

0.20

g/l

1.29

1481

6938

Open wound of lower leg

1125

6232

1.95

82.76

2.6

2.4

0.20

0.21

g/l

2.82

1047

5810

Amenorrhoea

463

1803

2.82

82.63

3.6

2.4

0.22

g/l

0.27

433

1696

Acute upper respiratory infections

6947

32595

1.31

82.47

2.5

2.3

0.21

g/l

1.23

6491

30326

Dental caries, including avohilmo

4838

18370

1.39

82.46

2.3

2.2

0.21

g/l

0.51

4459

17096

Fracture of skull and facial bones

1464

8731

1.78

82.28

2.5

2.4

0.21

g/l

0.85

1344

8212

Acidosis

256

738

4.55

82.16

2.9

2.4

0.19

0.21

g/l

1.48

232

698

Duodenal ulcer

819

4102

2.19

81.93

3.1

2.0

0.19

0.20

g/l

4.30

744

3787

Malignant neoplasm of urinary organs

650

2973

2.39

81.77

2.1

2.0

0.21

0.20

g/l

4.55

605

2698

Secondary and unspecified malignant neoplasm of lymph nodes

576

2507

2.54

81.76

2.3

2.1

0.19

0.20

g/l

4.08

542

2294

Asthma, hospital admissions , main diagnosis only

5365

35642

1.34

81.53

2.4

0.22

0.21

g/l

2.67

5043

33216

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

658

3029

2.38

81.44

2.1

2.0

0.21

0.20

g/l

4.55

612

2754

Other cataract

3030

15689

1.50

81.14

2.4

2.3

0.20

0.21

g/l

4.96

2794

14641

Persistent mood disorders

1283

7422

1.84

80.59

2.4

2.3

0.22

0.21

g/l

2.57

1177

6960

Asthma, including avohilmo

7813

34195

1.29

80.56

2.3

2.4

0.22

0.21

g/l

4.45

7309

31875

Psoriasis vulgaris

1324

7757

1.83

80.46

2.6

2.4

0.21

g/l

0.46

1242

7266

COPD, hospital admissions 3, with asthma pneumonia sepsis

1914

10474

1.66

80.45

2.2

0.19

0.20

g/l

2.20

1742

9684

Mental and behavioural disorders due to tobacco

695

3319

2.34

79.99

2.7

2.4

0.21

g/l

1.07

649

3121

Unspecified privation

818

4142

2.17

79.88

2.6

2.3

0.22

0.21

g/l

1.92

761

3876

Hypertension, portal

107

28.05

79.81

8.5

2.4

0.17

0.22

g/l

5.29

101

Malignant neoplasm of bladder

469

1873

2.76

79.74

2.5

1.9

0.21

0.19

g/l

4.20

438

1685

Disorders of eyelid, lacrimal system and orbit

5829

32999

1.33

79.71

2.3

0.21

g/l

4.67

5425

30762

Papulosquamous disorders

2682

18501

1.52

79.49

2.5

2.3

0.21

g/l

1.37

2512

17297

Traumatic subdural haemorrhage

1004

5063

2.00

79.41

2.4

2.3

0.19

0.20

g/l

0.88

911

4700

ILD, hospital admissions

1153

6549

1.92

79.22

2.4

2.2

0.21

0.20

g/l

1.82

1068

6089

Other interstitial pulmonary diseases

1166

6643

1.91

79.20

2.4

2.2

0.21

0.20

g/l

1.76

1079

6173

Other systemic involvement of connective tissue

1904

12255

1.64

79.10

2.5

2.2

0.21

g/l

0.83

1766

11418

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1634

9969

1.70

79.06

3.0

2.5

0.22

g/l

0.51

1535

9392

Ischaemic heart disease, wide definition

5196

24306

1.36

78.86

2.2

2.3

0.21

g/l

1.93

4796

22696

Other diseases of hard tissues of teeth

3674

13600

1.44

78.75

2.3

2.2

0.21

0.20

g/l

4.16

3400

12622

Interstitial lung disease

1166

6659

1.90

78.56

2.4

2.2

0.21

0.20

g/l

1.82

1079

6187

Interstitial lung disease endpoints

1166

6659

1.90

78.56

2.4

2.2

0.21

0.20

g/l

1.82

1079

6187

Other viral diseases

1847

11745

1.64

78.40

3.4

2.5

0.22

g/l

0.80

1748

11006

Endocarditis

339

1175

3.43

78.40

3.0

2.4

0.18

0.21

g/l

9.63

309

1105

Fracture of lower leg, including ankle

3699

26524

1.42

77.89

2.4

2.3

0.21

g/l

4.03

3440

24789

Smoking dependency

695

3355

2.31

77.82

2.7

2.4

0.21

g/l

1.09

649

3151

Tumor necrosis factor alpha inhibitors

1075

5977

1.93

77.59

3.0

2.5

0.23

0.22

g/l

6.15

1032

5625

Schizophrenia or delusion

1977

12851

1.61

77.48

2.2

2.4

0.22

g/l

0.01

1807

12030

Benign neoplasm: Sigmoid colon

1415

8554

1.78

77.43

2.6

2.2

0.22

0.20

g/l

8.89

1346

7971

Benign neoplasm: Rectum

1351

8085

1.81

76.98

2.5

2.2

0.22

0.20

g/l

9.21

1270

7545

Schizophrenia, schizotypal and delusional disorders

1982

12911

1.61

76.92

2.2

2.4

0.22

g/l

0.01

1811

12089

Coronary atherosclerosis

4343

20370

1.39

76.91

2.2

2.3

0.20

0.21

g/l

4.31

4006

18975

Benign neoplasm: Rectum, anus and anal canal

1481

9072

1.75

76.78

2.5

2.2

0.22

0.20

g/l

9.09

1387

8457

Other specified and unspecified personality disorders

635

2957

2.36

76.78

2.5

2.3

0.22

g/l

1.18

592

2797

Unspecified mental disorder

2499

17073

1.52

76.74

2.3

2.4

0.22

g/l

2.25

2289

15988

Extreme obesity with alveolar hypoventilation

383

1440

3.17

76.73

2.5

2.3

0.19

0.21

g/l

6.13

348

1355

Malignant neoplasm of larynx, including Hilmo

204

518

4.93

76.65

2.7

2.0

0.21

0.19

g/l

2.63

199

467

Vitamin deficiency

417

1628

2.95

76.34

3.2

2.3

0.19

0.21

g/l

8.32

388

1507

Vitamin deficiency, wide

417

1628

2.95

76.34

3.2

2.3

0.19

0.21

g/l

8.32

388

1507

Hypothyroidism, strict autoimmune, 3 medication purchases required

5389

27794

1.34

76.17

2.3

0.21

g/l

0.74

4982

25924

Other intervertebral disc disorders

5320

24236

1.34

76.00

2.3

0.22

0.21

g/l

9.00

4937

22644

AV-block

1252

6214

1.83

75.57

2.1

2.2

0.19

0.21

g/l

10.24

1152

5788

Mixed and other personality disorders

566

2534

2.47

75.41

2.3

2.4

0.22

g/l

0.10

513

2412

Amputation of foot

290

954

3.86

75.40

2.6

2.4

0.18

0.20

g/l

6.10

267

882

Serous carcinoma of ovary, including Hilmo

280

887

3.76

75.21

2.0

2.1

0.18

0.20

g/l

4.40

265

819

Other and unspecified drugs and medicaments

676

3280

2.30

74.69

2.7

2.2

0.21

g/l

0.91

635

3068

Stroke, including SAH

4325

23257

1.38

74.52

2.2

2.3

0.20

0.21

g/l

5.82

3971

21603

Other disorders starting during childhood or adolecense, excluding more controls

297

909

3.42

74.38

3.5

3.9

0.22

g/l

0.29

280

867

Behavioural syndromes associated with physiological disturbances and physical factors

6126

32492

1.31

73.61

2.3

2.4

0.22

0.21

g/l

21.49

5699

30396

Other retinal disorders

4390

25109

1.37

73.53

2.3

2.2

0.20

0.21

g/l

11.25

4021

23323

Other diseases of pericardium

405

1593

2.96

73.51

2.5

2.3

0.19

0.21

g/l

9.61

368

1502

Ulcerative enterocolitis

286

939

3.64

72.63

4.5

2.4

0.23

0.22

g/l

4.23

268

876

Drug-induced neutropenia

596

2801

2.42

72.51

2.5

2.2

0.20

0.21

g/l

5.01

569

2637

Psoriasis

1922

12649

1.60

72.10

2.6

2.3

0.22

0.21

g/l

1.04

1804

11836

Stroke, excluding SAH

4099

22108

1.39

72.07

2.2

2.3

0.20

0.21

g/l

5.01

3764

20527

Other problems related to primary support group, including family circumstances

745

3663

2.13

71.43

4.0

2.7

0.22

g/l

0.72

704

3461

Disorders of choroid and retina

5418

29442

1.32

71.36

2.4

2.3

0.20

0.21

g/l

14.10

5001

27422

Phlebitis and thrombophlebitis (not including DVT)

1526

9556

1.69

71.28

2.5

2.2

0.21

g/l

2.11

1424

8929

Malignant neoplasm of kidney, except renal pelvis

582

2693

2.36

71.24

2.1

0.21

0.20

g/l

4.66

543

2454

Epilepsy

2045

13606

1.57

70.94

2.5

0.21

g/l

1.08

1893

12682

Unspecified misadventure during surgical and medical care

498

2195

2.61

70.87

3.3

2.2

0.20

0.21

g/l

1.27

474

2055

Lung diseases due to external agents

1002

5641

1.91

70.10

2.7

2.2

0.19

0.20

g/l

4.00

907

5221

Other joint disorders

5454

21980

1.32

69.44

2.4

0.22

0.21

g/l

3.79

5065

20593

severe traumatic brain injury, does not include concussion

1545

9770

1.67

69.40

2.4

2.2

0.20

g/l

1.27

1413

9023

ILD, hospital admissions 1, main diag only

1025

5855

1.91

69.30

2.3

2.2

0.21

0.20

g/l

2.28

948

5447

Other diseases of arteries and capillaries

688

3448

2.20

69.26

2.5

2.3

0.21

g/l

0.11

628

3223

Primary_lymphoid and hematopoietic malignant neoplasms

1676

10826

1.64

69.10

2.4

2.3

0.19

0.20

g/l

4.37

1549

10055

Hepatomegaly and splenomegaly, not elsewhere classified

135

273

7.13

69.08

3.3

2.0

0.21

0.22

g/l

1.12

130

256

Fibromyalgia

651

3185

2.22

69.02

2.2

0.23

0.22

g/l

3.18

602

3021

Viral and other specified intestinal infections

1253

7296

1.75

68.90

3.1

2.5

0.22

g/l

1.53

1173

6800

Spinal stenosis

3488

18895

1.41

68.37

2.1

2.3

0.21

0.20

g/l

0.58

3228

17579

Other and unspecified local infections of skin and subcutaneous tissue

732

3773

2.12

67.87

3.0

2.3

0.20

0.21

g/l

3.35

679

3529

Urticaria and erythema

2304

15892

1.51

67.69

2.6

2.4

0.22

g/l

0.44

2142

14883

Myalgia

1570

9996

1.65

67.65

2.6

2.3

0.22

0.21

g/l

7.05

1474

9377

Arthropathies

5608

22044

1.31

67.52

2.4

2.5

0.22

0.21

g/l

1.61

5233

20657

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

450

1916

2.60

67.40

2.2

2.1

0.20

g/l

0.15

424

1742

Preparatory care for dialysis

396

1621

2.89

67.13

2.6

2.3

0.22

0.21

g/l

3.12

380

1515

Other metabolic disorders

895

4923

1.95

67.04

2.7

2.3

0.22

0.21

g/l

3.25

850

4650

Adrenocortical insufficiency

336

1265

3.14

67.03

2.9

2.3

0.22

0.21

g/l

0.23

310

1191

Abscess of anal and rectal regions

594

2844

2.28

66.73

3.0

2.2

0.22

g/l

0.14

556

2662

Other and unspecified mood [affective] disorders

461

1982

2.53

66.60

2.4

2.5

0.23

0.22

g/l

0.23

421

1877

Suppurative and necrotic conditions of lower respiratory tract

473

2093

2.58

66.48

2.6

2.3

0.19

0.21

g/l

5.90

436

1951

Viral infections characterized by skin and mucous membrane lesions

2779

19896

1.45

66.33

2.8

2.4

0.21

g/l

0.09

2612

18580

Benign neoplasm: Liver

245

783

3.86

65.97

2.7

2.3

0.23

0.22

g/l

1.06

237

738

Disorders of iron metabolism

187

503

4.82

65.95

3.0

2.5

0.24

0.22

g/l

2.72

178

472

Transport accidents

2799

16602

1.44

65.85

2.4

0.21

0.22

g/l

0.37

2609

15683

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

357

1385

2.93

65.75

2.3

2.0

0.19

g/l

0.92

321

1257

Secondary malignant neoplasm of respiratory and digestive organs

182

478

4.82

65.71

2.4

2.0

0.16

0.20

g/l

7.05

173

435

Arthrosis

4544

18972

1.35

65.37

2.2

2.3

0.21

g/l

0.72

4231

17766

Malignant neoplasm, without specification of site, including Hilmo

344

1306

2.94

65.33

2.1

1.9

0.17

0.19

g/l

3.66

306

1182

Other disorders of adrenal gland

395

1626

2.81

65.29

2.9

2.4

0.22

0.21

g/l

0.32

362

1535

Cytomegalovirus infection, IBD co-morbidity

242

776

3.92

65.29

4.7

2.4

0.21

0.22

g/l

0.50

230

732

Kela-code for severe mental illness

2206

15195

1.51

65.22

2.3

2.4

0.22

g/l

1.54

2014

14226

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

494

2228

2.46

64.98

2.5

0.22

g/l

0.15

450

2082

Malignant neoplasm of respiratory system and intrathoracic organs

1192

5885

1.76

64.84

2.2

2.0

0.20

g/l

0.63

1115

5337

Diseases of spleen

210

622

4.39

64.78

3.9

2.4

0.19

0.21

g/l

2.53

200

584

Benign neoplasm: Liver/bile ducts

261

874

3.63

64.73

2.7

2.3

0.23

0.22

g/l

1.24

253

825

Calcific aortic valvular stenosis, operated

2017

13193

1.55

64.70

2.3

2.1

0.19

0.20

g/l

6.17

1852

12154

Calcific aortic valvular stenosis

2017

13193

1.55

64.70

2.3

2.1

0.19

0.20

g/l

6.17

1852

12154

Stomatitis and related lesions

1334

8283

1.71

64.54

2.6

2.4

0.21

g/l

0.68

1234

7753

Other local infections of skin and subcutaneous tissue

758

4020

2.05

64.49

2.9

2.3

0.20

0.21

g/l

2.88

703

3759

Amputation of thigh

285

1002

3.38

64.42

2.3

2.1

0.17

0.19

g/l

6.77

256

918

Other disorders of kidney and ureter

956

5463

1.90

64.35

2.5

2.3

0.22

0.21

g/l

3.48

891

5094

Operations 2 for CAVS

2011

13170

1.54

64.09

2.2

2.1

0.19

0.20

g/l

6.01

1846

12131

Calcific aortic valvular stenosis, diagnosis (helper)

2011

13170

1.54

64.09

2.2

2.1

0.19

0.20

g/l

6.01

1846

12131

Other diseases of oesophagus

684

3515

2.12

63.75

2.8

2.0

0.20

g/l

0.54

632

3268

Fissure and fistula of anal and rectal regions

1481

9428

1.65

63.72

2.5

2.2

0.22

0.21

g/l

1.89

1386

8787

Benign neoplasm: Stomach

750

4005

2.07

63.57

2.8

2.2

0.21

g/l

1.15

701

3740

Abnormalities of gait and mobility

917

5202

1.92

63.47

2.2

2.4

0.21

0.20

g/l

1.49

860

4846

Cytomegaloviral disease, including avohilmo

247

814

3.76

63.46

4.7

2.4

0.21

0.22

g/l

0.50

235

765

Dialysis

346

1358

2.98

63.42

3.1

2.5

0.23

0.21

g/l

2.11

338

1270

Calcific aortic valvular stenosis, including rheumatic fever

2015

13214

1.54

63.41

2.2

2.1

0.19

0.20

g/l

5.95

1850

12172

Assault by bodily force

530

2478

2.33

63.20

2.5

0.22

0.23

g/l

1.33

487

2334

Other endocrine disorders

428

1766

2.64

63.08

3.4

3.3

0.21

g/l

0.37

403

1681

Psychotic depression

413

1737

2.61

63.06

2.6

2.5

0.22

0.21

g/l

0.49

383

1654

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

614

3065

2.23

63.04

2.5

2.1

0.19

0.20

g/l

3.38

567

2851

Polycystic ovarian syndrome, consortium definition

4253

18539

1.35

62.95

2.5

2.2

0.22

g/l

0.48

3977

17357

Malignant neoplasm of rectosigmoid junction

170

439

4.88

62.74

2.4

2.0

0.20

g/l

0.08

163

402

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

234

745

3.77

62.66

1.7

2.0

0.19

0.20

g/l

1.34

211

684

Cytomegaloviral disease

244

806

3.75

62.49

4.8

2.4

0.21

0.22

g/l

0.44

232

757

L04AC Interleukin inhibitors

492

2257

2.42

62.42

3.6

2.4

0.23

0.22

g/l

1.25

477

2124

Special screening examination for infectious and parasitic diseases

1272

5614

1.71

62.29

2.6

2.1

0.24

0.23

g/l

5.10

1182

5287

Congenital malformations, deformations and chromosomal abnormalities

3504

24862

1.37

62.12

2.7

2.4

0.22

g/l

0.58

3321

23306

Benign neoplasm: Small intestine

374

1551

2.87

62.11

2.9

2.2

0.21

0.20

g/l

1.57

351

1442

Acute posthaemorrhagic anaemia

309

1156

3.11

61.87

3.3

2.2

0.18

0.20

g/l

6.65

278

1072

Anaemia in chronic diseases classified elsewhere

245

815

3.70

61.83

3.3

2.4

0.21

g/l

0.01

224

756

Cardiomyopathy, other and unspecified

566

2753

2.27

61.77

2.3

0.20

0.21

g/l

3.95

534

2586

Idiopathic gout

717

3805

2.08

61.71

2.2

0.21

0.20

g/l

1.24

665

3536

Umbilical hernia

1777

11889

1.57

61.62

2.8

2.3

0.21

g/l

0.60

1660

11128

Disorders of parathyroid gland

1420

8964

1.66

61.29

2.6

2.1

0.21

0.20

g/l

5.44

1328

8315

Diseases of the eye and adnexa

4808

18596

1.32

61.28

2.6

2.4

0.22

g/l

0.45

4498

17471

Benign neoplasm: Duodenum

271

971

3.50

60.88

3.1

2.2

0.21

g/l

0.90

257

899

Social phobias

511

2376

2.30

60.81

2.5

2.6

0.23

g/l

0.12

465

2241

Adalimumab

679

3535

2.08

60.67

3.4

2.4

0.23

0.22

g/l

3.39

652

3329

Injuries to the elbow and forearm

4614

30808

1.32

60.61

2.4

0.21

g/l

8.04

4254

28833

Hyperlipidaemia, other/unspecified

2519

16168

1.46

60.61

2.1

2.3

0.21

0.20

g/l

5.09

2307

15053

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5861

36511

1.28

60.61

2.6

2.4

0.21

g/l

1.26

5507

34051

Other viral diseases, including avohilmo

2261

15703

1.48

60.21

3.1

2.5

0.22

g/l

0.71

2141

14752

Speech and linguistic disorders, excluding more controls

456

1895

2.41

60.09

3.7

3.1

0.22

g/l

0.24

429

1792

Disorders of skin appendages

3077

22639

1.39

59.82

2.5

2.4

0.22

g/l

3.71

2902

21198

Major coronary heart disease event excluding revascularizations

3976

20011

1.35

59.78

2.2

2.3

0.20

0.21

g/l

5.63

3654

18606

Type 1 diabetes, wide definition, subgroup 1

1202

7375

1.71

59.77

2.4

0.19

0.22

g/l

41.20

1094

6914

Sciatica+with lumbago

3326

21995

1.38

59.73

2.3

0.22

0.21

g/l

8.31

3093

20613

Diabetic maculopathy, excluding more controls

718

3826

2.02

59.67

2.2

0.19

0.21

g/l

8.94

655

3575

Heartburn

715

3796

2.01

59.54

2.5

2.0

0.22

g/l

0.68

666

3540

Paralytic ileus

323

1262

2.95

59.27

3.2

2.0

0.20

0.21

g/l

0.35

308

1171

Acute sinusitis

3215

21751

1.38

58.99

2.7

2.3

0.22

g/l

0.44

3024

20357

Ulcerative rectosigmoiditis

573

2844

2.20

58.89

2.7

2.2

0.23

0.22

g/l

5.77

538

2667

Other general symptoms and signs

376

1553

2.65

58.70

2.2

2.5

0.22

g/l

0.61

357

1474

Disorders of magnesium metabolism

129

297

6.90

58.44

2.9

2.6

0.19

0.21

g/l

2.31

119

280

Cardiodefibrillation

2379

16983

1.46

58.23

2.2

2.3

0.19

0.20

g/l

6.18

2180

15755

Leisure time condition

1218

7602

1.70

57.85

2.6

2.4

0.20

0.21

g/l

4.72

1109

7107

Chronic laryngitis and laryngotracheitis

992

5888

1.80

57.79

2.6

2.3

0.21

g/l

2.16

919

5519

Ischaemic Stroke, excluding all haemorrhages

3758

21103

1.35

57.51

2.1

2.3

0.20

g/l

3.97

3436

19584

Emotional disorders and disorders of social functioning with onset specific to childhood

348

1379

2.72

57.50

3.5

3.8

0.22

0.23

g/l

0.30

327

1303

Other/unspecified cytomegaloviral diseases

209

664

3.98

57.44

4.6

2.4

0.21

0.22

g/l

0.18

200

625

Other postsurgical states

497

2378

2.32

56.94

2.8

2.2

0.20

0.21

g/l

2.31

473

2234

Postmenopausal osteoporosis with pathological fracture

536

2658

2.28

56.85

2.2

2.0

0.19

0.20

g/l

2.35

475

2459

Family history of malignant neoplasm

717

3876

1.98

56.72

2.6

2.2

0.23

0.22

g/l

2.70

687

3649

Disturbance of activity and attention

711

3717

1.96

56.45

2.8

3.1

0.23

g/l

0.37

667

3505

Visual disturbances and blindness

3406

25807

1.36

56.40

2.4

2.3

0.21

g/l

2.16

3167

24083

Malignant neoplasm of hypopharynx, including Hilmo

157

8.60

56.22

3.0

2.1

0.20

g/l

0.12

136

Malignant neoplasm of anus and anal canal, including Hilmo

133

311

5.53

56.14

1.8

2.0

0.21

0.20

g/l

0.59

127

284

Follow-up examination after treatment for malignant neoplasms

711

3856

1.99

56.07

2.9

1.9

0.20

g/l

0.83

678

3586

Other congenital malformations of the digestive system

372

1584

2.67

56.06

6.7

2.9

0.21

g/l

0.46

357

1496

Faecal incontinence

634

3316

2.07

56.03

2.2

1.9

0.21

g/l

0.80

574

3074

Somatoform disorder

1021

6143

1.76

55.71

2.4

2.3

0.23

0.21

g/l

5.33

925

5774

Gonarthrosis [arthrosis of knee](FG)

4782

21600

1.30

55.65

2.1

2.3

0.21

g/l

0.58

4441

20141

COPD, hospital admissions 1, only main diagnosis

2257

13801

1.47

55.58

2.1

2.2

0.20

g/l

0.28

2076

12767

Intentional self-harm by sharp object

213

685

3.61

55.40

3.1

2.7

0.22

0.23

g/l

0.90

206

646

Myocardial infarction

3215

16847

1.38

55.18

2.2

2.3

0.20

0.21

g/l

9.11

2945

15673

Other diseases of upper respiratory tract

7097

30328

1.24

54.59

2.4

0.22

0.21

g/l

7.71

6618

28229

Pyothorax

368

1595

2.65

54.53

2.6

2.3

0.18

0.21

g/l

6.44

340

1484

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3847

27051

1.33

54.49

2.7

2.4

0.22

g/l

1.36

3640

25354

Need for other prophylactic measures

455

2147

2.38

54.49

3.0

2.5

0.22

0.21

g/l

0.56

436

2011

Volvulus

250

903

3.25

53.70

3.0

2.0

0.19

0.21

g/l

2.07

236

840

Haemorrhage, not elsewhere classified

316

1279

2.81

53.66

2.8

2.0

0.19

0.21

g/l

2.15

288

1196

Nonischemic cardiomyopathy

728

4046

1.95

53.62

2.2

2.4

0.19

0.21

g/l

4.91

672

3772

Other headache syndromes

2563

18686

1.41

53.54

2.2

2.4

0.22

0.21

g/l

6.96

2400

17513

Other and unspecified effects of external causes

1661

11258

1.54

53.51

2.4

2.5

0.22

g/l

0.07

1534

10561

Aortic aneurysm

1499

9778

1.58

53.36

2.1

2.3

0.20

g/l

0.39

1379

9038

Vascular diseases of the intestine

330

1372

2.76

53.29

2.9

2.2

0.19

0.20

g/l

0.76

298

1271

Other viral diseases, not elsewhere classified

1165

7308

1.67

53.11

3.5

2.5

0.21

0.22

g/l

0.78

1105

6851

Organic, including symptomatic, mental disorders

3448

18488

1.36

52.95

2.1

2.2

0.20

g/l

3.20

3097

17186

Other arthrosis

3406

17326

1.36

52.68

2.2

2.3

0.21

g/l

3.59

3169

16220

L01XE Protein kinase inhibitors

438

2080

2.42

52.55

2.7

2.2

0.20

0.21

g/l

1.65

410

1951

Spondylosis

3547

21249

1.34

52.49

2.1

2.3

0.21

g/l

4.71

3265

19851

Cerebral palsy and other paralytic syndromes

764

4338

1.89

52.09

2.9

2.4

0.21

g/l

0.26

711

4056

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

156

432

4.46

52.09

2.1

2.0

0.19

0.20

g/l

0.83

136

397

Agoraphobia

227

779

3.26

52.08

2.8

2.6

0.22

0.23

g/l

1.03

206

745

Injuries to the ankle and foot

4449

30039

1.29

51.73

2.5

2.4

0.22

g/l

1.86

4127

28224

Alcohol abuse counselling and surveillance

172

515

4.19

51.65

3.9

2.5

0.18

0.22

g/l

7.43

162

483

Intentional self-harm by unspecified means

136

343

4.94

51.65

3.5

2.8

0.22

0.23

g/l

0.45

125

319

Obsessive-compulsive disorder

396

1775

2.39

51.65

3.1

2.7

0.23

g/l

0.41

370

1680

All influenza (not pneumonia)

917

5468

1.77

51.65

2.8

2.4

0.21

g/l

0.00

861

5131

Mental and behavioural disorders due to cannabinoids

216

726

3.36

51.55

2.3

2.6

0.21

0.24

g/l

6.17

187

681

Other congenital malformations of the digestive system, including avohilmo

413

1902

2.43

51.53

6.2

2.8

0.21

g/l

0.19

393

1794

DVT of lower extremities

1224

7863

1.64

51.47

2.4

2.1

0.20

0.21

g/l

1.26

1132

7337

Disorders of lacrimal system

2850

21001

1.38

51.46

2.4

2.3

0.21

g/l

2.98

2628

19615

Pruritus

778

4456

1.87

51.24

2.8

2.2

0.21

g/l

0.10

720

4170

Diffuse large B-cell lymphoma, including Hilmo

331

1394

2.65

51.21

2.4

2.0

0.19

0.20

g/l

1.35

306

1274

Diffuse large B-cell lymphoma, helper endpoint

331

1394

2.65

51.21

2.4

2.0

0.19

0.20

g/l

1.35

306

1274

Diffuse large B-cell lymphoma

331

1394

2.65

51.21

2.4

2.0

0.19

0.20

g/l

1.35

306

1274

Neuromuscular dysfunction of bladder

643

3491

2.00

51.07

2.5

2.3

0.21

g/l

0.15

591

3270

Benign neoplasm: Caecum

798

4642

1.87

51.06

2.6

2.2

0.21

0.20

g/l

3.52

759

4327

Disorders resulting from impaired renal tubular function

318

1335

2.78

50.96

2.8

2.4

0.23

0.21

g/l

3.54

299

1247

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3274

24120

1.35

50.88

2.4

0.22

0.21

g/l

5.06

3060

22573

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1052

6334

1.71

50.83

3.2

2.7

0.21

g/l

0.90

1011

5949

Sequelae of injuries, of poisoning and of other consequences of external causes

1482

9939

1.56

50.82

2.5

2.4

0.21

g/l

0.03

1378

9318

Glomerulonephritis

686

3813

1.95

50.69

2.5

2.4

0.22

0.21

g/l

2.21

646

3568

Carcinoma in situ of other and unspecified digestive organs

386

1770

2.52

50.67

2.7

2.3

0.22

0.21

g/l

3.04

364

1656

Arthropathies in other diseases classified elsewhere

301

1230

2.81

50.54

2.6

2.3

0.20

0.21

g/l

0.84

273

1169

Other disorders of lacrimal gland

2373

17359

1.42

50.39

2.4

2.3

0.22

0.21

g/l

4.27

2191

16234

Other noninfective disorders of lymphatic vessels and lymph nodes

297

1207

2.82

50.28

2.9

2.1

0.21

0.22

g/l

1.10

278

1144

Coxarthrosis [arthrosis of hip](FG)

3563

18867

1.34

50.24

2.2

2.3

0.20

0.21

g/l

2.02

3320

17540

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1113

6828

1.67

50.08

3.1

2.7

0.21

g/l

1.02

1067

6415

Charcot foot

180

565

3.94

50.04

2.4

0.19

0.22

g/l

3.43

167

536

Fitting and adjustment of other devices

2191

13883

1.44

49.98

2.3

2.1

0.20

0.21

g/l

9.58

2033

12829

Osteonecrosis

492

2476

2.22

49.80

2.3

2.2

0.21

g/l

0.36

466

2319

Clear cell adenocarcinoma of kidney

318

1334

2.67

49.69

2.0

2.1

0.21

0.20

g/l

1.46

300

1213

Hyperkinetic disorders

742

4089

1.85

49.63

2.8

3.1

0.23

g/l

0.24

695

3854

Coxarthrosis

3275

16091

1.35

49.41

2.2

2.3

0.21

g/l

0.69

3051

15019

Gonarthrosis

4040

17811

1.31

49.24

2.1

2.3

0.21

g/l

1.55

3758

16660

Benign neoplasm: Transverse colon

790

4638

1.85

48.82

3.0

2.3

0.21

0.20

g/l

1.40

747

4324

Other and unspecified injuries of head

546

2854

2.09

48.77

2.4

2.3

0.20

0.21

g/l

2.83

498

2666

Sequelae of cerebrovascular disease

2371

14849

1.41

48.67

2.1

2.2

0.20

g/l

1.37

2145

13754

Other pulmonary heart/vessel disease

373

1705

2.48

48.65

2.7

2.2

0.18

0.20

g/l

4.49

351

1586

Polyuria

1445

9739

1.56

48.64

2.5

2.2

0.21

0.20

g/l

4.85

1339

9096

Disorders of psychological development

695

3599

1.89

48.39

3.4

3.1

0.22

g/l

0.75

653

3382

Valvular operations

899

5438

1.75

48.34

2.2

2.4

0.19

0.21

g/l

14.63

834

5093

Barrett oesophagus

400

1887

2.39

48.21

2.6

2.1

0.21

g/l

0.17

376

1763

Allergic asthma (mode), excluding more controls

1178

7368

1.61

48.14

2.3

0.23

0.22

g/l

1.39

1109

6923

Malignant neoplasm of palate, including Hilmo

150

8.01

47.87

2.9

2.2

0.22

0.21

g/l

0.70

137

Haemolytic anaemias

290

1197

2.80

47.85

3.3

2.4

0.21

g/l

0.15

273

1112

Spondyloarthritis

1064

6715

1.66

47.69

2.6

2.2

0.21

g/l

0.21

987

6247

Non-allergic asthma (mode), excluding more controls

1046

6502

1.66

47.52

2.4

2.3

0.22

g/l

0.36

983

6099

Hypersplenism

109

10.55

47.49

4.5

2.6

0.18

0.22

g/l

2.32

101

Amputation of ankle bones

210

743

3.40

47.47

2.7

2.4

0.18

0.21

g/l

3.16

195

678

Poisoning by narcotics and psychodysleptics [hallucinogens]

148

421

4.23

47.16

2.4

2.6

0.22

0.23

g/l

1.33

130

393

Benign neoplasm: Ascending colon

997

6268

1.71

47.03

2.7

2.2

0.21

0.20

g/l

4.97

945

5828

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2110

15330

1.43

46.76

2.3

2.4

0.22

0.21

g/l

2.81

1998

14346

Paracetamol or NSAID medication

945

2822

1.74

46.59

2.6

3.1

0.21

g/l

2.52

882

2618

Sequelae of other external causes

423

2056

2.27

46.54

2.6

2.2

0.20

0.21

g/l

1.37

402

1913

Visual disturbances

3092

23789

1.34

46.35

2.4

2.3

0.21

g/l

2.86

2879

22223

Other abnormal findings of blood chemistry

367

1696

2.42

46.25

2.6

2.2

0.21

g/l

0.51

342

1591

Other abnormalities of plasma proteins

171

551

3.92

46.10

2.9

2.2

0.19

0.21

g/l

2.78

157

517

Enteropathic arthropathies

197

678

3.40

46.05

3.1

2.4

0.24

0.22

g/l

1.82

182

646

Superficial injury of lower leg

1625

11302

1.49

45.98

2.4

0.21

g/l

0.49

1505

10553

Vasculitis limited to skin, not elsewhere classified

235

896

3.10

45.97

2.6

2.3

0.20

0.21

g/l

0.23

218

835

Diabetic nephropathy, excluding more controls

1106

5800

1.66

45.93

2.3

2.4

0.20

0.21

g/l

2.55

1019

5349

Dilated cardiomyopathy

804

4814

1.80

45.92

2.2

2.3

0.19

0.20

g/l

3.18

744

4475

Nonorganic sleeping disorders

1286

8543

1.57

45.87

2.4

0.23

0.22

g/l

3.93

1188

8007

Malignant melanoma, including Hilmo

912

5594

1.71

45.82

2.1

0.21

0.20

g/l

3.87

859

5096

Disturbances of skin sensation

1646

11494

1.49

45.54

2.3

0.23

0.22

g/l

12.06

1530

10750

Other neurological diseases

4630

28944

1.27

45.39

2.3

0.21

g/l

1.46

4303

26889

UC patients in KELA-register (code 208), prior to 1994

339

1536

2.51

45.31

3.8

2.2

0.23

0.21

g/l

3.26

318

1441

Malignant neoplasm of bronchus and lung, including Hilmo

1106

5899

1.63

45.24

2.1

2.0

0.20

g/l

0.12

1020

5345

Rheumatism, unspecified

886

5448

1.73

45.06

2.2

0.22

0.21

g/l

3.16

834

5115

Inflammatory diseases of female pelvic organs

3591

19195

1.31

44.81

2.4

2.2

0.22

g/l

1.45

3362

17982

Biliary cirrhosis, NAS

108

13.61

44.72

5.8

2.9

0.18

0.21

g/l

2.89

102

Hypocalcemia

220

828

3.19

44.49

3.1

2.4

0.19

0.21

g/l

3.01

205

780

Emotional disorders starting during childhood or adolescence

319

1386

2.49

44.41

3.4

3.8

0.22

0.23

g/l

0.23

299

1308

ILD-related respiratory insufficiency

296

1284

2.69

44.40

2.2

0.20

g/l

0.25

278

1199

Shoulder lesions

4713

22762

1.27

44.19

2.2

2.3

0.22

0.21

g/l

7.76

4431

21234

Malignant neoplasm of gallbladder, including Hilmo

172

6.87

44.18

3.6

1.9

0.19

0.20

g/l

0.83

152

Secondary right heart disease

334

1521

2.49

44.03

2.6

2.1

0.18

0.20

g/l

4.37

313

1411

Procreative management

1992

11854

1.43

43.96

2.7

2.6

0.23

0.22

g/l

2.07

1901

11154

Irregular menses

2614

14753

1.36

43.83

2.7

2.2

0.23

0.22

g/l

3.54

2455

13869

Malignant neoplasm of other connective and soft tissue, including Hilmo

275

1143

2.68

43.74

2.3

2.1

0.21

0.20

g/l

0.39

267

1044

Type 1 diabetes, wide definition

1230

8159

1.57

43.70

2.4

2.5

0.19

0.22

g/l

36.01

1120

7656

Malignant melanoma

816

4927

1.74

43.69

2.1

0.21

0.20

g/l

3.31

766

4489

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

547

2974

2.01

43.63

3.0

2.2

0.21

g/l

0.30

513

2780

Malignant neoplasm of palate

15.25

43.52

3.0

2.6

0.22

0.21

g/l

0.05

Zoster [herpes zoster]

1234

8251

1.57

43.48

2.5

2.2

0.21

0.20

g/l

0.89

1162

7675

Urticaria

1765

12587

1.45

43.35

2.5

2.4

0.22

g/l

1.01

1647

11824

Other degenerative diseases of the nervous system

1763

9092

1.46

43.29

2.1

2.3

0.20

g/l

1.28

1583

8508

Psoriatic and enteropathic arthropathies

743

4409

1.79

43.11

2.6

2.3

0.22

0.21

g/l

0.67

697

4141

Myocardial infarction, without ST-elevation

2584

17672

1.36

42.94

2.1

2.2

0.19

0.20

g/l

3.81

2340

16345

Statin medication

3931

17496

1.29

42.78

2.3

2.5

0.23

0.21

g/l

26.66

3672

16372

Haemorrhoids and perianal venous thrombosis

2020

14650

1.41

42.77

2.3

2.1

0.21

g/l

2.33

1881

13590

Injuries to unspecified part of trunk, limb or body region

694

4062

1.83

42.73

2.4

2.3

0.21

g/l

0.54

636

3788

Other and unspecified disorders of skin and subcutaneous tissue

449

2304

2.14

42.62

2.9

2.3

0.20

0.21

g/l

1.32

412

2153

Drug-induced osteoporosis with pathological fracture

171

579

3.71

42.49

3.8

2.3

0.21

g/l

0.01

164

541

Open wound of forearm

642

3678

1.87

42.43

2.6

2.3

0.21

g/l

0.78

601

3434

Other dialysis

263

1104

2.79

42.38

2.8

2.6

0.22

0.21

g/l

1.59

256

1031

Other disorders of bladder

787

4774

1.76

42.35

2.3

2.2

0.20

g/l

0.03

716

4469

Open wound of ankle and foot

677

3941

1.83

42.25

2.4

0.20

0.21

g/l

2.90

628

3698

Drug-induced adrenocortical insufficiency

178

615

3.53

42.21

3.2

2.4

0.23

0.21

g/l

2.28

164

582

Non-small cell lung cancer, including Hilmo

793

4493

1.73

41.86

2.1

2.0

0.20

g/l

0.88

729

4074

Colonic or urogenital fistula

1652

11754

1.46

41.61

2.6

2.3

0.21

g/l

1.22

1552

10981

Carcinoid syndrome

120

334

5.01

41.54

2.5

2.4

0.22

0.21

g/l

0.55

113

313

Infections with a predominantly sexual mode of transmission

1585

11130

1.47

41.50

2.6

2.4

0.23

0.22

g/l

0.46

1474

10474

Encephalopathy

120

331

4.84

41.48

5.5

2.3

0.15

0.21

g/l

11.42

113

307

Left hemicolectomy

210

801

3.14

41.47

2.8

2.3

0.20

g/l

0.88

194

743

Degeneration of nervous system due to alcohol

213

824

3.13

41.14

3.1

2.4

0.18

0.21

g/l

5.92

187

761

Allergic asthma (mode)

1178

7634

1.55

41.10

2.3

0.23

0.22

g/l

2.69

1109

7177

Diseases of salivary glands

2004

14745

1.41

41.07

2.5

2.3

0.22

0.21

g/l

1.74

1879

13781

Degeneration of the brain due to alcohol

213

826

3.12

40.95

3.1

2.4

0.18

0.21

g/l

5.63

187

764

Postprocedural endocrine and metabolic disorders, not elsewhere classified

744

4478

1.76

40.71

2.4

2.2

0.22

0.21

g/l

2.90

707

4232

Cardiac arrest

411

1731

2.16

40.60

2.5

2.3

0.19

0.21

g/l

4.68

380

1628

Iron deficiency

200

736

3.00

40.32

3.0

2.6

0.22

0.23

g/l

0.55

189

697

Anosmia

114

279

4.25

40.11

2.4

2.1

0.22

g/l

0.23

105

269

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

626

3637

1.86

40.06

2.3

0.21

g/l

0.53

590

3413

Failure and rejection of transplanted organs and tissues

137

418

4.08

40.00

6.8

2.8

0.23

0.22

g/l

0.74

130

397

Malignant neoplasm, without specification of site

220

858

2.85

39.84

2.1

1.9

0.17

0.19

g/l

2.14

194

778

Oesophagitis

387

1932

2.20

39.68

2.6

2.1

0.20

0.21

g/l

1.23

357

1796

malignant neoplasm of male genital organs, including Hilmo

1472

6107

1.49

39.42

2.2

0.21

0.20

g/l

1.31

1364

5560

Other infectious diseases

514

2826

1.97

39.36

3.1

2.2

0.20

0.21

g/l

0.61

473

2625

Other infectious diseases, including avohilmo

601

3459

1.87

39.35

3.1

2.2

0.20

0.21

g/l

0.77

557

3220

Hyperparathyroidism

1179

7882

1.55

39.31

2.5

2.1

0.22

0.20

g/l

7.76

1101

7301

Disorder of lipoprotein metabolism, unspecified

839

5267

1.69

39.26

2.2

0.21

0.20

g/l

3.68

767

4921

Disorders of oesophagus in diseases classified elsewhere

198

753

3.13

39.22

3.3

2.0

0.19

0.21

g/l

2.59

184

699

Abdominal aortic aneurysm (AAA)

620

3562

1.83

39.07

1.9

2.2

0.20

0.19

g/l

1.14

567

3245

Traumatic subarachnoid haemorrhage

280

1238

2.52

39.02

2.6

2.3

0.19

0.20

g/l

1.61

258

1165

Superficial injury of hip and thigh

969

6286

1.62

38.96

2.4

2.2

0.20

0.21

g/l

3.34

886

5840

Ulcerative proctitis

395

1991

2.15

38.95

3.1

2.2

0.23

0.22

g/l

4.76

369

1862

Other immunodeficiencies

118

333

4.51

38.94

4.8

3.2

0.23

0.22

g/l

0.31

112

318

Acquired haemolytic anaemia

213

842

2.98

38.91

3.5

2.3

0.21

g/l

0.01

202

782

Localized swelling, mass and lump of skin and subcutaneous tissue

1984

14719

1.39

38.60

2.4

2.3

0.21

g/l

2.50

1895

13739

Benign neoplasm of other and unspecified endocrine glands

862

5482

1.67

38.45

2.3

0.22

0.21

g/l

3.36

812

5138

Follow-up care involving plastic surgery

275

1215

2.52

38.44

2.5

2.1

0.20

0.22

g/l

2.46

259

1152

Sleep disorders

5521

31657

1.22

38.33

2.2

2.4

0.22

0.21

g/l

19.77

5152

29606

Other and unspecified vasculitis limited to skin

204

794

3.01

38.31

2.6

2.4

0.20

0.21

g/l

0.45

190

739

Non-Hodgkin lymphoma, all

281

1249

2.47

38.31

2.1

2.0

0.18

0.19

g/l

1.55

253

1122

Nephrotic syndrome

254

1095

2.67

38.30

2.6

2.8

0.23

0.21

g/l

2.98

240

1032

Unspecified acute lower respiratory infection

957

6218

1.62

38.27

2.7

2.3

0.21

g/l

1.04

890

5801

Non-allergic asthma (mode)

1046

6839

1.57

38.20

2.4

2.2

0.22

0.21

g/l

1.19

983

6397

Hypercalcemia

355

1758

2.28

38.11

3.0

2.2

0.19

0.21

g/l

1.68

326

1640

Zoster [herpes zoster], including avohilmo

3293

25249

1.29

38.09

2.3

2.2

0.21

g/l

1.52

3098

23483

Fall on and from stairs and steps

1640

11837

1.44

38.03

2.5

2.3

0.21

g/l

0.01

1519

11043

Wide developmental disorders, excluding more controls

187

664

2.99

37.99

2.8

4.1

0.23

g/l

0.16

173

639

Psoriasis (vulgaris), strict definition

266

1169

2.57

37.98

3.0

2.4

0.22

g/l

0.12

254

1101

Oesophageal obstruction

281

1267

2.51

37.95

2.7

2.0

0.19

0.20

g/l

1.86

264

1169

Recurrent aphthous stomatitis , including avohilmo

915

5906

1.63

37.93

2.6

2.3

0.21

g/l

0.69

847

5536

Other viral diseases, not elsewhere classified, including avohilmo

1533

10856

1.45

37.75

3.2

2.5

0.22

g/l

0.47

1460

10186

Other diseases of gallbladder

316

1489

2.35

37.75

2.8

1.9

0.21

g/l

0.33

300

1368

Sicca syndrome [Sjögren]

568

3269

1.88

37.50

2.5

2.2

0.21

g/l

0.02

527

3074

Malignant neoplasm of endocrine gland, including Hilmo

443

2344

2.01

37.48

2.0

2.2

0.22

0.21

g/l

3.70

421

2162

Polyarthrosis

1348

8470

1.50

37.47

2.1

2.2

0.20

0.21

g/l

0.59

1243

7935

Varicose veins

3699

22443

1.27

37.36

2.2

2.1

0.20

0.21

g/l

20.39

3438

20907

Other and unspecified psoriasis

476

2604

1.99

37.32

2.8

2.2

0.21

g/l

0.70

446

2432

Malignant neoplasm of other and unspecified female genital organs

140

450

3.76

37.28

1.7

1.9

0.19

0.20

g/l

1.08

130

417

malignant neoplasm of male genital organs

1434

6000

1.48

37.28

2.2

0.21

0.20

g/l

1.26

1328

5463

Emphysema

510

2847

1.94

37.22

2.1

2.2

0.20

g/l

0.25

470

2643

Chronic sinusitis

2533

19519

1.33

37.00

2.5

2.3

0.22

0.21

g/l

6.07

2373

18272

Myelodysplastic syndrome, including Hilmo

208

825

2.83

36.73

2.2

2.0

0.18

0.19

g/l

0.90

182

745

Combinations of oral blood glucose lowering drugs

1724

12636

1.42

36.58

2.4

2.3

0.21

g/l

2.00

1614

11815

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

136

431

3.70

36.57

2.1

1.9

0.18

0.20

g/l

2.27

128

391

Acquired absence of limb

112

320

4.51

36.50

2.7

2.3

0.19

0.21

g/l

0.84

103

297

Sulfasalazine

1601

11565

1.43

36.48

2.6

2.2

0.22

0.21

g/l

1.27

1486

10792

Other coagulation defects

485

2679

1.95

36.45

2.6

2.2

0.21

g/l

0.10

460

2506

Hidradenitis suppurativa

249

1078

2.55

36.16

2.5

2.4

0.22

g/l

0.09

239

1020

Cerebral cysts

377

1923

2.13

36.09

3.8

2.5

0.20

0.21

g/l

3.16

353

1797

Lumbar disc prolapse

3876

23268

1.26

35.79

2.3

0.22

0.21

g/l

11.26

3605

21796

Morphin

184

700

3.01

35.68

2.3

1.9

0.19

0.20

g/l

1.01

174

656

Myocarditis

278

1261

2.38

35.64

2.2

0.22

0.23

g/l

1.39

263

1185

Special screening examination for other diseases and disorders

691

4213

1.72

35.54

2.2

2.1

0.21

g/l

0.39

652

3930

Diseases of the ear and mastoid process

7050

30121

1.19

35.33

2.4

0.22

0.21

g/l

2.59

6624

28095

Injuries to the neck

1336

9415

1.47

35.32

2.2

2.4

0.22

0.21

g/l

0.74

1233

8804

Other and unspecified coagulation defects

338

1675

2.21

35.26

2.8

2.3

0.22

g/l

0.10

321

1573

Rheumatoid arthritis

1920

12681

1.38

35.25

2.2

2.3

0.20

0.21

g/l

2.48

1782

11882

Mental retardation, excluding more controls

245

1025

2.54

35.18

3.0

3.3

0.21

0.22

g/l

0.09

233

977

Malignant neoplasm of vulva

250

4.81

35.18

2.4

1.9

0.22

0.20

g/l

2.13

235

Idiopathic pulmonary fibrosis

540

3128

1.87

35.09

2.1

0.21

0.20

g/l

3.81

507

2888

Alcoholic gastritis

138

458

3.67

35.06

3.9

2.1

0.18

0.21

g/l

3.36

122

421

Ovarian cyst

1880

7924

1.39

34.53

2.3

2.2

0.22

0.21

g/l

4.47

1778

7384

Other blood glucose lowering drugs, excl. Insulins

994

6673

1.57

34.53

2.4

2.2

0.20

g/l

0.81

923

6217

Familial hypercholesterolemia

925

6113

1.59

34.48

2.3

2.2

0.20

g/l

0.49

863

5695

Adenocarcinoma of small intestine

11.57

34.45

7.2

1.8

0.19

0.22

g/l

1.20

Superficial injury of thorax

932

6166

1.58

34.39

2.4

2.3

0.20

0.21

g/l

1.75

855

5778

L02BA Anti-estrogens

1003

6749

1.56

34.36

1.7

2.2

0.22

0.21

g/l

3.06

957

6305

Malignant neoplasm of vulva, including Hilmo

115

346

4.00

33.90

2.6

1.9

0.22

0.20

g/l

2.24

107

324

Need for immunization against other single viral diseases

167

627

3.16

33.85

2.8

2.5

0.24

0.21

g/l

4.17

156

583

Other disorders of white blood cells

384

2028

2.08

33.79

2.6

2.3

0.21

g/l

0.50

354

1897

Migraine

2800

17134

1.30

33.67

2.5

0.23

0.22

g/l

11.49

2639

16110

Sub-endpoint used in defining T1D endpoints

1655

11983

1.40

33.52

2.5

0.19

0.21

g/l

32.67

1505

11162

Infection of intervertebral disc (pyogenic)

139

479

3.58

33.43

3.2

2.3

0.19

0.20

g/l

0.60

125

444

Other symptoms and signs involving general sensations and perceptions

311

1531

2.25

33.36

2.1

2.4

0.20

g/l

0.69

287

1430

Hypopituitarism

472

2660

1.91

33.26

2.8

2.7

0.22

g/l

0.64

446

2504

Lung cancer and mesothelioma

1119

6520

1.51

33.25

2.1

0.20

0.21

g/l

2.28

1036

6068

Other symptoms and signs involving the nervous and musculoskeletal systems

2487

19429

1.31

33.20

2.2

2.4

0.21

g/l

2.18

2309

18157

Benign neoplasm: Adrenal gland

545

3219

1.84

33.19

2.2

2.3

0.22

0.21

g/l

2.97

509

3029

Convalescence

338

1710

2.14

33.13

2.8

2.2

0.21

0.22

g/l

0.55

309

1616

Bronchiectasis

540

3180

1.83

33.05

2.7

2.2

0.20

g/l

0.91

509

2966

Pericarditis

256

1171

2.43

33.03

2.6

2.3

0.21

0.22

g/l

0.61

237

1105

Other condition

877

5785

1.59

32.90

2.8

2.4

0.20

0.21

g/l

3.33

828

5424

Persons with potential health hazards related to communicable diseases

1947

14578

1.36

32.83

2.7

2.6

0.22

g/l

0.30

1824

13722

Superficial injury of abdomen, lower back and pelvis

937

6261

1.56

32.83

2.4

0.22

0.21

g/l

0.85

853

5862

Maltreatment syndromes

309

1513

2.20

32.83

2.4

2.5

0.21

0.23

g/l

3.04

270

1428

Non-follicular lymphoma

632

3885

1.75

32.82

2.3

2.2

0.19

0.20

g/l

5.46

589

3615

Gingival hyperplasia

285

1373

2.33

32.78

4.0

2.9

0.22

0.21

g/l

2.15

269

1291

Deforming dorsopathies

1683

12480

1.39

32.72

2.3

2.4

0.22

0.21

g/l

2.16

1572

11703

Asthma and allergy, excluding more controls

622

3714

1.71

32.61

2.5

0.23

g/l

1.23

582

3502

Malignant neoplasm of prostate

1371

5733

1.46

32.56

2.2

2.1

0.21

0.20

g/l

1.29

1263

5213

Dissocial personality disorder

133

448

3.50

32.54

2.1

2.7

0.21

0.23

g/l

1.39

118

418

Malignant melanoma of skin, including Hilmo

716

4507

1.66

32.53

2.1

0.21

0.20

g/l

3.34

674

4118

Pneumocystosis

177

704

3.03

32.48

2.7

2.4

0.22

0.21

g/l

1.27

162

657

Pneumocystosis, including avohilmo

177

704

3.03

32.48

2.7

2.4

0.22

0.21

g/l

1.27

162

657

Drug-induced cataract

200

838

2.78

32.43

5.0

2.5

0.22

0.21

g/l

0.23

194

786

Appendectomy

3722

28999

1.24

32.30

2.4

2.3

0.22

g/l

1.63

3496

27190

Other follicular disorders

456

2562

1.90

32.23

2.6

2.3

0.22

g/l

0.69

439

2417

Malignant neoplasm of prostate, including Hilmo

1392

5830

1.45

32.21

2.3

2.1

0.21

0.20

g/l

1.55

1284

5305

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

324

1589

2.14

32.15

3.4

3.7

0.22

g/l

0.85

304

1513

Dependence on enabling machines and devices, not elsewhere classified

119

381

3.88

32.14

4.1

3.0

0.23

0.21

g/l

1.59

113

357

therapeutic use

244

1116

2.48

32.08

3.1

2.1

0.20

g/l

0.04

228

1036

Myocardial infarction, strict

2831

15896

1.29

32.07

2.2

2.3

0.20

0.21

g/l

5.75

2587

14779

Hypoparathyroidism

277

1333

2.34

31.98

3.0

2.1

0.20

0.21

g/l

0.94

259

1246

Monoamine oxidase A inhibitors

677

4238

1.68

31.93

2.3

0.21

g/l

1.17

625

4000

Secondary thrombocytopenia

124

411

3.74

31.87

3.9

2.5

0.18

0.21

g/l

4.47

117

389

Vitamin D deficiency

148

533

3.19

31.87

3.5

2.4

0.19

0.22

g/l

6.00

137

500

Dermatitis due to substances taken internally

368

1950

2.05

31.71

3.2

2.4

0.21

g/l

0.39

336

1825

Arterial embolism and thrombosis

381

2040

2.02

31.67

2.3

2.1

0.19

0.20

g/l

1.61

350

1889

Disorders of continuity of bone

616

3781

1.73

31.61

2.6

2.3

0.22

g/l

0.12

567

3557

Infections with a predominantly sexual mode of transmission, including avohilmo

2004

13961

1.34

31.51

2.6

2.4

0.23

0.22

g/l

0.57

1861

13148

Malignant neoplasm of mesothelium and soft tissue

245

1118

2.40

31.48

2.2

2.0

0.20

g/l

0.12

232

1014

Other specified/unspecified systemic involvement of connective tissue

380

2043

2.02

31.48

2.8

2.2

0.21

g/l

0.44

353

1919

Insomnia

5387

31705

1.20

31.46

2.2

2.4

0.22

0.21

g/l

18.96

5042

29649

Unspecified urinary incontinence

589

3591

1.75

31.42

2.8

2.2

0.20

0.21

g/l

2.71

532

3353

Malignant neoplasm of endocrine gland

379

2024

1.99

31.28

2.0

2.2

0.23

0.21

g/l

3.83

360

1867

Event of undetermined intent

407

2234

1.96

31.23

2.6

2.4

0.21

0.22

g/l

1.75

372

2095

Other and unspecified urticaria

1119

7819

1.49

31.19

2.6

2.4

0.22

g/l

0.58

1049

7350

Pyogenic arthritis

432

2417

1.92

31.18

2.5

2.3

0.20

0.21

g/l

1.75

400

2276

Thiazolidinediones

713

4578

1.65

30.73

2.8

2.2

0.20

g/l

0.12

665

4278

Personal history of other diseases and conditions

593

3597

1.72

30.71

3.2

2.6

0.22

g/l

0.18

557

3392

Malignant neoplasm of other and ill-defined sites, including Hilmo

119

386

3.55

30.67

2.5

2.0

0.18

0.20

g/l

1.50

113

349

Periapical abscess

2781

22253

1.28

30.52

2.4

0.21

g/l

0.34

2594

20865

Necrotizing fasciitis

172

5.89

30.50

2.8

2.2

0.17

0.22

g/l

5.48

159

Dissociative [conversion] disorders

224

994

2.44

30.49

2.6

2.3

0.23

0.22

g/l

0.91

204

943

Use of pramipexole

1354

9853

1.43

30.32

2.3

2.2

0.21

g/l

0.88

1242

9164

D07AA Corticosteroids, weak (group I)

864

5760

1.56

30.31

2.7

2.6

0.21

0.22

g/l

0.23

807

5408

Tubulo-interstitial nephritis, not specified as acute or chronic

419

2342

1.91

30.18

2.4

2.1

0.20

0.21

g/l

0.62

386

2174

Injury of intra-abdominal organs

188

785

2.70

30.13

2.9

2.5

0.21

0.22

g/l

0.52

179

740

Subjective visual disturbances

1532

11360

1.40

30.13

2.4

2.3

0.22

0.21

g/l

3.45

1429

10609

Idiopathic thrombocytopenic purpura

224

1012

2.49

30.12

3.9

2.4

0.20

0.21

g/l

0.96

217

946

Fracture of forearm

3361

24645

1.25

30.03

2.4

2.3

0.21

g/l

7.70

3095

23036

Open wound of abdomen, lower back and pelvis

223

1003

2.47

30.02

3.2

2.5

0.22

g/l

0.23

205

942

Acetic acid derivatives and related substances

1582

5975

1.40

29.94

2.2

2.4

0.21

0.20

g/l

5.26

1457

5534

Other and unspecified aplastic anaemias

109

346

3.86

29.91

2.8

2.7

0.21

g/l

0.10

101

319

Congenital malformations of the circulatory system

860

5598

1.56

29.88

3.2

2.8

0.21

0.22

g/l

2.36

828

5272

Viral pneumonia (unknown virus, not influenza)

433

2458

1.89

29.83

2.6

2.3

0.22

0.21

g/l

0.29

400

2300

Pneumonia due to other infectious organisms, not elsewhere classified

238

1104

2.40

29.83

2.9

2.3

0.21

g/l

0.33

222

1041

Burns and corrosions

806

5332

1.58

29.80

2.7

2.5

0.21

0.22

g/l

0.77

756

5002

Magnesium deficiency

109

8.27

29.71

4.5

2.5

0.21

0.22

g/l

0.36

102

Soft tissue disorders related to use, overuse and pressure

1695

12787

1.37

29.62

2.2

2.3

0.22

0.21

g/l

5.40

1573

11970

Folate deficiency anaemia

109

350

3.90

29.62

2.7

2.3

0.18

0.21

g/l

2.63

100

323

Methotrexate

795

5251

1.58

29.54

2.6

2.1

0.21

g/l

0.48

749

4893

Amiodarone users

652

4147

1.68

29.52

2.3

0.20

g/l

0.20

606

3862

Fracture of foot, except ankle

1414

10376

1.41

29.49

2.5

2.4

0.21

0.22

g/l

0.30

1292

9727

Carcinoma in situ of endometrium

148

6.41

29.44

1.4

2.3

0.24

0.21

g/l

2.50

141

Alcohol induced polyneuropathy

109

353

3.93

29.43

3.3

2.4

0.18

0.21

g/l

1.70

330

Asthma and allergy

621

3808

1.67

29.33

2.5

0.23

g/l

1.77

581

3589

Mixed disorders of conduct and emotions, excluding more controls

110

344

3.46

29.21

2.6

3.8

0.23

g/l

0.10

104

331

Shock, not elsewhere classified

260

4.27

29.16

4.0

2.1

0.18

0.21

g/l

1.77

245

Erosion of teeth , including avohilmo

1467

10846

1.39

29.06

2.9

2.5

0.22

g/l

2.16

1382

10189

Injury of unspecified body region

497

2958

1.80

29.04

2.4

2.3

0.21

g/l

0.37

457

2763

Congenital malformations of the urinary system, including avohilmo

400

2240

1.93

29.04

3.3

2.6

0.22

0.21

g/l

0.54

380

2109

Ulcer of oesophagus

433

2484

1.87

28.91

2.7

2.0

0.20

g/l

0.75

404

2310

Other abnormal uterine and vaginal bleeding

1309

6787

1.43

28.88

2.2

0.21

g/l

0.47

1203

6302

Benign neoplasm: Descending colon

490

2925

1.81

28.80

3.0

2.2

0.21

g/l

1.79

471

2719

Malignant neoplasm of parotid gland, including Hilmo

253

4.29

28.74

1.8

2.0

0.23

0.20

g/l

3.30

225

Focal brain injury

395

2199

1.91

28.72

2.5

2.4

0.20

0.21

g/l

0.33

364

2057

Other specified/unspecified bacterial intestinal infections

437

2522

1.87

28.70

2.9

2.2

0.21

g/l

0.20

416

2356

Sequelae of injuries of head

348

1876

2.01

28.55

2.6

2.4

0.21

0.22

g/l

0.91

319

1751

Dermatophytosis, including avohilmo

3927

32074

1.22

28.54

2.2

2.4

0.22

0.21

g/l

2.98

3645

30000

Blood alcohol or alcohol intoxication level

171

700

2.75

28.50

2.3

2.6

0.22

g/l

0.31

153

663

Diabetic retinopathy, excluding more controls

1755

7420

1.38

28.50

2.5

2.4

0.19

0.22

g/l

24.02

1623

6858

Personal history of certain other diseases

121

411

3.28

28.46

2.8

2.3

0.20

0.23

g/l

3.02

106

382

Chronic rhinitis, nasopharyngitis and pharyngitis

1880

14453

1.34

28.44

2.4

0.23

0.21

g/l

16.26

1740

13529

Diabetic nephropathy

1112

7856

1.48

28.32

2.3

2.4

0.20

g/l

0.03

1024

7262

SLE (Finngen)

231

1079

2.36

28.29

2.6

2.1

0.19

0.22

g/l

4.39

216

1032

Other disorders of ear

5694

31529

1.18

28.28

2.3

2.4

0.21

g/l

1.10

5302

29407

Acute gastritis

459

2692

1.82

28.16

2.6

2.0

0.19

0.21

g/l

3.03

423

2508

Acute myeloid leukaemia and myelodysplastic syndromes

159

632

2.81

28.05

1.9

2.0

0.19

g/l

0.37

141

575

Complications of cardiac and vascular prosthetic devices, implants and grafts

166

681

2.80

27.97

2.8

2.2

0.20

g/l

0.01

160

627

Childhood asthma (age<16), excluding more controls

533

2489

1.72

27.91

2.9

2.7

0.23

0.24

g/l

0.40

507

2336

Atopic dermatitis, strict definition with reimbursement

1542

11075

1.37

27.91

2.8

2.5

0.22

g/l

0.24

1442

10432

Cystic kidney disease, including avohilmo

246

1190

2.30

27.86

3.6

2.5

0.22

0.21

g/l

0.97

236

1113

Other aneurysm

356

1950

1.98

27.80

3.0

2.2

0.20

g/l

0.85

332

1813

Generalized skin eruption due to drugs and medicaments

271

1359

2.20

27.71

3.4

2.4

0.21

g/l

0.76

246

1259

Acute suppurative otitis media

1296

8792

1.41

27.71

3.0

2.6

0.22

0.23

g/l

0.71

1222

8258

Diabetic neuropathy

801

5400

1.58

27.57

2.8

2.4

0.19

0.21

g/l

9.16

736

5003

Malignant neoplasm of gallbladder

120

6.30

27.56

3.7

2.0

0.18

0.21

g/l

1.75

107

Acute generalized exanthematous pustulosis

306

1604

2.09

27.53

3.2

2.4

0.21

g/l

0.61

277

1492

Migraine without aura

998

6966

1.47

27.49

2.7

2.6

0.23

0.22

g/l

1.56

947

6610

Manic episode

196

866

2.49

27.32

2.3

2.4

0.22

g/l

0.32

179

823

Small fibre neuropathy

233

1119

2.36

27.26

3.0

2.4

0.22

0.21

g/l

1.37

222

1044

Congenital malformations of the urinary system

373

2086

1.93

27.25

3.5

2.7

0.22

0.21

g/l

0.88

356

1964

Diseases of external ear

2130

16753

1.31

27.24

2.5

2.4

0.21

g/l

2.00

1976

15630

Status epilepticus

262

1307

2.21

27.19

2.8

2.4

0.20

0.21

g/l

1.15

248

1221

Malignant neoplasm of retroperitoneum and peritoneum

193

4.81

27.17

2.1

0.19

0.21

g/l

0.59

173

Disorders of porphyrin and bilirubin metabolism

106

350

3.65

27.16

3.5

2.8

0.23

0.21

g/l

1.74

332

Carcinoma in situ of colon

238

1159

2.35

27.12

2.8

2.3

0.22

0.21

g/l

1.99

223

1088

Disorders of breast

2705

19194

1.27

27.09

2.1

2.2

0.22

0.21

g/l

10.30

2545

17963

Dermatophytosis

841

5737

1.54

27.07

2.3

0.21

g/l

0.57

770

5361

Fall on same level involving ice and snow

3505

29068

1.23

27.04

2.4

2.3

0.21

g/l

2.87

3255

27144

Thiamine deficiency

184

5.26

26.98

3.2

2.7

0.17

0.22

g/l

5.12

168

Discitis, unspecified

147

581

2.96

26.97

2.6

2.2

0.18

0.20

g/l

2.31

137

540

Eosinophilic disease (BM)

121

430

3.26

26.88

2.2

0.21

0.22

g/l

0.61

113

401

Other necrotizing vasculopathies (FG)

391

2228

1.89

26.86

2.5

2.2

0.22

0.20

g/l

2.52

363

2086

Childhood asthma (age<16)

534

2522

1.70

26.84

2.9

2.7

0.23

0.24

g/l

0.33

508

2367

Other disorders starting during childhood or adolescence

302

1562

2.05

26.75

3.6

4.0

0.22

g/l

0.06

285

1487

Degeneration of macula and posterior pole

3025

19072

1.25

26.72

2.2

0.20

g/l

0.53

2763

17663

Autism spe, excluding more controls

128

460

3.00

26.71

3.0

3.6

0.24

0.23

g/l

0.33

116

441

Infective dermatitis

675

4409

1.61

26.69

2.5

2.3

0.20

0.21

g/l

2.46

626

4122

Oter anti-inflammatory and antirheumatic agents, non-steroids

1299

5169

1.42

26.63

2.2

2.3

0.21

0.20

g/l

3.78

1190

4780

Disease of hard tissues of teeth, NOS

3107

13217

1.25

26.61

2.2

0.22

0.21

g/l

14.92

2916

12303

Presence of other devices

1416

10396

1.38

26.56

2.4

2.1

0.20

g/l

0.70

1333

9605

Excessive, frequent and irregular menstruation

2008

8274

1.32

26.55

2.5

2.3

0.22

0.21

g/l

2.10

1881

7705

Pneumonia derived septicemia

249

1232

2.24

26.54

3.3

2.6

0.19

0.21

g/l

2.17

224

1139

Disorders of tooth development and eruption

879

4885

1.51

26.52

2.6

2.3

0.22

0.21

g/l

4.70

833

4605

Focal epilepsy

1234

9025

1.42

26.50

2.5

0.21

g/l

0.58

1144

8430

Malignant neoplasm of bronchus and lung

899

5164

1.50

26.43

2.1

2.0

0.20

g/l

0.22

826

4672

Deficiency of other B group vitamins

159

654

2.75

26.42

3.0

2.2

0.19

0.21

g/l

2.82

151

602

Mental disorders, not otherwise specified

446

2633

1.79

26.41

2.3

2.4

0.23

0.22

g/l

2.23

417

2489

Schizoaffective disorder

429

2511

1.81

26.38

2.0

2.4

0.22

g/l

0.30

388

2371

Malignant neoplasm of thyroid gland, including Hilmo

369

2064

1.89

26.31

2.0

2.2

0.23

0.21

g/l

4.03

354

1899

Systemic sclerosis (FG)

180

787

2.59

26.29

2.8

2.1

0.20

0.21

g/l

1.67

168

744

Tobacco use

347

1920

1.95

26.24

2.3

0.21

0.22

g/l

0.80

313

1803

Later onset COPD

1727

10644

1.35

26.21

2.0

2.1

0.19

g/l

3.17

1567

9813

Coeliac disease

691

4555

1.59

26.12

3.1

2.3

0.21

g/l

2.88

635

4280

Abnormal findings on examination of urine, without diagnosis

296

1566

2.07

25.96

2.4

2.5

0.21

g/l

0.59

279

1466

Internal derangement of knee

2137

16719

1.29

25.92

2.4

0.22

0.21

g/l

2.59

1978

15653

Burns and corrosions of external body surface, specified by site

635

4117

1.62

25.91

2.7

2.5

0.21

0.22

g/l

0.70

594

3855

Urolithiasis

1882

14683

1.32

25.79

2.6

2.3

0.21

g/l

3.77

1748

13652

Carrier of infectious disease

177

772

2.57

25.78

2.6

2.4

0.20

0.22

g/l

1.34

164

732

Other mental disorders due to brain damage and dysfunction and to physical disease

747

5035

1.56

25.70

2.2

2.1

0.20

g/l

0.20

674

4678

Other disorders involving the immune mechanism, not elsewhere classified

227

1101

2.29

25.61

2.7

2.8

0.22

g/l

0.15

215

1035

Migraine with aura

1267

9331

1.39

25.49

2.4

2.5

0.23

0.22

g/l

6.04

1204

8803

Malignant melanoma of skin

580

3686

1.64

25.48

2.0

0.21

0.20

g/l

2.60

543

3371

Artrosis, including avohilmo

4912

22918

1.19

25.42

2.2

2.4

0.21

g/l

0.78

4576

21380

Protozoal diseases

225

1095

2.31

25.42

2.6

2.4

0.22

0.21

g/l

0.57

206

1031

Thoracic aortic aneurysm

867

6029

1.51

25.39

2.2

2.4

0.21

0.20

g/l

0.09

799

5641

Coxibs

1556

6112

1.37

25.34

2.1

2.5

0.21

0.20

g/l

6.18

1440

5661

Other ill-defined and unspecified causes of mortality

583

3740

1.65

25.32

2.3

2.1

0.18

0.20

g/l

7.09

526

3460

Other surgical follow-up care

210

984

2.32

25.31

2.7

2.3

0.21

0.22

g/l

1.45

201

922

Congenital malformations of heart and great arteries

746

4879

1.55

25.29

3.1

2.8

0.20

0.22

g/l

3.61

722

4596

Adverse effects, not elsewhere classified

1085

7833

1.43

25.19

2.5

2.4

0.22

g/l

0.93

1018

7354

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2045

15914

1.30

25.15

2.5

0.23

0.22

g/l

3.81

1912

14976

Other misadventures during surgical and medical care

188

856

2.49

25.12

3.0

2.4

0.20

0.21

g/l

2.11

176

804

Symptoms and signs involving speech and voice

1969

15522

1.30

24.84

2.4

2.2

0.21

g/l

2.83

1827

14495

Cystic kidney disease

224

1095

2.27

24.75

3.8

2.5

0.22

0.21

g/l

1.19

216

1021

Somnolence, stupor and coma

277

1453

2.06

24.67

2.7

2.3

0.20

0.21

g/l

1.40

246

1345

Lesion of lateral popliteal nerve

321

1770

1.96

24.65

2.7

2.3

0.21

g/l

0.47

300

1657

Gonarthrosis,primary

5554

28949

1.17

24.62

2.1

2.3

0.21

g/l

0.07

5167

26932

Corns and callosities

420

2506

1.79

24.45

2.3

2.2

0.20

0.21

g/l

2.86

402

2349

Acute pharyngitis

801

5439

1.51

24.44

3.0

2.6

0.22

g/l

0.08

763

5093

Striking against or struck by other objects

1881

14729

1.31

24.43

2.5

0.22

g/l

0.16

1744

13798

Scar conditions and fibrosis of skin

261

1347

2.10

24.40

2.8

2.2

0.23

0.22

g/l

0.39

249

1269

Protozoal diseases, including avohilmo

229

1139

2.25

24.36

2.6

2.4

0.21

g/l

0.40

210

1073

Speech disturbances, not elsewhere classified

572

3686

1.64

24.34

2.5

2.2

0.21

0.20

g/l

0.07

521

3424

Fistulae involving female genital tract

136

544

2.90

24.31

2.7

2.2

0.21

g/l

0.14

124

512

Late syphilis, including avohilmo

139

564

2.87

24.23

2.6

2.3

0.20

0.21

g/l

1.22

121

525

Colorectal neuroendocrine tumor and carcinoma

103

354

3.35

24.22

2.3

2.0

0.23

0.21

g/l

1.36

326

Complications following infusion, transfusion and therapeutic injection

121

457

3.08

24.19

3.6

2.3

0.21

g/l

0.05

114

425

Pneumococcal septicemia

235

1181

2.20

24.06

3.3

2.7

0.19

0.21

g/l

2.28

212

1099

Nail disorders

507

3180

1.69

24.05

2.3

2.4

0.22

0.21

g/l

2.52

474

2986

Calculus of kidney and ureter

1736

13532

1.32

24.03

2.6

2.3

0.21

g/l

4.17

1616

12597

Other female pelvic inflammatory diseases

871

6113

1.48

24.01

2.4

2.2

0.21

g/l

0.59

809

5735

Speech and linguistic disorders

483

2855

1.70

23.99

3.9

3.2

0.22

g/l

0.67

456

2688

Malignant neoplasm of parotid gland

210

4.28

23.99

1.9

2.0

0.24

0.21

g/l

2.32

186

Non-small cell lung cancer

501

3085

1.67

23.79

2.0

1.9

0.20

0.19

g/l

0.27

459

2788

Other skin changes

1199

8898

1.40

23.75

2.7

2.2

0.21

0.20

g/l

2.40

1130

8283

Heart failure and hypertrophic cardiomyopathy

155

670

2.70

23.71

2.5

2.4

0.18

0.21

g/l

3.04

144

622

Short stature, not elsewhere classified

171

705

2.54

23.69

5.1

4.9

0.21

g/l

0.01

166

683

Fracture of neck

395

2343

1.81

23.64

2.0

2.2

0.20

0.21

g/l

0.70

366

2178

Angina pectoris

3390

18767

1.22

23.56

2.0

2.3

0.21

g/l

0.33

3128

17468

Multiple myeloma, including Hilmo

247

1263

2.10

23.55

2.4

2.0

0.19

g/l

0.09

230

1147

Menorrhagia

1776

7664

1.32

23.41

2.4

2.2

0.21

g/l

1.01

1665

7133

Unspecified event, undetermined intent

180

825

2.43

23.38

2.8

2.6

0.21

0.22

g/l

0.49

162

774

Rotator cuff syndrome

3712

21510

1.21

23.38

2.2

2.3

0.22

0.21

g/l

6.86

3476

20062

Diffuse brain injury

214

1040

2.21

23.36

2.6

2.5

0.22

0.21

g/l

0.22

198

983

Late syphilis

121

469

3.07

23.34

2.5

2.4

0.20

0.21

g/l

0.76

107

437

Polycythaemia vera

193

905

2.32

23.32

2.0

0.20

g/l

0.86

182

823

Malignant neoplasm of thyroid gland

331

1860

1.88

23.32

1.9

2.2

0.23

0.21

g/l

3.29

318

1711

Systemic sclerosis

180

830

2.45

23.28

2.8

2.1

0.20

0.21

g/l

1.73

168

779

Pain associated with micturition

709

4818

1.54

23.26

2.4

2.3

0.21

g/l

1.61

653

4524

Left ventricular outflow tract obstruction (LVOTO), broad definition

600

3947

1.60

23.23

3.0

2.6

0.20

0.22

g/l

4.13

565

3719

Systemic sclerosis, icd10

178

818

2.46

23.22

2.8

2.2

0.20

0.21

g/l

1.77

166

770

Corticotropin deficiency

251

3.97

23.20

2.9

2.8

0.21

0.22

g/l

0.20

239

Other and unspecified abdominal hernia

272

1455

2.04

23.12

2.7

2.2

0.20

g/l

0.03

262

1353

Rash and other nonspecific skin eruption

578

3775

1.61

23.06

2.5

2.3

0.22

0.21

g/l

1.67

543

3534

Fluid overload

7.20

23.06

2.3

2.9

0.19

0.20

g/l

0.42

Other extrapyramidal and movement disorders in other diseases

1466

11257

1.34

22.89

2.2

2.3

0.22

0.21

g/l

5.89

1367

10502

Assault by unspecified means

140

580

2.69

22.74

2.6

2.7

0.22

0.24

g/l

1.35

127

547

Spondylopathies (FG)

726

4966

1.52

22.74

2.5

2.3

0.22

g/l

0.49

675

4677

Ill-defined and unknown causes of mortality

619

4126

1.58

22.58

2.2

2.1

0.18

0.20

g/l

6.75

557

3808

Other necrotizing vasculopathies

457

2850

1.71

22.58

2.6

2.2

0.22

0.20

g/l

2.79

426

2658

Fall involving bed

241

1253

2.12

22.49

2.1

2.3

0.18

0.20

g/l

2.64

225

1157

Other disorders of the musculoskeletal system and connective tissue

874

6228

1.46

22.35

2.1

2.2

0.21

g/l

0.13

814

5824

Myelodysplastic syndrome

316

3.38

22.32

1.9

1.8

0.17

0.20

g/l

2.31

284

Benign neoplasm of mouth and pharynx

645

4345

1.56

22.31

2.7

2.3

0.22

0.21

g/l

2.05

611

4055

Thyroiditis, ILD-related definition

620

4138

1.56

22.08

2.7

2.2

0.21

g/l

0.03

593

3886

Abnormal involuntary movements

794

5572

1.49

22.06

2.4

0.22

0.21

g/l

4.75

743

5220

Meniscus derangement

3212

17790

1.22

22.06

2.2

2.3

0.21

g/l

2.40

3005

16653

Pneumothorax

418

2557

1.74

22.05

2.4

2.2

0.21

g/l

0.09

390

2373

Focal epilepsy, strict definition

1127

8373

1.39

22.05

2.5

0.21

g/l

0.59

1040

7817

Viral pneumonia (known virus, not influenza)

209

1043

2.23

22.00

3.1

2.7

0.20

0.21

g/l

1.47

199

968

Disorders of phosphorus metabolism and phosphatases

170

4.93

21.90

6.2

2.7

0.20

0.22

g/l

0.71

162

Sequelae of injuries of neck and trunk

201

988

2.24

21.82

2.6

2.4

0.20

0.21

g/l

0.98

189

930

Disorders of muscles

596

3960

1.57

21.78

2.4

2.3

0.21

g/l

0.67

557

3710

Other symptoms and signs involving the circulatory and respiratory systems

398

2408

1.75

21.75

2.3

0.21

g/l

0.27

371

2271

Other diseases of blood and blood-forming organs

432

2680

1.72

21.75

2.5

2.2

0.21

g/l

0.60

402

2508

Arthropathy in Crohn disease

297

3.52

21.71

3.6

2.6

0.24

0.23

g/l

1.09

277

Arthropathy in ulcerative colitis

107

402

3.11

21.70

2.9

2.6

0.23

0.22

g/l

0.57

384

Chronic tubulo-interstitial nephritis

233

1206

2.09

21.66

2.3

2.0

0.21

g/l

0.02

212

1122

Sulfonylureas

1956

12399

1.28

21.64

2.3

2.1

0.19

0.20

g/l

2.26

1798

11446

Extrapyramidal and movement disorders

2296

18714

1.26

21.62

2.1

2.3

0.21

0.20

g/l

4.07

2127

17420

Isolated proteinuria

193

940

2.27

21.56

2.4

2.5

0.22

0.21

g/l

0.78

182

885

1823

12425

1.29

21.53

2.1

0.20

g/l

0.27

1663

11451

Cystic fibrosis, other manifestations/unspecified

12.53

21.47

8.9

2.3

0.21

0.23

g/l

0.87

Anorexia

114

443

2.94

21.45

3.1

2.6

0.21

0.22

g/l

0.64

418

Bullous disorders

372

2236

1.79

21.30

2.5

2.2

0.21

0.20

g/l

0.42

351

2087

Disorders of sclera, cornea, iris and ciliary body

3168

26640

1.21

21.29

2.4

2.3

0.21

g/l

0.04

2979

24897

Injuries to the wrist and hand

6107

35604

1.15

21.28

2.4

0.22

0.21

g/l

4.97

5675

33284

Superficial injury of wrist and hand

1142

8539

1.38

21.22

2.5

0.22

g/l

0.24

1066

8029

Abnormal findings in nipple discharge synovial fluid wound secretions

118

471

2.89

21.20

3.5

2.3

0.22

g/l

0.08

112

442

Allergic urticaria

460

2905

1.66

21.14

2.5

2.4

0.22

g/l

0.20

423

2729

Polycystic kidney disease

182

875

2.32

21.12

3.7

2.5

0.22

0.21

g/l

0.79

175

819

Systemic lupus erythematosus

231

1208

2.09

21.04

2.6

2.2

0.19

0.22

g/l

4.18

216

1136

Disorders of conjunctiva

4911

33042

1.17

21.02

2.4

0.22

0.21

g/l

4.96

4574

30920

Complications of other internal prosthetic devices, implants and grafts

263

1433

1.98

21.01

2.6

2.1

0.20

g/l

0.58

240

1327

Acute and transient psychotic disorders

622

4200

1.54

20.98

2.2

2.4

0.21

0.22

g/l

1.40

575

3953

Diplopia

772

5443

1.48

20.97

2.4

2.3

0.22

0.21

g/l

2.28

710

5095

Pain and other conditions associated with female genital organs and menstrual cycle

1017

6223

1.40

20.90

2.4

2.3

0.23

0.22

g/l

4.45

961

5837

Sarcoidosis

756

5315

1.49

20.89

2.7

2.3

0.21

g/l

0.67

708

4985

Syphilis, including avohilmo

179

858

2.31

20.87

2.5

0.21

0.22

g/l

0.89

160

798

Syphilis

179

858

2.31

20.87

2.5

0.21

0.22

g/l

0.89

160

798

Artificial joint operation, meniscal resection

5555

31102

1.16

20.81

2.2

2.3

0.21

g/l

0.77

5177

28929

Suppurative and unspecified otitis media

1797

12619

1.29

20.81

2.8

2.5

0.22

g/l

0.80

1692

11834

Intracranial and intraspinal abscess and granuloma

104

396

3.12

20.81

3.0

2.6

0.18

0.21

g/l

2.09

369

Lesion of ulnar nerve

797

5654

1.47

20.81

2.4

0.21

g/l

0.26

740

5287

Paraplegia, diplegia of upper limbs

163

757

2.42

20.77

2.8

2.4

0.19

0.21

g/l

1.44

150

705

Scoliosis

481

3082

1.64

20.72

2.5

0.21

g/l

0.61

449

2895

Inflammatory diseases of the central nervous system

485

3123

1.64

20.67

2.6

2.4

0.21

g/l

0.00

457

2929

Thyrotoxicosis, other and/or unspecified

1116

8359

1.38

20.66

2.3

2.2

0.21

g/l

0.16

1048

7840

Other obstructive and reflux uropathy

242

1285

2.01

20.66

2.4

2.3

0.21

g/l

0.45

228

1198

Benign neoplasm: Oesophagus

104

398

3.10

20.60

3.1

2.5

0.21

g/l

0.23

372

Hypertrophy of breast in women and men

1031

7641

1.39

20.44

2.4

2.3

0.23

0.22

g/l

4.13

966

7186

CR(E)ST syndrome

123

511

2.78

20.42

3.0

2.2

0.20

0.21

g/l

1.81

115

484

Car occupant injured in other and unspecified transport accidents

981

7211

1.40

20.41

2.4

0.22

g/l

0.34

911

6748

Other disorders of eye and adnexa

802

5717

1.46

20.33

2.4

0.22

0.21

g/l

1.59

758

5363

Conjunctivitis

4385

30496

1.17

20.29

2.4

0.22

0.21

g/l

4.38

4081

28569

Asthma and opportunity respiratory infection

312

1819

1.86

20.20

2.8

2.2

0.20

g/l

0.01

296

1689

Postmenopausal bleeding

1572

6402

1.32

20.17

2.1

0.21

g/l

2.00

1483

5943

Papillary adenocarcinoma of thyroid gland

255

1386

1.95

20.16

1.9

2.1

0.23

0.21

g/l

3.56

244

1279

Molar incisor enamel hypoplasia

242

1241

2.01

20.09

6.3

4.0

0.22

g/l

0.85

237

1189

!Aliquae complicationes praecoces traumatis

282

1593

1.91

20.07

2.4

0.21

g/l

0.67

255

1477

Early complications of trauma

282

1593

1.91

20.07

2.4

0.21

g/l

0.67

255

1477

Other and unspecified tonsillitis

1650

10806

1.29

19.94

2.8

2.5

0.23

g/l

0.20

1552

10147

Herpesviral [herpes simplex] infections

659

4555

1.51

19.85

2.8

2.3

0.21

g/l

1.04

613

4274

Foreign body in alimentary tract

340

2033

1.79

19.80

2.8

2.5

0.21

g/l

0.47

307

1887

Carcinoma in situ of breast, intraductal

507

3338

1.61

19.80

2.0

2.2

0.23

0.21

g/l

9.04

485

3141

Laparoscopic left hemicolectomy

143

647

2.56

19.77

2.6

2.4

0.21

0.20

g/l

0.70

137

604

Certain conditions originating in the perinatal period

434

2424

1.66

19.69

3.8

3.5

0.22

0.23

g/l

1.30

408

2281

Drug-induced osteoporosis

111

449

2.90

19.63

3.6

2.2

0.21

0.22

g/l

0.06

104

422

Polymyalgia rheumatica

814

5869

1.45

19.62

2.1

0.20

g/l

1.00

755

5431

SLE, ICD10

215

1127

2.08

19.50

2.5

2.2

0.20

0.22

g/l

3.60

200

1061

SLE, strict definition

215

1127

2.08

19.50

2.5

2.2

0.20

0.22

g/l

3.60

200

1061

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

200

1025

2.15

19.48

2.8

0.22

g/l

0.03

188

965

Seropositive rheumatoid arthritis

1390

10759

1.32

19.47

2.2

0.20

0.21

g/l

2.77

1290

10048

Malignant neoplasm of other connective and soft tissue

147

666

2.42

19.47

2.2

2.1

0.20

g/l

0.25

142

615

Focal epilepsy, mode (most common among epilepsy diagnosis)

1047

7842

1.38

19.46

2.5

2.4

0.21

g/l

0.50

976

7315

Symptoms and signs involving emotional state

184

910

2.19

19.42

2.3

2.5

0.23

0.22

g/l

1.33

172

857

Injury of other and unspecified intrathoracic organs

384

2382

1.71

19.28

2.6

2.3

0.20

0.21

g/l

2.68

355

2224

Hyperosmolality and hypernatraemia

113

463

2.81

19.27

2.0

2.3

0.20

g/l

0.06

102

428

Alzheimer’s disease (Atypical or mixed), excluding more controls

516

2524

1.59

19.25

1.6

2.0

0.19

g/l

0.55

462

2330

Chronic lymphocytic leukaemia, helper endpoint

169

813

2.26

19.23

1.9

2.0

0.19

g/l

0.13

154

738

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

169

813

2.26

19.23

1.9

2.0

0.19

g/l

0.13

154

738

Chronic lymphocytic leukaemia

169

813

2.26

19.23

1.9

2.0

0.19

g/l

0.13

154

738

Other maltreatment syndromes

180

887

2.20

19.19

2.8

2.5

0.22

0.23

g/l

0.96

166

836

Primary adrenocortical insufficiency

330

3.19

19.17

2.5

2.7

0.21

0.22

g/l

0.78

309

Migraine with aura and triptan purchases

771

5498

1.44

19.17

2.5

0.23

0.22

g/l

2.99

732

5189

Atopic dermatitis, strict definition

1449

11081

1.31

19.16

2.8

2.6

0.22

g/l

0.08

1358

10430

Other peripheral vascular diseases

459

2970

1.62

19.12

2.3

0.21

g/l

0.31

430

2788

Disorders of synovium and tendon

3040

21758

1.20

19.11

2.2

2.3

0.22

0.21

g/l

2.36

2846

20352

Diseases of tongue

361

2206

1.73

19.09

2.3

2.1

0.22

0.20

g/l

2.58

344

2073

Necrosis of pulp, including avohilmo

3275

27530

1.19

19.09

2.4

0.22

g/l

0.32

3072

25846

Other and unspecified disorders of white blood cells

262

1476

1.93

19.03

2.7

2.3

0.20

0.21

g/l

0.59

239

1378

Visual impairment including blindness (binocular or monocular)

428

2737

1.65

18.92

2.3

2.2

0.20

g/l

0.33

396

2540

Schizophrenia

830

6020

1.42

18.91

2.0

2.4

0.22

g/l

0.23

758

5674

Congenital malformations of cardiac septa

398

2421

1.69

18.91

3.2

3.1

0.21

g/l

1.80

388

2293

Hypoplasia of dental enamel , including avohilmo

228

1178

2.01

18.90

6.5

3.9

0.23

0.22

g/l

0.92

223

1129

Redundant prepuce, phimosis and paraphimosis

1125

8410

1.35

18.78

2.4

2.6

0.21

0.22

g/l

1.75

1056

7846

Hypertrophy of breast

882

6468

1.41

18.77

2.1

2.3

0.23

0.22

g/l

4.92

823

6103

Moderate visual impairment, binocular

202

1050

2.10

18.76

2.3

2.2

0.19

0.20

g/l

0.55

186

970

Post-traumatic wound infection, not elsewhere classified

185

934

2.17

18.74

2.4

2.5

0.21

g/l

0.70

165

871

Otitis externa

1276

9878

1.33

18.71

2.4

0.22

0.21

g/l

1.56

1193

9249

Cervical disc disorders

2063

16885

1.25

18.64

2.2

2.3

0.22

0.21

g/l

3.77

1928

15811

Cervicalgia

1166

8920

1.34

18.64

2.2

2.3

0.22

0.21

g/l

5.02

1082

8352

Other autoimmune haemolytic anaemias

109

450

2.86

18.63

2.5

2.4

0.21

g/l

0.09

100

423

Other epidermal thickening

287

1667

1.85

18.62

3.0

2.4

0.21

g/l

0.44

266

1559

Other disorders of nervous system

413

2635

1.66

18.59

2.5

2.3

0.20

0.21

g/l

1.38

387

2468

Other shoulder lesions

539

3628

1.55

18.58

2.3

0.22

0.21

g/l

1.72

518

3417

Marginal zone B-cell lymphoma, including Hilmo

107

433

2.79

18.50

2.3

2.1

0.18

0.20

g/l

1.46

395

Fibroblastic disorders

1328

10352

1.32

18.46

2.4

2.2

0.21

0.20

g/l

0.88

1226

9641

Insulin, fast-acting (human)

691

4871

1.46

18.45

2.3

2.2

0.19

0.22

g/l

27.30

628

4551

Systemic lupus erythematosus, unspecified

187

953

2.15

18.44

2.5

2.2

0.19

0.22

g/l

4.31

173

897

Other disorders of bone

1035

7797

1.37

18.44

2.5

2.4

0.22

g/l

0.84

963

7319

Inflammatory disease of uterus

665

4658

1.47

18.40

2.4

2.2

0.22

g/l

0.58

628

4386

Open wound of shoulder and upper arm

141

646

2.42

18.40

2.4

2.6

0.21

0.22

g/l

1.04

132

598

Carcinoma in situ of rectum

116

498

2.75

18.30

2.3

2.4

0.23

0.21

g/l

2.32

110

472

Rare circulating lymphoid malignancy, including Hilmo

169

829

2.21

18.30

2.6

2.7

0.20

g/l

0.04

156

764

Pain in thoracic spine

837

6114

1.41

18.25

2.3

0.22

0.21

g/l

3.34

786

5740

Ovarian dysfunction

331

1989

1.73

18.23

2.2

0.23

g/l

1.14

310

1882

Non-small cell lung cancer, adenocarcinoma

309

1832

1.78

18.20

2.2

2.0

0.20

0.19

g/l

0.21

284

1664

2493

18733

1.22

18.16

2.3

2.1

0.20

g/l

2.24

2330

17302

Senility

273

3.21

18.11

1.8

0.18

0.19

g/l

0.35

248

Abscess of lung

122

535

2.60

17.96

2.7

2.5

0.20

0.21

g/l

0.92

111

496

Superficial injury of ankle and foot

660

4644

1.47

17.92

2.5

2.6

0.23

0.22

g/l

1.33

613

4370

Seborrhoeic dermatitis

566

3882

1.52

17.88

2.8

2.3

0.21

g/l

0.45

527

3629

Other disorders of eyelid

2663

21144

1.21

17.87

2.1

2.2

0.21

0.20

g/l

3.71

2481

19633

172

869

2.20

17.65

2.5

2.2

0.19

0.20

g/l

0.30

162

803

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

887

6564

1.39

17.65

2.4

2.3

0.22

g/l

0.73

836

6168

Dental pulpitis, including avohilmo

5234

29542

1.15

17.64

2.4

0.22

g/l

8.25

4919

27725

Neuralgia and neuritis, unspecified

313

1887

1.76

17.61

2.4

2.2

0.22

0.21

g/l

0.85

294

1773

Vitreous haemorrhage

593

4122

1.51

17.60

2.4

2.3

0.20

0.21

g/l

2.09

554

3847

Toxic effects of substances chiefly nonmedicinal as to source

611

4263

1.49

17.53

2.4

0.21

0.22

g/l

1.24

578

3998

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

298

1762

1.76

17.53

2.4

2.1

0.23

g/l

0.30

281

1672

1302

9513

1.31

17.51

2.1

2.0

0.19

0.20

g/l

0.15

1178

8763

Postprocedural musculoskeletal disorders, not elsewhere classified

448

2960

1.61

17.38

2.0

2.2

0.20

0.21

g/l

1.07

420

2764

Conjunctivitis (acute, non atopic)

1555

12386

1.28

17.34

2.4

2.5

0.22

0.21

g/l

0.93

1449

11616

Psoriatic arthropathies

563

3879

1.51

17.33

2.4

0.21

g/l

0.04

530

3640

Aortic valve malfunction, age under 60 years

531

3626

1.54

17.30

2.8

2.5

0.20

0.22

g/l

3.52

501

3410

Arterial embolism and thrombosis of lower extremity artery

218

1192

1.97

17.29

2.1

2.3

0.18

0.20

g/l

3.01

204

1101

Injuries involving multiple body regions

227

1256

1.94

17.28

2.5

2.3

0.21

0.22

g/l

1.17

207

1171

Radiculopathy

904

6753

1.38

17.22

2.0

2.2

0.21

0.20

g/l

4.61

831

6291

Carcinoma in situ of oral cavity, oesophagus and stomach

183

4.08

17.18

2.8

2.5

0.21

g/l

0.08

165

Seronegative rheumatoid arthritis

649

4600

1.47

17.16

2.2

0.20

0.21

g/l

0.81

611

4308

Olecranon bursitis

375

2382

1.67

17.16

2.3

2.4

0.21

g/l

0.52

344

2221

Presbycusis

832

6064

1.40

17.16

2.0

0.19

g/l

0.03

734

5532

Primary hyperparathyroidism

655

4664

1.47

17.14

2.5

2.1

0.22

0.21

g/l

2.82

620

4353

Tetraplegia

246

3.53

17.09

3.2

2.7

0.18

0.22

g/l

2.05

226

Mixed hyperlipidaemia

249

1425

1.88

17.06

2.0

2.3

0.22

0.21

g/l

1.48

227

1336

Open wound of hip and thigh

202

1084

2.01

16.96

2.5

2.6

0.21

0.22

g/l

2.54

186

1013

Noninflammatory disorders of female genital tract

2032

8314

1.25

16.94

2.4

2.3

0.22

0.21

g/l

3.82

1912

7744

Other enthesopathies

1649

13310

1.27

16.94

2.2

2.3

0.22

0.21

g/l

4.01

1540

12494

Eosinophilia

122

550

2.52

16.88

2.1

2.4

0.21

g/l

0.26

114

517

Single delivery by forceps and vacuum extractor

327

3137

0.60

16.80

2.0

2.5

0.24

0.23

g/l

1.92

312

2964

Specific development disorders of scholastic skills

230

1258

1.89

16.69

4.1

3.7

0.22

0.23

g/l

1.22

218

1197

Lichen simplex chronicus and prurigo

376

2407

1.65

16.65

2.5

2.2

0.20

0.21

g/l

0.85

347

2257

Achalasia of cardia

124

564

2.46

16.62

2.7

2.0

0.20

0.21

g/l

1.27

119

525

Other noninflammatory disorders of vulva and perineum

511

3479

1.53

16.61

2.4

2.2

0.22

0.21

g/l

0.70

468

3241

Malignant neoplasm of other and ill-defined digestive organs

209

3.57

16.60

2.0

1.9

0.18

0.20

g/l

1.57

187

Benign neoplasm: Other and unspecified parts of small intestine

120

542

2.52

16.58

2.5

2.1

0.22

0.21

g/l

0.95

112

505

Primary gonarthrosis, bilateral

3172

22799

1.19

16.55

2.1

2.3

0.21

g/l

0.13

2940

21199

Oxicams

1252

5510

1.32

16.52

2.0

2.4

0.21

0.20

g/l

4.75

1165

5095

Other diseases of spinal cord

194

1042

2.03

16.46

2.5

2.4

0.20

0.21

g/l

1.88

182

972

Cyst of kidney

440

2931

1.59

16.43

2.2

0.21

g/l

1.14

408

2724

Gastrojejunal ulcer

375

2.81

16.33

3.2

2.1

0.18

0.21

g/l

2.56

348

Other or ill-defined heart diseases

294

1773

1.74

16.32

2.4

2.3

0.20

0.22

g/l

2.59

272

1670

Mental retardation

248

1425

1.85

16.27

3.0

3.6

0.21

g/l

0.10

236

1354

Cardiomyopathy, Hypertrophic obstructive

127

589

2.40

16.23

2.3

2.4

0.19

0.21

g/l

2.85

117

560

Malignant neoplasm of renal pelvis, including Hilmo

300

3.02

16.14

1.7

2.1

0.21

0.19

g/l

0.75

267

Other (seronegative) rheumatoid arthritis, wide

1055

8140

1.34

16.12

2.2

0.20

0.21

g/l

0.60

983

7590

Other hearing loss

1660

13072

1.26

16.07

2.3

2.1

0.20

g/l

0.24

1513

12078

Hypertensive Renal Disease

219

1227

1.91

15.99

2.1

0.21

0.20

g/l

2.09

199

1143

Malignant neoplasm of adrenal gland, including Hilmo

194

3.66

15.97

2.3

2.6

0.21

g/l

0.04

177

Thyrotoxicosis

1377

10984

1.28

15.93

2.2

0.21

g/l

0.21

1286

10257

Arthropathic psoriasis

620

4421

1.46

15.93

2.4

2.3

0.21

g/l

0.03

583

4151

Bacterial, viral and other infectious agents, including avohilmo

482

3280

1.53

15.85

3.1

2.5

0.21

0.22

g/l

1.14

453

3083

Hypertrophic cardiomyopathy

265

1584

1.80

15.74

2.3

2.4

0.20

0.21

g/l

1.11

244

1471

Other sleep disorders

610

4346

1.45

15.61

2.2

2.4

0.21

g/l

1.02

556

4053

Reactive arthropathies

469

3184

1.54

15.60

2.6

2.4

0.22

0.21

g/l

0.99

430

2994

Carpal tunnel syndrome

3544

26697

1.17

15.49

2.2

2.3

0.21

g/l

1.52

3313

24950

Carcinoma in situ of skin of other and unspecified parts of face

527

3680

1.50

15.48

2.3

2.0

0.20

0.19

g/l

1.52

489

3374

Bacterial, viral and other infectious agents

450

3036

1.55

15.48

3.2

2.5

0.21

0.22

g/l

1.32

422

2847

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

204

1130

1.93

15.45

2.2

2.3

0.20

0.23

g/l

7.63

186

1075

Hyperhidrosis

168

871

2.05

15.43

2.7

2.1

0.23

0.22

g/l

0.47

157

819

Migraine without aura and triptan purchases

764

5644

1.39

15.41

2.7

2.5

0.23

0.22

g/l

1.07

720

5332

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

379

2.73

15.40

2.1

2.9

0.20

0.22

g/l

1.64

357

Atrophic disorders of skin

858

6473

1.37

15.36

2.5

2.2

0.22

0.21

g/l

0.86

798

6059

Special screening examination for neoplasms

359

2309

1.63

15.36

3.1

2.0

0.21

g/l

0.26

334

2139

Other other unspecified disorders of the circulatory system

231

1338

1.86

15.35

3.1

2.4

0.21

g/l

0.16

213

1246

Conductive and sensorineural hearing loss

4760

27973

1.14

15.29

2.2

2.3

0.21

g/l

2.70

4393

26038

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

358

2319

1.64

15.27

2.4

2.2

0.21

g/l

0.28

330

2177

Complications of genitourinary prosthetic devices, implants and grafts

152

769

2.14

15.26

2.4

2.0

0.21

g/l

0.20

140

714

Spontaneous rupture of synovium and tendon

485

3339

1.52

15.20

2.1

2.2

0.21

g/l

0.34

447

3128

Systemic disorders of connective tissue in diseases classified elsewhere

103

4.98

15.19

6.8

2.2

0.22

0.21

g/l

0.15

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

314

1959

1.67

15.14

2.1

2.2

0.22

0.21

g/l

3.04

289

1794

Acute laryngitis and tracheitis

565

3918

1.46

15.11

3.0

2.6

0.22

0.23

g/l

0.64

532

3654

Other arterial embolism and thrombosis

171

905

2.04

15.09

2.7

2.3

0.20

g/l

0.67

153

834

Dermatopolymyositis (FG)

101

440

2.59

15.07

3.1

2.2

0.21

g/l

0.19

416

Contusion of other and unspecified parts of foot

286

1751

1.72

15.05

2.6

0.22

g/l

0.11

274

1656

Prolonged pregnancy

303

4097

0.62

14.95

2.1

2.4

0.23

g/l

0.09

291

3885

Contact with sharp glass

215

1222

1.87

14.94

2.3

2.6

0.22

g/l

0.22

200

1149

Single spontaneous delivery

1557

10113

0.80

14.87

2.1

2.2

0.21

g/l

0.13

1455

9393

Sensorineural hearing loss

4555

26867

1.14

14.80

2.2

2.3

0.20

0.21

g/l

2.44

4206

24997

Pneumonia due to Streptococcus pneumoniae

231

1346

1.82

14.73

3.0

2.3

0.20

0.21

g/l

2.31

209

1263

Polycystic ovarian syndrome

230

1329

1.80

14.71

2.2

2.3

0.23

g/l

0.83

211

1251

Disorders of ocular muscles, binocular movement, accommodation and refraction

2609

22088

1.19

14.66

2.6

2.5

0.22

g/l

0.21

2446

20723

Erythema intertrigo

167

889

2.05

14.66

2.5

2.2

0.21

g/l

0.28

152

826

Hallux valgus (acquired)

1850

10930

1.23

14.63

2.1

2.2

0.21

g/l

0.23

1722

10274

Skin changes due to chronic exposure to nonionizing radiation

2326

17836

1.20

14.63

2.3

2.1

0.20

g/l

2.26

2176

16449

Other renal tubulo-interstitial diseases

141

705

2.17

14.62

2.8

2.1

0.20

0.22

g/l

1.27

132

657

Evidence of alcohol involvement determined by level of intoxication

287

2.96

14.62

2.8

2.7

0.21

0.23

g/l

1.18

267

Other noninflammatory disorders of uterus, except cervix

1197

6297

1.30

14.56

2.0

2.2

0.21

g/l

0.88

1122

5841

Delivery

1572

10155

0.80

14.55

2.1

2.2

0.21

g/l

0.03

1472

9430

Other and unspecified diseases of blood and blood-forming organs

174

943

2.02

14.51

3.1

2.3

0.21

g/l

0.19

162

882

Ingrowing nail

298

1865

1.69

14.50

2.4

0.23

0.22

g/l

3.25

281

1744

Pemphigoid

184

1016

1.98

14.50

2.2

0.20

g/l

0.06

171

946

Other and unspecified types of non-Hodgkin lymphoma, hilmo

256

1550

1.77

14.49

2.4

2.3

0.19

0.20

g/l

0.96

235

1434

Drug-induced obesity

244

3.16

14.43

2.3

2.5

0.21

0.23

g/l

1.19

228

Cardiomyopathy in other diseases

160

3.86

14.39

2.5

3.1

0.18

0.21

g/l

1.52

154

Rheumatoid arthritis, including avohilmo

2111

17771

1.21

14.38

2.3

2.2

0.20

0.21

g/l

1.62

1964

16576

Trochanteric bursitis

831

6305

1.36

14.38

2.2

0.22

0.21

g/l

7.00

770

5916

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

6.38

14.37

3.1

1.6

0.21

0.23

g/l

0.52

Keratitis

1962

16406

1.22

14.31

2.3

0.22

0.21

g/l

0.73

1836

15321

Acute bronchiolitis

315

1797

1.65

14.31

4.7

3.6

0.21

0.22

g/l

0.34

305

1690

Postviral fatigue syndrome

211

3.29

14.31

2.4

2.9

0.25

0.23

g/l

1.47

204

106

475

2.38

14.25

2.5

2.3

0.23

g/l

0.07

449

Acne

470

3219

1.49

14.23

2.5

3.0

0.23

g/l

0.20

445

3021

All dysplastic lesions of the vulva

246

1478

1.77

14.20

2.6

2.0

0.21

0.22

g/l

0.41

235

1391

Mental retardation, wide definition

253

1519

1.76

14.19

2.9

3.6

0.21

g/l

0.04

240

1442

Contact with heat and hot substances

300

1891

1.67

14.19

2.7

2.6

0.21

0.22

g/l

1.16

278

1770

Superficial injury of forearm

532

3772

1.46

14.03

2.5

2.4

0.21

0.22

g/l

0.92

492

3548

Otitis media, unspecified

564

3708

1.44

14.03

3.5

2.9

0.22

g/l

0.90

539

3472

Malignant neoplasm of lip, including Hilmo

263

2.97

14.02

2.0

0.20

0.19

g/l

0.94

228

Fenamates

774

3932

1.38

13.97

2.2

2.4

0.22

0.20

g/l

8.84

688

3667

Impetigo

250

1510

1.75

13.96

3.3

2.8

0.22

g/l

0.29

233

1429

Exposure to other and unspecified inanimate mechanical forces

421

2867

1.53

13.92

2.9

2.5

0.22

g/l

0.21

396

2697

Dermatopolymyositis

105

482

2.45

13.92

3.1

2.4

0.21

0.22

g/l

0.24

100

454

Ankylosing spondylitis

455

3144

1.50

13.87

2.5

2.4

0.22

0.21

g/l

0.86

421

2963

Follicular cysts of skin and subcutaneous tissue

982

7657

1.32

13.82

2.5

2.3

0.22

0.21

g/l

1.43

928

7164

Atopic dermatitis

3125

21588

1.17

13.81

2.4

0.22

g/l

4.47

2894

20293

Chronic nephritic syndrome

230

1370

1.80

13.81

2.0

2.3

0.22

0.21

g/l

1.41

217

1285

Evidence of alcohol involvement determined by blood alcohol level

100

450

2.47

13.78

1.9

2.7

0.22

g/l

0.07

424

Carcinoma in situ of skin of trunk

216

1271

1.84

13.74

2.3

2.1

0.20

g/l

0.69

204

1169

Toxic effect of ethanol

214

1246

1.82

13.73

2.7

2.5

0.21

0.22

g/l

1.38

200

1162

Anxious personality disorder

109

505

2.34

13.73

2.8

2.4

0.22

0.23

g/l

0.81

479

Diseases of male genital organs

2805

12108

1.18

13.72

2.5

2.6

0.22

0.21

g/l

1.90

2620

11274

Other hammer toe(s) (acquired)

975

6915

1.32

13.62

2.1

2.2

0.20

0.21

g/l

0.79

908

6472

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

103

469

2.39

13.60

4.2

2.7

0.22

0.23

g/l

0.58

447

Actinic keratosis

2254

17437

1.20

13.57

2.3

2.1

0.20

g/l

1.97

2111

16071

Cramp and spasm

268

1665

1.71

13.55

3.1

2.4

0.23

0.22

g/l

1.82

256

1554

Herpesviral [herpes simplex] infections, including avohilmo

1301

10499

1.26

13.53

2.5

2.3

0.22

g/l

0.20

1221

9835

Intrahepatic Cholestasis of Pregnancy (ICP)

298

1888

1.64

13.51

2.4

2.3

0.23

g/l

0.08

281

1801

Other crystal arthropathies

136

697

2.16

13.48

2.3

0.19

0.20

g/l

0.46

126

656

Myeloproliferative diseases

473

3325

1.49

13.43

2.2

0.21

g/l

0.02

436

3090

Endocrine disorders, other/unspecified

120

587

2.24

13.38

2.1

2.3

0.20

0.22

g/l

0.98

106

557

Behavioural disorders, excluding more controls

391

2.46

13.37

2.5

3.4

0.22

0.23

g/l

0.82

376

Salpingitis and oophoritis

894

6923

1.33

13.33

2.5

2.2

0.22

0.21

g/l

0.09

828

6501

Any dementia, excluding more controls

2037

11766

1.21

13.31

1.8

2.1

0.20

g/l

0.40

1803

10934

Gonarthrosis, primary, with knee surgery

3512

24010

1.16

13.30

2.1

2.3

0.21

g/l

0.27

3255

22303

Bell's palsy

630

4643

1.40

13.29

2.3

0.22

0.21

g/l

2.55

590

4336

Alzheimer disease, excluding more controls

987

4965

1.32

13.29

1.7

2.3

0.20

g/l

0.04

873

4647

Conjunctivitis (acute, non atopic), including avohilmo

5997

32705

1.12

13.26

2.4

0.22

0.21

g/l

16.52

5599

30556

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

892

6887

1.32

13.26

2.8

2.4

0.23

g/l

0.59

840

6490

Strabismus

1380

11208

1.25

13.25

2.5

0.21

g/l

0.10

1290

10494

Orthopaedic devices associated with adverse incidents

134

692

2.17

13.20

3.0

2.1

0.19

0.20

g/l

1.39

125

642

Perforation of oesophagus

154

3.83

13.20

3.5

2.2

0.17

0.21

g/l

3.19

144

Endometriosis

1633

7798

1.24

13.19

2.3

2.2

0.21

g/l

1.09

1535

7265

Artificial joint re-operation

419

2896

1.53

13.18

1.9

2.2

0.20

g/l

1.15

391

2697

Otitis externa, unspecified

606

4445

1.41

13.16

2.4

0.22

0.21

g/l

0.33

578

4168

Amyloidosis

149

793

2.05

13.15

2.3

0.19

0.20

g/l

0.77

142

747

Diseases of middle ear and mastoid

2996

21253

1.16

13.11

2.6

2.4

0.22

g/l

1.75

2815

19911

Multiple myeloma

146

768

2.04

13.07

1.9

0.20

0.19

g/l

0.28

135

694

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

146

768

2.04

13.07

1.9

0.20

0.19

g/l

0.28

135

694

Essential (haemorrhagic) thrombocythaemia

184

1041

1.87

13.03

2.0

2.1

0.21

0.20

g/l

0.60

169

957

Crystal arthropathies, rheuma endpoint

136

706

2.13

13.02

2.3

0.19

0.20

g/l

0.69

126

663

Other diseases of peritoneum

253

1569

1.71

12.97

2.9

2.2

0.21

g/l

0.03

235

1457

Somnolence

360

2.60

12.94

2.1

2.7

0.20

0.21

g/l

0.67

337

Prurigo nodularis

161

884

1.99

12.94

2.4

2.2

0.19

0.21

g/l

1.32

145

828

Open wound of neck

236

3.07

12.94

2.4

2.7

0.19

0.23

g/l

2.41

219

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

370

2485

1.54

12.93

2.4

2.2

0.22

g/l

0.10

346

2348

Intracerebral haemorrhage

695

5221

1.37

12.92

2.5

2.1

0.20

g/l

0.06

645

4801

Maternal care for other conditions predominantly related to pregnancy

868

6531

1.32

12.87

2.4

0.23

g/l

0.36

807

6201

Acne vulgaris

353

2340

1.55

12.87

2.5

3.0

0.23

g/l

0.32

333

2191

Lichen ruber planus, wide definition including periferal and oral lichen planus

1251

10135

1.27

12.83

2.3

2.2

0.21

g/l

0.98

1158

9462

Drug-induced hypoglycaemia without coma

109

524

2.30

12.80

2.4

2.5

0.18

0.21

g/l

4.54

488

Hodgkin lymphoma, hilmo

168

935

1.94

12.79

2.8

2.5

0.19

0.21

g/l

2.77

153

868

Disorders of optic nerve and visual pathways

492

3505

1.46

12.78

2.4

0.22

0.21

g/l

0.65

466

3290

Lactose intolerance

171

954

1.91

12.75

2.8

2.4

0.23

0.21

g/l

2.16

158

901

Vasomotor and allergic rhinitis

1939

15975

1.20

12.74

2.4

2.5

0.23

0.22

g/l

6.09

1828

14988

Nontraumatic intracranial haemmorrhage

1084

8644

1.28

12.69

2.4

2.2

0.20

g/l

0.06

1005

7998

Other fall from one level to another

1193

9610

1.27

12.68

2.5

2.6

0.21

g/l

0.54

1105

8989

Other disorders of breast

687

5165

1.37

12.66

2.1

2.2

0.23

0.21

g/l

8.18

646

4861

Other and unspecified erythematous conditions

195

1139

1.84

12.62

2.5

2.2

0.21

g/l

0.08

185

1064

Medical abortion

3275

15483

1.16

12.61

2.2

0.22

0.21

g/l

0.81

3091

14471

Other and specified injuries of hip and thigh

144

768

2.03

12.57

2.2

2.4

0.19

0.21

g/l

2.68

134

717

Uterine polyps

1472

7039

1.25

12.52

2.1

2.2

0.22

0.21

g/l

7.65

1381

6560

Superficial injuries involving multiple body regions

154

839

1.97

12.48

2.6

2.4

0.21

0.22

g/l

0.87

142

783

Right bundle-branch block

217

1306

1.76

12.45

2.8

2.2

0.21

g/l

0.46

204

1232

Other juvenile arthritis

195

1135

1.81

12.44

4.1

3.0

0.23

0.22

g/l

1.20

183

1079

Restless leg syndrome

780

5996

1.34

12.40

2.2

0.22

0.21

g/l

3.61

731

5614

Excessive attrition of teeth

3328

28991

1.15

12.38

2.4

0.22

g/l

9.80

3103

27225

ILD and respiratory illness in diseases classified elsewhere

166

3.60

12.34

2.2

2.4

0.20

0.21

g/l

0.54

155

Wide developmental disorders

188

1083

1.83

12.34

2.8

3.8

0.23

0.22

g/l

0.72

174

1031

Other bacterial agents as the cause of diseases classified to other chapters

333

2.67

12.34

4.0

2.4

0.20

0.21

g/l

0.56

315

Spondylolisthesis/Spondylolysis

992

7863

1.29

12.30

2.2

2.3

0.21

g/l

1.92

926

7375

Myositis

157

867

1.95

12.29

2.8

2.3

0.22

0.21

g/l

0.89

146

807

Other predominantly sexually transmitted diseases, not elsewhere classified

748

5704

1.34

12.29

2.9

2.4

0.23

0.22

g/l

1.01

705

5371

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2925

24449

1.16

12.28

2.3

0.22

g/l

3.66

2723

22953

Malignant neoplasm of accessory sinuses

6.45

12.28

2.8

2.3

0.24

0.22

g/l

0.57

Other and unspecified epidermal thickening

159

882

1.94

12.24

3.5

2.4

0.21

g/l

0.00

150

819

Dislocation, sprain and strain of joints and ligaments at neck level

738

5630

1.34

12.19

2.3

2.4

0.23

0.22

g/l

2.51

684

5284

Septal defects

351

2324

1.55

12.16

3.1

0.20

0.21

g/l

1.75

341

2202

Enthesopathies of lower limb, excluding foot

1209

9803

1.26

12.15

2.5

2.3

0.22

0.21

g/l

4.56

1153

9198

Congenital malformations of the musculoskeletal system, not elsewhere classified

408

2.42

12.12

4.5

2.8

0.22

0.23

g/l

0.42

389

Other erythematous conditions

211

1273

1.77

12.12

2.5

2.2

0.21

g/l

0.11

200

1191

152

3.72

12.11

2.1

2.4

0.20

0.21

g/l

0.42

141

Coxarthrosis, primary

3579

26306

1.14

12.11

2.2

0.20

g/l

0.39

3335

24375

Secondary parkinsonism, excluding more controls

138

732

2.01

12.07

1.8

2.2

0.21

0.20

g/l

0.51

131

691

Nummular dermatitis

469

3356

1.46

12.02

2.5

2.3

0.21

g/l

0.25

431

3126

Cauda equina syndrome

412

2.44

12.01

2.6

2.4

0.21

0.22

g/l

0.29

391

Benign neoplasm of ovary

897

7059

1.31

11.92

2.3

2.1

0.21

g/l

0.81

861

6587

Fracture at wrist and hand level

1855

15642

1.20

11.91

2.5

0.21

0.22

g/l

0.13

1711

14656

Autism

136

720

2.00

11.86

3.0

3.5

0.24

0.23

g/l

0.92

123

679

Oligomenorrhoea

170

967

1.85

11.77

2.6

2.4

0.21

g/l

0.02

161

912

Lichen planus

719

5513

1.35

11.75

2.3

2.2

0.21

g/l

0.69

668

5151

Nonsuppurative otitis media

1076

7473

1.27

11.75

3.1

2.6

0.22

g/l

0.86

1009

7002

Toxic effect of other and unspecified substances

350

2.52

11.73

2.0

2.8

0.22

0.23

g/l

0.67

326

Allergic colitis

121

619

2.09

11.73

3.5

3.3

0.22

g/l

0.04

116

586

Carcinoma in situ of lip, oral cavity and pharynx

5.34

11.69

2.9

2.6

0.21

g/l

0.05

Polyp of the female genital tract

1539

7210

1.23

11.68

2.1

2.2

0.22

0.21

g/l

4.28

1448

6712

Other localized connective tissue disorders

123

640

2.10

11.64

3.0

2.1

0.22

0.21

g/l

0.41

114

601

Other congenital malformations

433

3065

1.46

11.63

2.8

0.22

g/l

0.43

408

2899

Kyphosis

431

2.37

11.62

2.2

0.21

g/l

0.02

407

Sequelae of injuries of lower limb

485

3509

1.43

11.57

2.1

2.3

0.22

g/l

0.13

450

3291

Reactive arthropathies, FINNGEN

360

2469

1.52

11.53

2.6

2.3

0.22

g/l

0.51

332

2321

Mixed specific developmental disorders

136

674

2.01

11.52

3.4

4.7

0.22

g/l

0.01

128

644

Specific development disorders of speech and language

300

1907

1.58

11.52

3.7

3.3

0.21

0.22

g/l

0.15

283

1798

Left bundle-branch block

391

2726

1.49

11.52

2.1

2.2

0.20

0.21

g/l

0.96

357

2551

Ocular pain

449

3211

1.45

11.47

2.4

0.22

g/l

0.59

429

3010

Marginal zone B-cell lymphoma

275

2.76

11.47

2.2

2.0

0.20

g/l

0.33

246

Transient ischemic attack

3000

20989

1.15

11.43

2.1

2.3

0.20

g/l

0.00

2772

19486

Other specified disorders of kidney and ureter

193

1157

1.79

11.42

2.3

2.2

0.20

0.21

g/l

0.69

178

1071

Hypotension due to drugs

104

516

2.25

11.41

2.5

2.2

0.21

0.20

g/l

0.39

474

Benign neoplasm: Ill-defined sites within the digestive system

173

3.37

11.41

3.0

2.5

0.21

g/l

0.15

160

Myeloproliferative diseases (CML excluded)

423

3006

1.47

11.40

2.1

2.2

0.20

g/l

0.09

391

2793

Congenital malformations and deformations of the musculoskeletal system

433

3059

1.46

11.39

3.0

0.22

g/l

0.79

414

2899

Other abnormal immunological findings in serum

120

622

2.09

11.39

2.5

2.8

0.22

g/l

0.13

112

583

Malignant neoplasm of eye, brain and central nervous system

197

1179

1.75

11.38

2.1

2.2

0.23

0.21

g/l

2.65

187

1085

Perineal laceration during delivery

352

4126

0.68

11.37

2.1

2.4

0.22

0.23

g/l

0.66

334

3905

Other infective otitis externa

332

2252

1.54

11.37

2.4

2.3

0.21

g/l

0.26

308

2103

Xerosis cutis

115

592

2.13

11.30

2.4

0.19

0.21

g/l

1.18

103

550

Hemiplegia

268

1739

1.62

11.27

2.9

2.3

0.22

0.21

g/l

1.41

246

1616

Erythema multiforme

136

739

1.99

11.24

2.9

2.3

0.20

0.21

g/l

1.43

121

690

Propionic acid derivatives

1564

6523

1.22

11.24

2.3

2.7

0.21

0.20

g/l

3.65

1458

6057

Chronic myeloproliferative disease

101

501

2.27

11.21

2.2

2.3

0.20

0.21

g/l

0.45

469

Other strabismus

1097

8848

1.26

11.20

2.5

2.6

0.21

g/l

0.02

1033

8295

Other salmonella infections

202

1229

1.74

11.19

3.9

2.1

0.21

g/l

0.04

185

1149

Lactose intolerance, other/unspecified

151

846

1.90

11.18

2.8

2.4

0.23

0.21

g/l

1.54

141

798

Other bursopathies

714

5502

1.34

11.18

2.0

2.2

0.21

g/l

1.07

658

5139

Familial hypercholesterolemia, with ischemic heart disease

529

3915

1.41

11.16

2.2

0.20

g/l

0.34

490

3632

Superficial injury of shoulder and upper arm

626

4737

1.36

11.11

2.2

2.4

0.21

g/l

0.15

569

4427

Allergic conjunctivitis

3037

25746

1.15

11.10

2.3

2.4

0.22

g/l

3.73

2825

24162

Disorders of vestibular function (Vertigo)

2667

22726

1.16

11.09

2.1

2.2

0.22

0.21

g/l

6.60

2495

21161

Bullous pemphigoid

142

790

1.96

11.06

2.0

2.1

0.20

g/l

0.06

129

734

Other and unspecified injuries of shoulder and upper arm

187

1119

1.78

11.05

2.4

0.22

0.21

g/l

0.42

172

1036

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

174

3.19

11.05

2.1

1.9

0.21

0.20

g/l

0.30

150

Renal cell carcinoma of kidney

152

854

1.88

11.05

2.1

1.9

0.22

0.19

g/l

3.95

136

772

Disorders of myoneural junction and muscle in diseases classified elsewhere

246

2.86

10.98

2.0

2.4

0.21

0.22

g/l

0.66

229

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

370

2572

1.49

10.95

2.4

2.3

0.22

g/l

0.07

346

2437

Sleep disorders, other/unspecified

185

1103

1.76

10.93

2.5

0.24

0.22

g/l

1.28

166

1037

Pure hyperglyceridaemia

139

769

1.95

10.88

3.1

2.4

0.22

0.21

g/l

1.26

130

728

Unspecified/other endometriosis

386

2645

1.47

10.87

2.3

0.23

0.22

g/l

2.15

361

2490

Other disorders of penis

537

3991

1.39

10.81

2.7

2.6

0.21

g/l

0.96

496

3720

Viral warts

506

3728

1.40

10.78

3.7

2.4

0.22

g/l

0.71

481

3508

Atrial septal defect

221

1382

1.69

10.78

3.5

3.3

0.20

0.21

g/l

0.99

216

1312

Voice disturbances

1438

12026

1.22

10.74

2.3

2.2

0.22

0.21

g/l

3.36

1344

11233

Left ventricular outflow tract obstruction, narrow definition

278

1845

1.59

10.69

3.1

2.9

0.20

0.22

g/l

3.35

264

1744

Malignant neoplasm of eye and adnexa, including Hilmo

410

2.31

10.67

2.7

2.1

0.20

g/l

0.15

378

Other salmonella infections, including avohilmo

228

1445

1.66

10.65

3.9

2.1

0.22

0.21

g/l

0.33

210

1354

Mixed connective tissue disease

112

583

2.10

10.65

2.9

2.2

0.21

0.22

g/l

0.30

103

550

339

2324

1.50

10.63

2.1

2.3

0.23

g/l

0.74

325

2216

Open wound of wrist and hand

2411

20285

1.16

10.61

2.4

2.5

0.22

0.21

g/l

1.56

2238

19031

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

547

4062

1.38

10.58

3.0

2.9

0.22

g/l

0.85

518

3825

Intermittent heterotropia

290

1935

1.56

10.58

2.8

3.1

0.21

g/l

0.34

276

1837

Amyloidosis, other/unspecified

122

656

2.03

10.58

2.2

2.3

0.20

g/l

0.42

117

618

Acute lymphadenitis

279

1850

1.57

10.56

2.6

2.5

0.21

0.22

g/l

0.86

269

1734

Open wound of thorax

446

2.25

10.55

2.2

2.6

0.20

0.22

g/l

1.30

423

Lichen planus, including avohilmo

1038

8433

1.26

10.50

2.3

0.21

g/l

0.43

962

7883

Other inflammation of eyelid

769

6035

1.31

10.48

2.3

0.22

0.21

g/l

6.44

725

5648

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

183

1102

1.75

10.45

3.9

3.0

0.23

0.22

g/l

0.44

174

1042

Malignant neoplasm of adrenal gland

127

3.68

10.44

2.2

2.8

0.22

0.21

g/l

0.37

114

Pollen allergy

866

6783

1.28

10.40

2.9

2.8

0.23

0.22

g/l

1.62

811

6393

Other noninflammatory disorders of vagina

405

2895

1.45

10.39

2.7

2.2

0.22

0.21

g/l

1.22

385

2699

Raynaud syndrome

451

3286

1.42

10.37

2.4

2.3

0.22

0.21

g/l

0.55

422

3084

Mixed disorders of conduct and emotions

110

568

2.05

10.36

2.6

3.4

0.23

g/l

0.04

104

538

Abnormal findings on diagnostic imaging of central nervous system

263

1735

1.59

10.32

2.6

2.3

0.22

g/l

0.91

247

1622

Other nutritional anaemias

301

2.56

10.32

2.2

2.3

0.20

0.21

g/l

1.01

280

Ptosis of eyelid

625

4795

1.35

10.28

2.0

2.2

0.22

0.20

g/l

5.01

582

4472

Other and unspecified mental retardation

118

630

2.05

10.27

3.0

4.3

0.21

g/l

0.02

113

599

Other disorders of electrolyte and fluid balance, not elsewhere classified

284

2.62

10.27

2.6

0.20

g/l

0.08

264

Other enthesopathy of foot (+metatarsalgia)

540

4049

1.37

10.27

2.1

2.3

0.22

0.21

g/l

2.44

500

3820

Benign neoplasm: Rectosigmoid junction

245

1602

1.63

10.26

2.7

2.2

0.21

g/l

0.99

232

1490

Other psoriatic arthropathies

533

3996

1.38

10.25

2.3

0.21

g/l

0.17

502

3748

Psoriatic arthropathies, ICD10

547

4117

1.37

10.24

2.4

2.3

0.21

g/l

0.15

516

3862

Anankastic personality disorder

190

1162

1.72

10.22

2.3

2.4

0.23

0.22

g/l

0.64

170

1106

Other factor of the environment

394

2.33

10.17

2.7

2.5

0.20

0.22

g/l

0.57

375

Anti-inflammatory and antirheumatic products, non-steroids

1550

6524

1.21

10.16

2.3

2.7

0.21

0.20

g/l

3.72

1441

6058

Lifestyle-related condition

369

2.38

10.12

2.6

2.5

0.21

0.22

g/l

0.29

346

Delivery, wide proxy

1322

8425

0.82

10.10

2.1

2.2

0.21

g/l

0.07

1237

7784

Childhood allergy (age < 16)

542

3332

1.37

10.09

3.6

3.3

0.23

g/l

0.05

512

3135

Other disorders of optic [2nd] nerve and visual pathways

342

2392

1.49

10.07

2.4

0.21

g/l

0.35

322

2243

Cluster headache, strict

182

1106

1.73

10.06

2.1

2.4

0.22

g/l

0.00

170

1045

Haemangioma and lymphangioma, any site

482

3573

1.40

10.01

2.6

2.4

0.22

0.21

g/l

0.79

457

3353

Impacted cerumen

644

4980

1.33

9.98

2.5

2.3

0.21

0.20

g/l

0.59

583

4632

Campylobacter enteritis

155

908

1.82

9.98

3.0

2.5

0.22

0.21

g/l

0.87

146

860

Routine general health check-up of defined subpopulation

106

548

2.04

9.97

2.0

1.9

0.22

g/l

0.58

518

Autoimmune hyperthyroidism

299

2038

1.52

9.92

2.3

2.0

0.21

0.22

g/l

0.45

278

1931

Recurrent dislocation and subluxation of joint

318

2191

1.50

9.91

2.4

0.23

0.22

g/l

0.34

299

2070

Pyoderma

115

620

2.01

9.83

2.6

2.4

0.20

0.21

g/l

0.76

107

579

Burn and corrosion of hip and lower limb, except ankle and foot

135

764

1.89

9.81

2.9

2.5

0.21

g/l

0.03

121

712

Supervision of normal pregnancy

600

4477

0.75

9.79

2.2

2.4

0.23

g/l

0.58

572

4227

Ehlers-Danlos syndrome, including avohilmo

307

2.44

9.74

3.3

2.7

0.22

0.23

g/l

0.38

293

Metatarsalgia

501

3747

1.38

9.73

2.2

2.3

0.22

0.21

g/l

2.35

463

3534

Viral infections of the central nervous system, including avohilmo

386

2772

1.44

9.71

2.4

2.3

0.22

0.21

g/l

0.40

362

2601

Autonomic disorders

140

804

1.86

9.69

2.6

2.3

0.22

0.21

g/l

0.96

129

750

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

369

2625

1.45

9.68

2.4

2.3

0.23

0.22

g/l

1.01

347

2479

Burn and corrosion of trunk

168

1015

1.76

9.67

2.7

2.6

0.22

0.21

g/l

0.10

157

955

Acne, including avohilmo

885

5728

1.27

9.67

2.4

2.8

0.23

g/l

0.53

828

5409

Scabies, including avohilmo

709

5556

1.30

9.66

2.7

2.6

0.22

g/l

0.31

658

5214

Other/unspecified rheumatoid arthritis

653

5081

1.32

9.64

2.2

2.1

0.20

g/l

0.40

609

4721

Benign paroxysmal vertigo

1623

13854

1.19

9.64

2.1

2.2

0.22

0.21

g/l

6.04

1517

12902

Infectious mononucleosis, including avohilmo

344

2415

1.46

9.62

2.7

2.6

0.23

g/l

0.42

326

2261

Infectious mononucleosis

344

2415

1.46

9.62

2.7

2.6

0.23

g/l

0.42

326

2261

Impotence

323

2260

1.50

9.58

2.6

2.5

0.21

0.20

g/l

0.78

300

2100

Burns and corrosions of multiple and unspecified body regions

130

733

1.90

9.58

2.7

0.21

g/l

0.24

120

683

Persistent delusional disorders

393

2844

1.43

9.50

2.1

2.2

0.21

g/l

0.08

361

2660

Ankylosing spondylitis, ICD10

437

3216

1.41

9.50

2.5

2.3

0.22

g/l

0.20

405

3021

Other and unspecified haemorrhagic conditions

516

2.09

9.42

3.3

2.4

0.21

g/l

0.32

480

Viral infections of the central nervous system

358

2553

1.45

9.41

2.4

2.3

0.22

g/l

0.21

334

2395

Hydrocele

602

4643

1.33

9.40

2.7

2.4

0.20

g/l

0.54

557

4294

Encephalitis

164

993

1.76

9.37

3.0

2.5

0.22

0.21

g/l

0.65

151

930

Oral lichen planus and hypothyroidism or thyroxine medication

121

676

1.95

9.37

2.3

2.0

0.21

g/l

0.44

115

639

Other mycoses, not elsewhere classified/unspecified, including avohilmo

109

587

2.01

9.37

3.7

2.3

0.22

g/l

0.02

100

553

Other and unspecified injuries of lower leg

382

2754

1.43

9.35

2.5

2.4

0.22

g/l

0.02

358

2593

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

402

2.25

9.28

3.9

2.4

0.20

0.21

g/l

0.47

378

Pediculosis, acariasis and other infestations

308

2145

1.49

9.26

2.6

2.5

0.22

g/l

0.19

290

2014

Nosocomial condition (hospital)

176

3.03

9.23

2.3

0.17

0.21

g/l

2.27

161

Other specified congenital malformation syndromes affecting multiple systems

104

555

2.04

9.22

3.1

4.0

0.23

0.22

g/l

0.45

530

Polyarteritis nodosa and related conditions

423

2.20

9.20

2.3

2.5

0.20

0.22

g/l

0.71

396

Polycystic ovarian syndrome, broad definition

394

2851

1.41

9.20

2.3

0.23

g/l

0.51

366

2694

Infective bursitis

168

1031

1.74

9.17

2.0

2.2

0.22

0.21

g/l

0.80

159

962

Malignant neoplasm of accessory sinuses, including Hilmo

3.72

9.15

2.5

2.0

0.24

0.20

g/l

1.64

Hypermobility syndrome

231

1518

1.58

9.14

2.6

2.3

0.23

g/l

0.04

208

1444

Injury of eye and orbit

674

5292

1.30

9.09

2.6

2.5

0.22

g/l

0.40

629

4991

Temporal arteritis

216

1413

1.62

9.08

2.2

2.0

0.22

0.20

g/l

2.01

192

1310

Brain meningioma, including Hilmo

221

1442

1.59

9.07

2.1

2.2

0.22

0.20

g/l

2.40

205

1320

Other orthopaedic follow-up care

272

1856

1.52

9.04

2.3

2.2

0.21

0.22

g/l

0.28

253

1748

Benign neoplasm: salivary glands, exclude unknown (D119)

464

3482

1.38

9.00

2.4

2.2

0.21

g/l

0.83

433

3252

Acute myeloid leukaemia, including Hilmo

345

2.30

8.98

1.8

2.1

0.21

0.20

g/l

0.36

315

Acute myeloid leukaemia

345

2.30

8.98

1.8

2.1

0.21

0.20

g/l

0.36

315

Acute myeloid leukaemia, helper endpoint

345

2.30

8.98

1.8

2.1

0.21

0.20

g/l

0.36

315

Assault by blunt object

412

2.18

8.97

2.7

2.8

0.20

0.23

g/l

2.13

386

Sequelae of injuries of upper limb

501

3798

1.36

8.96

2.4

0.22

g/l

0.07

465

3551

Diseases of inner ear

3074

26313

1.13

8.96

2.2

2.3

0.21

g/l

4.03

2882

24480

Sacroiliitis, not elsewhere classified

211

1365

1.60

8.95

2.2

2.3

0.23

0.22

g/l

0.35

199

1304

Giant cell arteritis

245

1651

1.57

8.95

2.3

2.1

0.22

0.20

g/l

1.97

221

1529

Congenital iodine-deficiency syndrome/hypothyroidism

163

1000

1.73

8.90

2.8

2.2

0.20

0.21

g/l

0.47

152

945

Hypertrophic disorders of skin

272

1862

1.52

8.90

3.2

2.3

0.22

g/l

0.05

252

1760

Autism spe

128

732

1.84

8.86

3.0

3.3

0.24

0.23

g/l

0.87

116

688

Cluster headache, wide

192

1222

1.64

8.85

2.1

2.4

0.22

g/l

0.17

180

1150

Acute nephritic syndrome

121

686

1.90

8.85

2.3

2.7

0.22

0.21

g/l

0.73

115

640

Burns classified according to extent of body surface involved

310

2.41

8.84

2.7

0.20

0.22

g/l

0.83

291

Isolated growth hormone deficiency

262

2.63

8.83

3.6

5.6

0.22

0.21

g/l

0.64

257

Leiomyoma of uterus

3233

16216

1.13

8.83

2.2

0.22

0.21

g/l

3.40

3033

15186

Heterophoria

392

2868

1.41

8.83

2.3

2.5

0.22

g/l

0.08

365

2695

Brain meningioma

215

1404

1.59

8.81

2.1

2.2

0.22

0.20

g/l

2.46

199

1289

Ectropion of eyelid

227

1506

1.58

8.81

2.3

2.1

0.19

g/l

0.59

200

1381

Scabies

239

1600

1.56

8.81

2.6

2.5

0.22

g/l

0.24

223

1510

Other encephalitis

156

949

1.75

8.81

3.0

2.5

0.22

0.21

g/l

0.74

143

890

Juvenile arthritis (FINNGEN)

207

1340

1.61

8.80

3.9

2.9

0.23

0.22

g/l

0.62

195

1277

Unspecified nephritic syndrome

129

747

1.86

8.79

2.7

2.3

0.20

0.21

g/l

0.51

124

701

Varicella [chickenpox]

231

1537

1.57

8.77

3.2

2.8

0.22

g/l

0.03

213

1450

Other and unspecified intracranial injuries

165

1018

1.71

8.75

2.5

0.20

0.21

g/l

0.35

150

948

Malignant neoplasm of bone and articular cartilage

259

2.52

8.73

2.4

2.7

0.20

0.21

g/l

0.65

236

Cardiac murmurs and other cardiac sounds

473

3522

1.36

8.73

2.8

2.6

0.21

g/l

0.07

451

3321

Pulmonary oedema

109

601

1.95

8.71

2.8

2.2

0.19

0.20

g/l

0.29

101

545

Generalized epilepsy

207

1348

1.61

8.67

2.3

2.8

0.22

g/l

0.30

199

1272

Diabetic retinopathy

2166

11786

1.16

8.66

2.5

2.4

0.19

0.21

g/l

15.98

1989

10900

Gout due to impairment of renal function

381

2.26

8.65

2.8

2.5

0.22

0.20

g/l

1.18

354

Sequelae of infectious and parasitic diseases, including avohilmo

373

2718

1.42

8.64

2.2

0.21

g/l

0.14

346

2540

Haemangioma, any site

445

3338

1.38

8.63

2.5

2.3

0.22

0.21

g/l

0.94

421

3131

Other and unspecified nail disorders

135

796

1.81

8.59

2.1

2.3

0.22

g/l

0.06

125

749

Nonpyogenic thrombosis of intracranial venous system

294

2.42

8.59

2.6

2.9

0.23

0.22

g/l

0.33

277

Parkinson's disease, strict definition, excluding more controls

625

4566

1.31

8.58

2.0

2.3

0.20

g/l

0.25

572

4267

Parkinson's disease, excluding more controls

668

4851

1.30

8.58

2.0

2.3

0.20

g/l

0.22

613

4538

Asthma mixed form (mode), excluding more controls

225

1490

1.56

8.56

2.4

2.2

0.21

0.22

g/l

0.59

214

1391

Other disorders of patella

807

6518

1.26

8.56

2.4

0.22

g/l

1.57

748

6152

Anogenital herpesviral [herpes simplex] infection

270

1857

1.50

8.55

2.7

2.3

0.23

0.22

g/l

0.95

253

1752

Background retinopathy and retinal vascular changes

123

708

1.86

8.54

3.4

2.3

0.21

g/l

0.09

116

658

Astigmatism

330

2362

1.45

8.49

2.8

0.22

0.21

g/l

0.82

315

2220

Gonococcal infection, including avohilmo

180

1142

1.66

8.49

1.9

2.4

0.22

g/l

0.05

166

1074

Benign neoplasm of major salivary glands

510

3913

1.35

8.47

2.4

2.2

0.21

g/l

0.56

477

3648

Myeloid leukaemia

154

945

1.74

8.47

2.7

2.4

0.21

g/l

0.20

139

881

Respiratory disorders in diseases classified elsewhere

459

2.10

8.46

2.2

2.4

0.20

0.21

g/l

0.74

428

Recurrent dislocation of patella

213

1398

1.57

8.45

2.1

2.5

0.23

g/l

0.57

204

1322

Giant cell arteritis with polymyalgia rheumatica

216

1438

1.59

8.42

2.2

2.1

0.22

0.20

g/l

1.96

192

1332

Other specified/unspecified spondylopathies

145

877

1.76

8.42

2.5

2.1

0.20

g/l

0.21

132

821

Sequelae of infectious and parasitic diseases

363

2646

1.42

8.41

2.2

0.21

g/l

0.18

337

2471

Antenatal screening

656

4653

0.78

8.40

2.3

2.4

0.24

0.23

g/l

2.39

626

4390

Pediculosis, acariasis and other infestations, including avohilmo

832

6757

1.26

8.40

2.6

0.22

g/l

0.09

775

6340

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

264

1821

1.51

8.39

2.3

0.22

g/l

0.72

248

1722

Generalized epilepsy, mode (most common among epilepsy diagnosis)

154

944

1.72

8.36

2.0

2.8

0.22

g/l

0.21

148

895

Gonococcal infection

168

1054

1.68

8.34

1.9

2.3

0.22

g/l

0.06

156

990

Labour and delivery complicated by fetal stress [distress]

584

4872

0.77

8.33

2.2

2.4

0.23

g/l

0.63

555

4614

Other/unspecified enthesopathies, not elsewhere classified

433

3250

1.37

8.32

2.3

2.2

0.22

0.21

g/l

1.79

412

3047

Exclusion endpoint for clefts

116

661

1.88

8.29

3.1

3.9

0.22

g/l

0.25

110

633

Erectile dysfunction, exclusion

107

3.59

8.28

2.8

2.7

0.19

0.22

g/l

1.05

Sequelae of other and unspecified infectious and parasitic diseases

261

1802

1.51

8.26

2.3

0.21

0.22

g/l

0.85

245

1703

Lesion of radial nerve

203

1336

1.60

8.22

2.3

0.21

g/l

0.56

191

1240

Malignant neoplasm of pyriform sinus, including Hilmo

8.98

8.21

3.0

2.6

0.19

0.20

g/l

0.17

Anogenital herpesviral [herpes simplex] infection, including avohilmo

461

3489

1.35

8.19

2.6

2.4

0.23

0.22

g/l

1.59

431

3282

Other congenital malformations, including avohilmo

617

4860

1.30

8.19

2.6

2.7

0.22

g/l

1.27

586

4577

Ehlers-Danlos syndrome

253

2.46

8.18

3.5

2.8

0.22

0.23

g/l

0.18

243

Iridocyclitis

1158

9746

1.21

8.18

2.4

2.3

0.21

g/l

0.51

1092

9107

Wet age-related macular degeneration

961

7668

1.23

8.16

2.0

0.20

0.19

g/l

0.55

885

7039

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1552

13378

1.18

8.13

2.5

2.4

0.22

0.21

g/l

0.26

1412

12513

Benign neoplasm: Parotid gland

415

3114

1.38

8.12

2.5

2.2

0.21

g/l

0.76

385

2917

Otalgia

435

3281

1.37

8.11

2.5

2.6

0.22

0.21

g/l

2.04

404

3101

Ethmoidectomy

636

5041

1.29

8.10

2.5

2.4

0.22

0.21

g/l

0.18

604

4735

Allergic rhinitis

1459

12348

1.18

8.09

2.6

0.23

0.22

g/l

3.89

1372

11637

Tongue abnormality

332

2409

1.44

8.09

2.3

2.2

0.22

0.21

g/l

1.11

315

2246

Transepidermal elimination disorders

5.83

8.07

2.2

3.7

0.20

0.21

g/l

0.31

Other benign neoplasms of skin

2017

17728

1.15

8.06

2.4

2.2

0.21

g/l

4.02

1895

16502

Alcoholic cardiomyopathy

165

2.93

8.05

2.4

2.6

0.21

g/l

0.03

151

Hyperplasia of prostate

1963

9647

1.16

8.04

2.3

2.5

0.21

0.20

g/l

1.47

1833

8947

Other specified/unspecified inflammatory spondylopathies

219

1467

1.55

8.01

2.5

2.3

0.22

g/l

0.04

205

1387

Osteosarcoma, including Hilmo

3.85

8.01

3.1

3.6

0.20

0.22

g/l

0.45

Congenital malformations of aortic and mitral valves

226

1531

1.55

8.00

3.1

2.9

0.20

0.22

g/l

3.78

218

1445

Cardiomyopathies, Secondary/extrinsic

227

2.60

7.96

2.3

3.0

0.21

0.22

g/l

0.05

217

Schizotypal disorder

112

638

1.86

7.95

1.8

2.6

0.22

0.23

g/l

0.46

101

603

Dissection of aorta

173

1108

1.65

7.94

2.2

2.4

0.21

0.20

g/l

0.44

164

1023

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

330

2346

1.42

7.93

3.8

3.0

0.22

g/l

0.38

313

2223

Malignant neoplasm of lip

188

2.69

7.92

1.9

0.20

0.19

g/l

0.39

164

Burn and corrosion of wrist and hand

191

1249

1.60

7.92

2.6

0.22

g/l

0.21

176

1172

Seropositive rheumatoid arthritis, wide

1390

11917

1.19

7.92

2.2

0.20

0.21

g/l

2.37

1290

11103

Other secondary coxarthrosis

187

1221

1.62

7.91

2.1

2.3

0.20

0.21

g/l

0.59

176

1149

Adhesive capsulitis of shoulder

869

7146

1.24

7.91

2.3

0.21

g/l

1.63

801

6688

Hyperfunction of pituitary gland

222

1496

1.54

7.91

2.7

2.3

0.22

g/l

0.23

200

1405

Golimumab

172

1099

1.64

7.88

2.1

2.4

0.24

0.23

g/l

0.90

163

1033

Oral lichen planus, including avohilmo , including avohilmo

377

2803

1.40

7.87

2.3

0.22

0.21

g/l

1.35

355

2642

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

179

1156

1.62

7.86

2.5

0.22

g/l

0.30

170

1087

Orchitis and epididymitis

473

3626

1.34

7.85

2.6

2.5

0.21

g/l

0.04

433

3362

Car occupant injured in noncollision transport accident

178

1148

1.62

7.84

2.6

2.4

0.21

0.22

g/l

1.38

169

1071

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1449

12457

1.18

7.82

2.3

2.5

0.22

g/l

1.03

1350

11720

Varicella [chickenpox], including avohilmo

262

1830

1.49

7.80

3.3

3.0

0.22

g/l

0.12

243

1740

Corneal ulcer

922

7635

1.23

7.78

2.1

2.3

0.22

0.21

g/l

0.58

870

7155

Other and unspecified diseases of spleen

122

3.27

7.75

2.4

2.6

0.22

0.21

g/l

0.12

114

Lymphoid leukaemia

303

2183

1.45

7.74

2.3

2.4

0.19

0.20

g/l

0.97

276

2030

IgA nephropathy (IgA glomerulonephritis)

132

798

1.76

7.72

2.9

2.5

0.22

g/l

0.07

124

747

Localized skin eruption due to drugs and medicaments

369

2.17

7.67

2.8

2.4

0.21

0.22

g/l

0.52

349

Dislocation, sprain and strain of joints and ligaments of head

193

1272

1.58

7.67

2.3

2.7

0.21

0.22

g/l

1.02

180

1195

Inflammatory disorders of male genital organs, not elsewhere classified

482

2.01

7.66

2.2

2.7

0.21

g/l

0.24

441

Other specified/unspecified soft tissue disorders

248

1726

1.49

7.58

2.7

2.1

0.21

g/l

1.35

234

1604

Other/unspecified seropositive rheumatoid arthritis

1371

11785

1.18

7.58

2.2

0.20

0.21

g/l

2.37

1272

10983

Injury of urinary and pelvic organs

117

688

1.81

7.57

2.6

2.5

0.21

g/l

0.26

110

642

Female infertility, associated with anovulation

261

1822

1.46

7.55

2.3

0.24

0.23

g/l

1.53

245

1722

FESS (DNB20)

611

4864

1.29

7.54

2.5

2.4

0.22

g/l

0.08

579

4572

Unstable angina pectoris

2008

13898

1.15

7.53

1.9

2.3

0.20

g/l

0.12

1867

12858

Nonspecific lymphadenitis

276

1960

1.46

7.51

2.5

2.2

0.21

0.22

g/l

1.11

262

1853

Erythema nodosum

155

981

1.67

7.51

2.7

2.2

0.22

0.21

g/l

0.29

140

915

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1348

11584

1.18

7.49

2.2

0.20

0.21

g/l

2.15

1249

10804

Disorders of vitreous body and globe

2947

25157

1.12

7.42

2.3

0.21

g/l

2.15

2743

23463

Corneal scars and opacities

159

1017

1.66

7.42

2.5

2.4

0.20

0.21

g/l

0.30

151

959

Peritonsillar abscess

959

8000

1.22

7.42

2.3

2.4

0.22

g/l

0.62

906

7510

Injury of nerves and spinal cord at neck level

129

785

1.76

7.41

2.1

2.4

0.20

0.21

g/l

0.65

118

733

Other symptoms and signs involving the urinary system

525

4117

1.31

7.38

2.3

2.2

0.21

g/l

0.69

483

3849

Other/unspecified enthesopathies of lower limb, excluding foot

358

2662

1.39

7.36

2.6

2.3

0.22

0.21

g/l

1.84

337

2520

Hyperaldosteronism

158

1012

1.66

7.36

2.1

2.3

0.23

0.21

g/l

2.01

144

949

Adenocarcinomas of cervix

3.41

7.36

2.8

2.6

0.26

0.21

g/l

2.94

Porphyria cutanea tarda

10.34

7.34

1.8

3.3

0.21

0.20

g/l

0.26

Intussusception

116

686

1.80

7.33

2.8

2.1

0.22

0.21

g/l

0.12

110

649

Respiratory tuberculosis, confirmed, including avohilmo

104

597

1.86

7.32

2.5

2.3

0.19

0.20

g/l

0.85

548

Respiratory tuberculosis, confirmed

103

590

1.86

7.31

2.4

2.3

0.19

0.20

g/l

0.88

541

Simple and mucopurulent chronic bronchitis

207

1401

1.54

7.31

2.6

2.3

0.20

g/l

0.18

188

1299

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

485

1.94

7.29

1.6

2.3

0.23

g/l

0.01

466

Crushed, pushed or stepped on by crowd or human stampede

340

2510

1.39

7.28

3.2

2.6

0.22

g/l

0.19

315

2356

Other obstetric conditions, not elsewhere classified

1151

6123

1.20

7.28

2.2

2.4

0.23

g/l

0.16

1088

5801

Hypothermia

110

645

1.83

7.26

2.3

2.4

0.18

0.21

g/l

3.81

597

Other injuries of spine and trunk, level unspecified

269

2.33

7.19

2.3

2.6

0.20

0.22

g/l

1.42

252

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

332

2.22

7.19

2.2

2.3

0.19

0.21

g/l

1.22

310

Other and unspecified follicular disorders

205

1391

1.54

7.18

2.6

2.4

0.23

0.22

g/l

1.19

197

1302

Palmar fascial fibromatosis [Dupuytren]

785

6458

1.24

7.18

2.4

2.2

0.20

g/l

0.05

715

6003

Other/unspecified reactive arthropathies

321

2362

1.41

7.14

2.6

2.3

0.22

g/l

0.31

296

2212

Temporomandibular joint disorders, including avohilmo

2186

18830

1.14

7.11

2.4

0.23

0.22

g/l

4.53

2053

17691

Other congenital malformations of intestine

278

2.32

7.11

6.0

3.0

0.23

0.22

g/l

0.29

261

Pustulosis palmaris et plantaris

219

1512

1.51

7.08

2.1

2.2

0.23

0.21

g/l

1.32

203

1430

Aneurysms, operations, SAH

834

6913

1.23

7.08

2.2

0.21

g/l

0.57

775

6446

Other and unspecified mononeuropathies, also in other diseases

159

1028

1.63

7.07

2.3

2.2

0.20

0.21

g/l

0.45

149

952

Exposure to smoke, fire and flames

132

816

1.71

7.07

2.2

2.5

0.20

0.22

g/l

0.74

120

763

Allergic purpura

150

956

1.65

7.04

3.2

2.3

0.20

0.22

g/l

1.55

140

895

Vascular dementia

487

3665

1.31

7.03

1.6

2.0

0.20

0.19

g/l

1.97

427

3346

Entropion and trichiasis of eyelid

454

3523

1.33

7.01

2.1

0.20

g/l

0.86

422

3249

Other bullous disorders

150

960

1.65

7.01

2.7

2.4

0.21

g/l

0.31

144

900

Toxic effect of corrosive substances

128

2.98

6.99

3.0

2.6

0.19

0.23

g/l

2.82

119

Carbimazole or st.post thyroidectomy, condition for graves disease

1032

8727

1.20

6.98

2.2

2.3

0.22

0.21

g/l

0.69

973

8182

Chronic Coagulation defects

120

726

1.75

6.97

2.5

2.7

0.22

g/l

0.00

115

688

Other sexually transmitted chlamydial diseases

229

1588

1.48

6.96

2.3

2.6

0.24

0.23

g/l

0.53

209

1487

Hypoplasia of dental enamel, prenatal , including avohilmo

186

2.74

6.96

7.3

4.6

0.20

g/l

0.09

178

All dysplastic lesions of the vagina

135

842

1.69

6.95

3.2

2.1

0.22

g/l

0.17

130

797

Acute alcohol intoxication ICD-9

165

1078

1.60

6.95

2.3

2.2

0.19

0.21

g/l

2.82

153

1009

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

114

683

1.78

6.94

2.3

2.5

0.22

0.21

g/l

0.76

106

637

Contusion of toe(s) without damage to nail

131

810

1.70

6.93

2.5

0.22

g/l

0.01

116

767

Other inflammation of eyelid, including avohilmo

2295

20514

1.13

6.93

2.3

2.4

0.22

g/l

7.69

2153

19262

Dermatographic urticaria

312

2294

1.40

6.92

2.2

2.3

0.23

0.22

g/l

1.76

291

2157

Mantle cell lymphoma, including Hilmo

375

2.06

6.90

2.0

0.19

0.20

g/l

0.15

340

Memory loss

471

3683

1.32

6.89

2.1

0.21

0.20

g/l

3.74

411

3423

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

233

2.37

6.89

2.6

2.7

0.20

0.21

g/l

0.59

214

Melanocytic naevi

1564

13664

1.16

6.88

2.6

2.4

0.22

0.21

g/l

5.36

1492

12785

Disorders of vitreous body

2862

24649

1.12

6.86

2.3

0.21

g/l

2.46

2664

23003

Renal tubulo-interstitial disorders in diseases classified elsewhere

316

2.20

6.86

2.5

2.2

0.23

0.21

g/l

0.68

290

Deviated nasal septum

1708

14998

1.15

6.86

2.3

2.4

0.22

0.21

g/l

6.09

1569

14022

Pustular psoriasis

241

1705

1.47

6.85

2.1

2.3

0.22

0.21

g/l

1.37

225

1609

Nonsuppurative otitis media, including avohilmo

1460

10952

1.17

6.84

2.9

2.5

0.22

g/l

2.04

1377

10274

Other superficial mycoses, including avohilmo

490

3842

1.30

6.84

2.3

2.4

0.23

0.22

g/l

1.55

440

3600

Viral warts, including avohilmo

1070

9089

1.20

6.83

3.1

2.5

0.23

0.22

g/l

3.51

1000

8518

Benign neoplasm: Pituitary gland, craniopharyngeal duct

260

1865

1.45

6.80

2.4

2.3

0.22

0.21

g/l

0.19

247

1743

Erectile dysfunction

409

3148

1.34

6.80

2.8

2.3

0.20

g/l

0.80

379

2906

Viral encephalitis, not elsewhere classified/unspecified

112

672

1.78

6.79

2.3

2.5

0.22

0.21

g/l

0.87

104

626

Benign neoplasm: Tongue

154

1000

1.63

6.79

2.9

2.3

0.22

0.21

g/l

0.92

145

932

Inguinal hernia

3125

18838

1.11

6.77

2.5

2.3

0.21

g/l

0.20

2893

17507

Atypical facial pain

261

1875

1.45

6.77

2.3

2.2

0.23

0.21

g/l

2.72

240

1758

Postpartum haemorrhage

718

7219

0.81

6.76

2.2

2.3

0.23

g/l

0.42

687

6835

Primary coxarthrosis, bilateral

1583

13879

1.16

6.74

2.1

2.2

0.20

g/l

0.20

1480

12876

Hordeolum and other deep inflammation of eyelid

302

2222

1.40

6.74

2.4

2.5

0.22

0.21

g/l

0.24

290

2085

Benign neoplasm: Appendix

367

2.09

6.73

2.5

2.3

0.22

0.21

g/l

0.02

342

Postzoster neuralgia

562

1.86

6.73

2.1

2.2

0.20

g/l

0.11

517

Dementia, including avohilmo

2651

16291

1.12

6.72

1.9

2.2

0.20

g/l

0.43

2372

15118

Seborrhoeic keratosis

1333

11551

1.17

6.69

2.6

2.2

0.21

g/l

4.58

1247

10788

Other and unspecified glaucoma

377

2875

1.36

6.68

2.4

2.1

0.20

g/l

0.00

348

2647

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

205

2.48

6.68

2.7

2.1

0.16

0.20

g/l

2.59

183

Dronedarone medication

157

1028

1.61

6.67

2.6

2.2

0.21

g/l

0.37

143

974

Phakomatoses, not elsewhere classified

346

2.11

6.66

2.6

2.9

0.22

g/l

0.43

323

Other and unspecified paralytic syndromes

460

1.95

6.66

2.5

2.4

0.21

0.22

g/l

0.37

433

Hypertrophic scar

238

1684

1.46

6.65

2.8

2.3

0.22

g/l

0.21

219

1588

Dislocation, sprain and strain of joints and ligaments of thorax

175

1170

1.56

6.63

2.5

2.3

0.21

0.22

g/l

0.28

156

1102

Pre-eclampsia

843

7030

1.22

6.62

2.2

2.3

0.22

g/l

0.30

799

6626

Ascorbic acid deficiency

10.20

6.62

9.6

6.0

0.21

0.22

g/l

0.45

Contact with other hot fluids

157

1027

1.60

6.60

2.8

2.7

0.22

g/l

0.23

146

963

Retinal vascular disorders

637

5181

1.26

6.60

2.3

2.1

0.20

g/l

0.23

589

4790

Respiratory tuberculosis, bacteriologically and histologically confirmed

103

608

1.80

6.60

2.4

2.3

0.19

0.20

g/l

0.97

556

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

102

600

1.80

6.60

3.0

3.1

0.22

g/l

0.04

566

Pre-eclampsia or eclampsia

919

7728

1.21

6.59

2.2

2.3

0.22

g/l

0.34

871

7285

Malignant neoplasm of pyriform sinus

12.83

6.57

3.5

3.6

0.18

0.23

g/l

0.99

Disorder of the sleep-wake schedule

556

1.83

6.57

2.6

2.9

0.22

g/l

0.14

519

Monoarthritis, not elsewhere classified

208

1442

1.50

6.56

2.3

0.22

0.21

g/l

0.42

196

1361

Universal erythroderma, KELA reimbursement

448

1.95

6.55

2.5

2.3

0.20

0.21

g/l

0.49

418

Other abnormal findings in urine

567

1.84

6.55

2.4

2.3

0.20

g/l

0.07

525

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

160

1050

1.59

6.55

3.0

3.6

0.22

g/l

0.40

151

997

Urethritis and urethral syndrome

116

708

1.73

6.54

2.5

2.3

0.22

0.21

g/l

0.71

109

666

Pleural plaque

471

3708

1.31

6.52

2.3

2.1

0.18

0.19

g/l

2.72

423

3408

Asthma mixed form (mode)

225

1580

1.47

6.50

2.4

2.2

0.21

g/l

0.30

214

1475

Habit and impulse disorders

439

1.93

6.50

2.4

2.8

0.23

g/l

0.12

413

Cerebral aneurysm, nonruptured

438

3419

1.32

6.49

2.1

2.2

0.21

g/l

0.39

406

3210

Status post-ami

1386

9132

1.17

6.49

2.1

2.3

0.19

0.20

g/l

4.61

1259

8455

Carcinoma in situ of skin of scalp and neck

165

1102

1.59

6.48

3.1

2.2

0.20

0.19

g/l

0.62

156

1006

Osteosarcoma

4.20

6.48

3.8

0.20

0.23

g/l

0.59

Embolic stroke with flimmer

131

826

1.66

6.44

1.7

2.1

0.18

0.20

g/l

2.43

119

760

Malignant neoplasm of brain, including Hilmo

195

1337

1.50

6.42

1.8

2.2

0.24

0.21

g/l

4.47

183

1231

Panhypopituitarism

577

1.82

6.41

2.6

0.21

g/l

0.42

533

Hyperkinetic disorders (excl. ADHD)

101

588

1.79

6.40

3.4

4.1

0.21

0.22

g/l

0.53

559

Diabetic retinopathy, strict definition

992

7495

1.20

6.40

2.4

2.5

0.19

0.21

g/l

18.44

895

6940

Anterior Iridocyclitis

993

8440

1.20

6.38

2.4

2.3

0.21

g/l

0.61

936

7890

Mild mental retardation

133

846

1.66

6.38

2.8

3.4

0.22

g/l

0.18

126

806

Other keratitis

544

4365

1.27

6.33

2.3

2.4

0.22

g/l

0.22

511

4100

Abnormality of white blood cells, not elsewhere classified

284

2.21

6.33

2.4

2.3

0.21

0.22

g/l

0.13

267

Bruxism

555

1.81

6.32

2.9

2.5

0.23

g/l

0.14

525

Impaction of intestines

204

2.44

6.31

3.4

1.9

0.18

0.21

g/l

1.81

184

Optic neuritis

186

1271

1.52

6.31

2.5

2.3

0.22

g/l

0.04

178

1205

Effects of foreign body entering through natural orifice

1204

10397

1.18

6.31

2.6

2.5

0.22

0.21

g/l

0.60

1114

9754

Long labour

687

7070

0.81

6.30

2.2

2.3

0.23

g/l

1.71

656

6691

Tuberculosis, IBD comorbidity

339

2565

1.36

6.30

2.3

2.1

0.19

0.20

g/l

1.04

315

2361

Vascular dementia (mixed)

112

686

1.73

6.29

1.4

2.1

0.20

0.19

g/l

0.72

100

633

Retinal vascular occlusion

626

5112

1.25

6.29

2.3

2.1

0.20

g/l

0.19

581

4731

Other injuries of upper limb, level unspecified

389

2.00

6.27

2.5

0.22

g/l

0.15

359

Disorders of speech understanding and production

216

1492

1.47

6.26

3.8

3.3

0.21

g/l

0.04

202

1408

Polyarthritis, unspecified

186

1278

1.52

6.21

2.5

2.3

0.22

0.21

g/l

0.39

177

1210

Other prurigo

348

2.05

6.20

3.8

2.1

0.21

g/l

0.19

328

Malignant neoplasm of brain

139

895

1.61

6.19

1.8

2.3

0.24

0.21

g/l

3.55

133

826

Benign neoplasm: Anus and anal canal

153

1014

1.59

6.17

2.3

2.2

0.21

g/l

0.16

139

949

Other and unspecified injuries of ankle and foot

200

1392

1.49

6.16

3.5

2.5

0.21

0.22

g/l

1.58

189

1317

Bitten or struck by other mammals

527

4226

1.27

6.16

2.4

0.23

0.22

g/l

1.20

482

3983

Other and unspecified rosacea

446

3518

1.30

6.08

2.5

2.2

0.21

g/l

0.12

410

3307

Congenital malformations of the nervous system

111

683

1.71

6.08

2.6

3.3

0.21

0.22

g/l

0.48

101

649

Dislocation, sprain and strain of joint and ligaments of hip

198

1386

1.49

6.04

2.2

2.3

0.21

g/l

0.08

183

1295

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1102

5930

1.18

6.04

2.3

2.4

0.23

g/l

0.19

1043

5617

Symptoms and signs involving appearance and behaviour

234

2.28

6.02

2.3

2.4

0.21

0.22

g/l

0.46

223

Personal history of medical treatment

338

2.05

5.99

4.5

2.5

0.22

0.21

g/l

0.39

317

L01XX Other antineoplastic agents

311

2350

1.37

5.99

1.9

2.2

0.20

g/l

0.28

287

2190

Acute and subacute iridocyclitis

931

7917

1.20

5.98

2.4

2.3

0.21

g/l

0.63

876

7400

Meningitis

236

1705

1.43

5.96

2.3

2.4

0.22

g/l

0.32

224

1598

Other otitis externa (chronic)

333

2537

1.35

5.96

2.5

2.3

0.22

0.21

g/l

0.42

300

2365

Abnormal blood-pressure reading, without diagnosis

234

1688

1.43

5.95

2.4

2.3

0.22

0.21

g/l

0.69

211

1601

Perforation of tympanic membrane

481

3839

1.28

5.94

2.2

2.3

0.21

g/l

0.04

449

3587

Chondropathies

714

5936

1.23

5.92

2.7

2.4

0.22

g/l

1.21

658

5582

Carcinoma in situ of skin of upper limb, including shoulder

152

1020

1.58

5.89

2.4

2.2

0.22

0.20

g/l

2.15

141

942

Alzheimer’s disease (Early onset)

1604

0.60

5.89

1.6

2.0

0.20

g/l

0.26

1470

Dependent personality disorder

104

637

1.73

5.87

2.2

2.3

0.22

g/l

0.26

604

Melanocytic naevi of trunk

589

4811

1.25

5.87

2.7

2.3

0.22

0.21

g/l

3.82

565

4514

Benign neoplasm of meninges

530

4288

1.27

5.87

2.2

0.21

g/l

0.79

492

4012

Pleural plaque with presence of asbestos

368

2854

1.33

5.84

2.4

2.2

0.18

0.19

g/l

2.52

325

2631

Vulvovaginal ulceration/inflammation in other diseases

286

2132

1.38

5.83

2.7

2.2

0.23

0.22

g/l

1.37

271

2010

Other specified disorders of muscle

145

960

1.58

5.82

2.2

0.20

0.21

g/l

0.71

134

898

Chronic myeloid leukaemia, including Hilmo

244

2.23

5.82

3.3

2.1

0.22

0.21

g/l

0.46

221

Varicose veins of other sites

308

2329

1.36

5.80

3.6

2.2

0.20

0.22

g/l

4.68

281

2182

Other acute skin changes due to ultraviolet radiation

173

1190

1.52

5.80

2.2

2.3

0.21

g/l

0.05

157

1100

Diabetic maculopathy

706

5565

1.23

5.78

2.2

2.5

0.19

0.21

g/l

8.34

644

5164

Other specified and unspecified disorders of eye and adnexa

188

1314

1.49

5.78

2.5

2.3

0.22

0.21

g/l

1.72

175

1229

Carcinoma in situ of skin

457

3648

1.29

5.76

2.8

2.1

0.21

0.20

g/l

1.21

429

3379

Dementia in other diseases classified elsewhere

243

1779

1.42

5.74

2.1

2.2

0.21

0.20

g/l

1.25

218

1655

Poisoning by medicine, drug-induced

409

1.92

5.71

2.0

2.5

0.20

0.23

g/l

2.32

385

Adult respiratory distress syndrome

432

1.90

5.69

2.7

2.4

0.21

g/l

0.03

400

Unspecified lump in breast

747

6264

1.21

5.69

2.1

2.2

0.22

0.21

g/l

3.17

710

5857

Other superficial mycoses

113

711

1.67

5.68

2.5

2.7

0.22

g/l

0.13

104

673

Eustachian salpingitis and obstruction

330

2522

1.34

5.67

2.9

2.5

0.23

g/l

0.10

316

2365

Panniculitis affecting regions of neck and back

179

1243

1.50

5.67

2.3

2.2

0.22

0.21

g/l

0.59

165

1170

Viral meningitis, including avohilmo

166

1135

1.52

5.66

2.6

2.4

0.22

g/l

0.24

155

1072

Benign thyroid growths and nodules

1697

14035

1.14

5.65

2.1

2.2

0.21

g/l

1.94

1593

13083

HSIL lesion of the cervix uteri, vagina or vulva

777

6530

1.21

5.65

2.4

2.3

0.23

0.22

g/l

1.02

729

6179

Convergent concomitant strabismus

252

1855

1.40

5.64

3.2

2.6

0.22

g/l

0.30

239

1747

Obstructed labour due to malposition and malpresentation of fetus

624

6994

0.82

5.63

2.3

0.23

g/l

1.30

592

6637

Tuberculosis, wide, including avohilmo

351

2714

1.33

5.63

2.3

2.1

0.19

0.20

g/l

0.74

326

2490

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

131

2.71

5.62

1.9

2.3

0.20

g/l

0.03

117

Paranoid personality disorder

552

1.76

5.61

2.5

2.4

0.22

g/l

0.15

522

All dysplastic lesions of the cervix uteri, vagina or vulva

1186

10055

1.16

5.61

2.4

2.3

0.22

g/l

0.48

1117

9510

Dyshidrosis [pompholyx]

447

1.84

5.57

2.2

2.4

0.21

0.22

g/l

0.35

427

Etanercept

306

2326

1.35

5.57

2.8

2.4

0.22

g/l

0.11

285

2184

Visual field defects

424

3366

1.29

5.56

2.1

2.2

0.21

g/l

0.10

395

3146

Tuberculosis, wide

346

2676

1.33

5.54

2.4

2.1

0.19

0.20

g/l

0.85

322

2457

Epidural haemorrhage

269

2.12

5.54

2.5

3.0

0.20

0.21

g/l

0.48

254

Diseases of appendix

3964

32839

1.09

5.54

2.4

0.22

0.21

g/l

5.10

3713

30714

Respiratory conditions due to other external agents

116

743

1.66

5.54

2.1

0.21

0.20

g/l

0.24

109

691

Benign neoplasm of urinary organs

248

1834

1.40

5.52

2.2

2.3

0.21

g/l

0.73

228

1709

Single delivery by caesarean section

560

3913

0.80

5.48

2.4

2.5

0.23

g/l

0.79

531

3703

Thyrotoxicosis with diffuse goitre

650

5399

1.23

5.47

2.2

0.21

g/l

0.14

603

5081

Other and unspecified nerve root and plexus disorders, also in other diseases

1029

8886

1.18

5.47

2.2

2.3

0.22

0.21

g/l

4.60

935

8319

Caries of enamel

5394

33033

1.07

5.46

2.7

2.3

0.22

0.21

g/l

23.61

5068

30922

Allergic contact dermatitis

607

5011

1.23

5.44

2.3

0.22

g/l

0.54

568

4716

Oral leukoplakia, including avohilmo

151

1028

1.55

5.42

2.2

0.21

g/l

0.25

144

959

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

287

2166

1.36

5.41

2.6

2.2

0.23

g/l

0.12

277

2061

Bronchitis, not specified as acute or chronic

404

3195

1.29

5.40

2.5

2.2

0.21

g/l

0.37

383

2975

Neovascular glaucoma

205

1474

1.44

5.40

2.2

2.3

0.19

0.21

g/l

1.51

192

1366

Pre-eclampsia or poor fetal growth

1215

10565

1.16

5.40

2.3

0.22

g/l

0.83

1143

9989

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

6.08

5.39

3.3

1.6

0.21

0.23

g/l

0.21

Other secondary gonarthrosis

279

2109

1.37

5.39

2.1

2.2

0.21

g/l

0.15

261

1978

Other nonautoimmune haemolytic anaemias

3.87

5.38

3.2

2.5

0.20

0.21

g/l

0.03

Cutaneous lupus erythematosus

122

794

1.62

5.38

2.5

2.2

0.20

0.21

g/l

0.68

117

744

Mouth breathing

2065

18622

1.12

5.37

2.2

2.5

0.22

0.21

g/l

2.32

1900

17486

Inflammatory disorders of breast

264

1973

1.37

5.35

2.0

2.2

0.22

g/l

0.01

249

1866

Radial styloid tenosynovitis [de Quervain]

254

1889

1.38

5.34

2.3

0.22

g/l

0.68

239

1793

Carcinoma in situ of other and unspecified sites

213

1549

1.44

5.33

1.8

2.3

0.21

0.20

g/l

0.96

195

1433

Alzheimer’s disease (Atypical or mixed)

562

4560

1.24

5.32

1.6

2.0

0.19

g/l

1.22

501

4161

Demyelinating diseases of the central nervous system

362

2830

1.31

5.31

2.5

2.4

0.22

g/l

0.01

345

2661

Coxarthrosis, primary, with hip surgery

2640

22382

1.10

5.30

2.1

2.2

0.20

g/l

0.24

2463

20736

Benign neoplasm: Cerebral meninges

479

3880

1.27

5.30

2.2

0.21

g/l

1.08

449

3626

Dislocation of lens

516

1.77

5.29

2.5

2.2

0.19

0.20

g/l

0.43

474

Other lack of coordination

602

1.72

5.29

2.4

2.6

0.21

g/l

0.15

557

Dislocation, sprain and strain of joints and ligaments of knee

3115

25907

1.09

5.25

2.3

2.4

0.22

g/l

5.25

2925

24336

Systemic atrophies primarily affecting the central nervous system

218

1594

1.42

5.25

2.3

2.4

0.21

g/l

0.60

209

1478

Hypothyroidism due to medicaments and other exogenous substances

376

1.91

5.24

2.3

2.2

0.22

0.21

g/l

0.61

363

Other and unspecified injuries of wrist and hand

184

1304

1.46

5.23

2.5

2.6

0.22

g/l

0.25

170

1221

Complications of labour and delivery

2546

15514

0.90

5.22

2.2

2.3

0.22

g/l

0.62

2403

14574

Acute appendicitis

3658

31446

1.09

5.22

2.4

0.22

0.21

g/l

4.50

3420

29425

Cluster headache, strict, including avohilmo

220

1608

1.41

5.20

2.3

2.4

0.22

g/l

0.02

208

1512

Benign neoplasm: Long bones of lower limb

152

1042

1.52

5.19

2.8

2.4

0.22

g/l

0.16

147

979

Other complications of labour and delivery, not elsewhere classified

239

2848

0.73

5.19

2.0

2.4

0.23

g/l

0.33

228

2698

Other and unspecified acute skin changes due to ultraviolet radiation

131

875

1.57

5.17

2.2

2.3

0.21

0.20

g/l

0.21

117

800

Non-small cell lung cancer, squamous

178

1253

1.46

5.15

1.8

1.9

0.20

0.19

g/l

1.08

161

1122

Multiple myeloma and malignant plasma cell neoplasms

252

1892

1.38

5.14

2.4

2.2

0.19

0.20

g/l

1.03

235

1755

Lichen simplex chronicus

171

1203

1.48

5.14

2.4

2.2

0.21

g/l

0.00

161

1128

Pneumonia due to Haemophilus influenzae

107

2.85

5.13

2.8

2.4

0.22

g/l

0.11

101

Use of biperiden

248

1856

1.38

5.10

2.0

2.3

0.21

0.22

g/l

0.61

221

1745

Chromosomal abnormalities, not elsewhere classified

110

707

1.63

5.09

2.8

3.9

0.22

0.21

g/l

0.65

105

673

Complications following abortion and ectopic and molar pregnancy

171

1207

1.48

5.08

2.5

2.2

0.21

g/l

0.12

161

1137

Suggestive for eosinophilic asthma

445

3591

1.27

5.08

2.2

2.3

0.21

g/l

0.52

420

3365

Malignant immunoproliferative diseases

360

1.94

5.08

3.3

2.4

0.17

0.21

g/l

4.05

333

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

101

640

1.67

5.07

2.6

2.3

0.19

0.20

g/l

1.71

597

Other sideroblastic anaemias

102

2.90

5.07

2.3

2.1

0.20

0.21

g/l

0.30

Sudden idiopathic hearing loss

510

4179

1.25

5.06

2.5

2.3

0.21

g/l

0.14

473

3910

Alzheimer’s disease (Late onset), excluding more controls

754

4134

1.20

5.06

1.7

2.2

0.20

g/l

0.75

648

3854

Tooth eruption problems

571

4550

1.23

5.05

3.5

3.0

0.23

g/l

0.11

538

4288

Benign neoplasm: Other/unspecified site

525

1.75

5.02

2.2

0.22

0.21

g/l

0.44

490

Rosacea

610

5085

1.22

5.01

2.5

2.3

0.22

0.21

g/l

0.97

565

4778

Viral agents as the cause of diseases classified to other chapters, including avohilmo

127

848

1.57

5.00

3.2

2.7

0.21

0.22

g/l

0.09

121

805

Conduct disorder

560

1.69

4.99

2.4

3.1

0.22

0.23

g/l

0.64

529

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1585

10416

0.88

4.98

2.3

0.23

0.22

g/l

0.77

1503

9822

Other congenital malformations of intestine, including avohilmo

376

1.89

4.97

5.4

2.7

0.23

0.22

g/l

0.55

353

Appendicitis, broad definition

3915

32682

1.08

4.97

2.4

0.22

0.21

g/l

5.12

3666

30568

Testicular hypofunction

174

1236

1.46

4.95

2.7

2.5

0.24

0.22

g/l

1.14

166

1151

Mature T/NK-cell lymphomas, hilmo

467

1.79

4.94

2.9

2.5

0.19

0.21

g/l

0.77

433

Plantar fascial fibromatosis

474

3861

1.25

4.93

2.2

0.23

0.21

g/l

4.45

442

3643

Other degenerative diseases of the basal ganglia

111

727

1.63

4.92

2.0

2.4

0.20

g/l

0.20

101

674

Follicular lymphoma, hilmo

225

1675

1.40

4.91

1.9

2.2

0.20

0.21

g/l

1.36

210

1550

Burns and corrosions confined to eye and internal organs

126

842

1.56

4.91

2.6

2.5

0.22

g/l

0.19

117

791

Benign neoplasm of middle ear and respiratory system

381

3037

1.29

4.88

2.6

2.2

0.21

g/l

0.56

362

2837

Other forms of systemic lupus erythematosus

255

2.09

4.88

2.6

2.3

0.19

0.22

g/l

1.94

241

Chondrocostal junction syndrome [Tietze]

182

1307

1.44

4.87

2.5

2.2

0.22

0.21

g/l

0.78

164

1222

Glaucoma secondary to other eye disorders

206

1511

1.41

4.86

2.2

2.3

0.19

0.20

g/l

1.05

193

1401

Disorders of ornithine metabolism

16.67

4.86

4.0

3.5

0.24

0.20

g/l

—

Other demyelinating diseases of the central nervous system

157

1098

1.48

4.82

2.3

2.4

0.22

g/l

0.04

150

1041

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

186

1345

1.44

4.82

2.3

2.2

0.21

g/l

0.40

174

1258

Osteitis due to dental implant

272

2.06

4.80

2.3

2.6

0.22

0.21

g/l

0.33

255

Problems related to social environment

135

919

1.52

4.78

2.6

2.3

0.20

0.21

g/l

0.82

126

855

Coronary artery bypass grafting

1343

8824

1.14

4.78

2.0

2.3

0.19

0.20

g/l

7.60

1231

8177

Endometriosis of ovary

758

6081

1.19

4.78

2.5

2.2

0.22

0.21

g/l

0.63

721

5689

Dementia

2433

15206

1.10

4.77

1.9

2.2

0.20

g/l

0.18

2172

14104

Embolic stroke

226

1685

1.38

4.75

1.8

2.1

0.19

g/l

0.22

202

1555

Traumatic ischaemia of muscle

434

1.79

4.71

2.5

0.21

0.22

g/l

0.07

402

Pregnancy hypertension

1767

14229

1.12

4.70

2.2

2.3

0.22

g/l

0.17

1680

13409

Carcinoma in situ of skin of ear and external auricular canal

543

1.70

4.69

2.1

2.2

0.21

0.19

g/l

1.46

494

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

862

7443

1.18

4.67

2.5

2.4

0.22

0.21

g/l

1.50

817

6957

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

131

2.54

4.66

2.1

0.17

0.20

g/l

1.18

118

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

127

859

1.53

4.66

2.9

2.3

0.22

g/l

0.10

119

808

Guttate psoriasis

435

1.78

4.65

1.9

2.3

0.22

g/l

0.04

411

Optic atrophy

615

1.65

4.64

2.7

0.20

0.21

g/l

0.57

582

Other congenital malformations of nervous system

273

2.00

4.63

2.2

3.3

0.21

0.23

g/l

0.80

262

Rapidly progressive nephritic syndrome

3.49

4.62

3.4

2.0

0.26

0.22

g/l

0.77

Pilonidal cyst

346

2739

1.29

4.61

2.9

2.5

0.22

0.23

g/l

2.96

327

2570

Examination and encounter for administrative purposes

374

2992

1.28

4.61

2.1

0.21

0.20

g/l

0.59

356

2769

Disorders of refraction and accommodation

1367

12126

1.13

4.61

2.7

2.6

0.22

g/l

1.09

1288

11387

Malignant neoplasm of bone and articular cartilage of limbs

113

2.66

4.60

3.0

3.4

0.19

0.22

g/l

0.86

103

Granulomatous disorders of skin and subcutaneous tissue

123

830

1.54

4.60

2.2

2.3

0.22

g/l

0.01

112

772

Chronic iridocyclitis

237

1793

1.36

4.58

2.5

2.4

0.21

g/l

0.58

228

1674

Enteropathogenic Escherichia coli infection

108

2.76

4.58

3.7

2.9

0.20

0.22

g/l

0.87

101

Burn and corrosion of other internal organs

2.92

4.54

4.3

2.4

0.19

0.23

g/l

1.53

Mild or no visual impairment, binocular

146

2.44

4.53

2.3

2.4

0.22

g/l

0.14

139

Postpartum care and examination

359

2827

0.79

4.52

2.2

2.4

0.22

0.23

g/l

0.82

331

2657

Viral meningitis

154

1088

1.46

4.51

2.7

2.4

0.22

g/l

0.12

143

1026

Burn and corrosion of shoulder and upper limb, except wrist and hand

107

706

1.59

4.49

2.5

2.6

0.20

0.22

g/l

0.84

663

Other and unspecified vascular occlusions

478

3944

1.24

4.49

2.2

2.1

0.20

g/l

0.04

437

3642

Phantom limb syndrome

3.08

4.49

2.8

2.9

0.22

g/l

0.10

Viral agents as the cause of diseases classified to other chapters

112

748

1.57

4.47

3.4

2.7

0.21

0.22

g/l

0.22

107

710

Cluster headache, wide,, including avohilmo

230

1737

1.36

4.46

2.3

2.4

0.22

g/l

0.03

218

1633

Carcinoma in situ of oesophagus

4.32

4.46

3.1

3.0

0.19

0.21

g/l

0.49

Optic atrophy, wide definition

645

1.62

4.45

2.6

0.20

0.21

g/l

0.58

611

Cervicobrachial syndrome

1055

9271

1.15

4.45

2.1

2.3

0.22

0.21

g/l

5.33

987

8690

Benign neoplasm: Other and unspecified parts of mouth

164

1179

1.45

4.44

3.0

2.2

0.22

0.21

g/l

0.36

153

1100

LSIL lesion of the vulva

133

920

1.51

4.42

2.8

2.1

0.21

0.22

g/l

0.53

128

875

Benign neoplasm of other and unspecified sites

163

1172

1.45

4.41

2.1

2.3

0.22

0.21

g/l

0.39

152

1096

Residual foreign body in soft tissue

235

1785

1.35

4.39

2.2

2.3

0.22

0.21

g/l

0.95

222

1674

116

782

1.54

4.38

2.3

0.21

0.23

g/l

1.82

104

740

Personal history of allergy to drugs, medicaments and biological substances

337

1.86

4.37

2.1

0.23

0.22

g/l

0.39

318

Trigger finger

713

6105

1.19

4.35

2.2

2.3

0.22

0.21

g/l

1.08

669

5733

Hypogonadotropic hypogonadism

146

1031

1.47

4.35

2.6

2.7

0.23

g/l

0.23

139

959

Retinal detachments and breaks

1895

17249

1.11

4.34

2.4

2.2

0.21

g/l

0.03

1776

16064

Other neurotic disorders

221

1670

1.36

4.32

2.5

2.2

0.21

g/l

0.37

204

1559

Operations for atrial fibrillation

549

1.68

4.32

1.9

2.6

0.19

0.21

g/l

1.75

506

Benign neoplasm of bone and articular cartilage

378

3056

1.26

4.29

2.7

2.3

0.23

0.22

g/l

1.45

362

2860

Spirochaetal infections, other/unspecified

444

3656

1.24

4.29

2.6

2.3

0.22

0.21

g/l

2.73

414

3432

Flat foot [pes planus] (acquired)

466

3852

1.23

4.27

2.5

2.3

0.22

0.21

g/l

1.03

435

3620

Behçet disease

3.03

4.27

2.6

2.7

0.23

g/l

0.15

Benign neoplasm of breast

544

4567

1.21

4.24

2.1

0.21

g/l

0.67

506

4284

Benign neoplasm: Kidney

182

1343

1.41

4.24

1.8

2.3

0.21

g/l

0.56

168

1258

Drug-induced headache, not elsewhere classified

143

2.36

4.24

2.1

2.3

0.22

g/l

0.14

137

Hyperprolactinaemia

138

967

1.47

4.23

2.2

2.4

0.22

g/l

0.11

125

916

Other disorders of bone density and structure

119

813

1.52

4.22

2.4

0.22

g/l

0.28

109

769

Secondary parkinsonism+Parkinsonism in other disease

143

1014

1.47

4.22

1.8

2.3

0.21

0.20

g/l

0.23

136

941

Spinal instabilities

137

963

1.48

4.21

3.2

2.3

0.23

0.21

g/l

1.40

128

916

Behavioural disorders

586

1.61

4.21

2.5

3.3

0.22

0.23

g/l

0.50

552

False labour

905

6443

0.86

4.20

2.2

2.3

0.23

g/l

1.18

855

6107

Amblyopia ex anopsia

194

1445

1.39

4.19

2.6

3.0

0.21

g/l

0.08

182

1362

Papilloedema, unspecified

108

725

1.55

4.19

3.3

2.5

0.21

0.22

g/l

0.23

103

677

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

120

1724

0.68

4.18

1.9

2.3

0.22

g/l

0.33

111

1625

Other and unspecified visual disturbances

517

4328

1.22

4.17

2.5

2.2

0.22

0.21

g/l

1.73

480

4067

Necrobiosis lipoidica, not elsewhere classified

144

2.34

4.17

2.2

2.4

0.21

0.22

g/l

0.42

139

Calculus of lower urinary tract

259

2015

1.32

4.14

2.5

2.2

0.19

0.20

g/l

0.66

231

1868

Other specified/unspecified disorders of bone/cartilage

128

891

1.49

4.14

2.1

2.4

0.21

0.22

g/l

0.59

116

846

Gluteal tendinitis

216

1639

1.36

4.13

2.4

2.3

0.22

0.21

g/l

2.14

205

1547

Outcome of delivery

451

3357

0.81

4.13

2.0

2.3

0.24

0.23

g/l

3.68

431

3167

Transient acantholytic dermatosis [Grover]

3.39

4.13

1.8

2.1

0.25

0.21

g/l

1.57

Pedestrian injured in transport accident

325

2597

1.28

4.13

2.1

2.3

0.21

g/l

0.11

302

2424

Unknown and unspecified causes of morbidity

277

2167

1.30

4.12

2.4

2.1

0.21

g/l

1.13

259

2050

Anomalies of pupillary function

655

1.58

4.12

2.2

2.6

0.22

g/l

0.02

624

Other deformities of toe(s)

174

1280

1.41

4.10

2.2

2.3

0.21

g/l

0.07

162

1215

Other infective spondylopathies

3.34

4.10

4.1

1.9

0.18

0.21

g/l

0.69

Pregnancy, childbirth and the puerperium

1230

7213

0.88

4.10

1.9

2.3

0.21

g/l

0.51

1161

6645

Superficial injury of neck

567

1.62

4.09

2.3

2.6

0.23

g/l

0.02

528

Hallux rigidus

689

5923

1.18

4.06

2.1

2.3

0.22

0.21

g/l

2.52

633

5573

Any dementia

2163

13714

1.10

4.04

1.8

2.1

0.20

g/l

0.11

1914

12683

384

1.77

4.04

2.4

2.6

0.20

0.21

g/l

0.42

355

Hypertrophy of tongue papillae

446

1.71

4.03

3.1

2.3

0.22

g/l

0.07

422

Adenomyosis (Endometriosis of uterus)

622

5299

1.19

4.00

2.1

2.2

0.21

g/l

0.62

586

4940

Right side

203

0.23

3.98

1.2

2.2

0.19

0.21

g/l

—

189

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

154

1116

1.42

3.96

2.3

2.5

0.22

g/l

0.24

139

1053

Other disorders of the genitourinary system

628

5379

1.19

3.93

2.3

2.2

0.22

0.21

g/l

3.00

570

5019

Abscess of Bartholin gland

110

750

1.52

3.93

2.4

2.2

0.22

g/l

0.07

101

707

Sequelae of poliomyelitis, including avohilmo

283

1.90

3.92

1.8

2.1

0.21

g/l

0.12

259

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

201

2.03

3.91

2.0

2.2

0.23

0.22

g/l

0.17

195

Exposure to controlled fire, not in building or structure

2.80

3.90

2.5

3.0

0.21

0.22

g/l

0.31

Herpesviral keratitis and keratoconjunctivitis

205

1559

1.36

3.90

2.3

2.2

0.20

0.21

g/l

1.20

191

1450

Congenital malformations of the respiratory system, including avohilmo

102

690

1.55

3.89

2.4

3.0

0.21

g/l

0.16

653

Secondary parkinsonism

138

988

1.45

3.89

1.8

2.3

0.21

0.20

g/l

0.38

131

913

Crowding of teeth, including avohilmo

376

2535

1.25

3.88

3.8

3.4

0.22

g/l

0.02

354

2394

Overexertion and strenuous or repetitive movements

454

3783

1.22

3.88

2.6

2.3

0.22

g/l

0.22

409

3540

Exposure to other and unspecified animate mechanical forces

139

994

1.44

3.87

2.3

2.6

0.23

0.22

g/l

0.34

127

939

Personality and behavioural disorders due to brain disease, damage and dysfunction

498

1.65

3.86

2.2

2.6

0.21

g/l

0.07

464

Testicular dysfunction

187

1406

1.37

3.84

2.6

0.23

0.22

g/l

1.16

179

1311

Acute nasopharyngitis (common cold)

518

4335

1.20

3.81

2.5

0.22

g/l

0.50

485

4060

Sacrococcygeal disorders, not elsewhere classified

140

1006

1.44

3.80

2.1

2.2

0.22

0.21

g/l

0.66

133

962

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

752

6539

1.17

3.79

2.4

0.22

0.21

g/l

1.93

713

6116

Degenerative macular diseases

599

5128

1.19

3.78

2.3

2.1

0.21

0.20

g/l

1.10

546

4756

Excessive vomiting in pregnancy

302

2415

1.27

3.78

2.1

2.4

0.22

g/l

0.10

280

2294

Henoch-Schönlein purpura nephritis (HSPN)

105

2.55

3.78

2.2

2.8

0.19

0.23

g/l

1.53

Other specified and unspecified retinal disorders

176

1317

1.38

3.77

2.8

2.2

0.21

g/l

0.09

166

1229

Chronic mastoiditis

126

893

1.47

3.77

1.9

2.3

0.20

g/l

0.03

113

825

Dementia due to Parkinsons disease, excluding more controls

111

767

1.50

3.76

1.7

2.1

0.20

0.19

g/l

0.42

711

Postprocedural disorders of nervous system

278

2204

1.29

3.76

2.4

0.23

0.22

g/l

0.86

263

2083

Other specified/unspecified deforming dorsopathies

532

1.61

3.75

2.0

2.2

0.21

0.22

g/l

0.70

509

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1990

15827

1.10

3.75

2.2

2.3

0.22

g/l

0.32

1893

14877

Synovial cyst of popliteal space [Baker]

357

2918

1.25

3.75

2.0

2.2

0.21

g/l

0.01

333

2742

Other disorders of binocular movement

645

1.54

3.72

2.1

2.7

0.22

g/l

0.03

607

Calcification and ossification of muscle

3.06

3.72

1.5

2.0

0.22

g/l

0.16

Disorders of optic nerve, not elsewhere classified

108

747

1.52

3.72

2.4

2.5

0.22

0.21

g/l

0.93

102

697

Contact with other sharp object(s)

285

2271

1.28

3.72

2.3

2.5

0.23

g/l

0.22

268

2139

Ulcer of vagina/vulva

127

902

1.46

3.71

2.3

0.22

0.21

g/l

0.13

118

845

Impingement syndrome of shoulder

1189

10664

1.13

3.70

2.5

2.3

0.22

0.21

g/l

2.72

1118

9994

Other disorders of iris and ciliary body

136

980

1.44

3.69

2.2

2.3

0.20

0.21

g/l

0.80

125

907

Collapsed vertebra, not elsewhere classified

259

1.91

3.69

2.9

1.9

0.21

0.20

g/l

0.56

240

Myocardial infarction, with ST-elevation

841

7389

1.15

3.68

2.2

0.19

0.20

g/l

0.88

779

6816

Biomechanical lesions, not elsewhere classified

245

1925

1.31

3.68

2.4

2.2

0.22

0.21

g/l

1.41

227

1806

Other osteochondropathies

306

2465

1.27

3.67

2.7

2.3

0.22

g/l

0.65

283

2326

Hirsprung

4.67

3.67

10.8

4.8

0.22

0.21

g/l

0.35

Unspecified chronic bronchitis

161

1191

1.39

3.67

2.7

2.2

0.20

g/l

0.38

145

1103

Guillain-Barre syndrome

537

1.61

3.66

2.6

2.4

0.21

g/l

0.03

512

Chronic diseases of tonsils and adenoids

4158

24692

1.07

3.66

2.4

0.22

0.21

g/l

14.27

3923

23152

Other sexually transmitted chlamydial diseases, including avohilmo

338

2743

1.25

3.66

2.1

2.7

0.24

0.23

g/l

0.71

312

2574

Crossbite

330

2464

1.26

3.66

4.6

3.4

0.22

g/l

0.06

308

2339

Other and unspecified degenerative diseases of nervous system

141

1026

1.43

3.64

2.1

2.2

0.20

g/l

0.01

125

949

Immunodeficiency associated with other specified major defects, or unspecified

6.64

3.64

5.2

2.9

0.21

0.25

g/l

—

Ankylosing spondylitis, strict definition

184

1391

1.36

3.64

2.6

2.4

0.23

g/l

0.38

175

1315

Tonsillectomy and adenotomy

2569

16569

1.08

3.63

2.5

2.6

0.23

0.22

g/l

2.03

2433

15639

Fibrosarcoma, including Hilmo

201

2.01

3.62

2.6

2.1

0.21

0.20

g/l

0.38

182

Glaucoma

3144

24977

1.08

3.62

2.1

2.2

0.20

g/l

0.56

2880

23178

Chronic suppurative otitis media, including avohilmo

359

2947

1.24

3.61

2.1

2.5

0.21

g/l

0.15

336

2753

Other congenital malformations of integument, including avohilmo

2.73

3.61

1.6

3.5

0.20

0.21

g/l

0.23

Generalized epilepsy, strict definition

100

683

1.52

3.60

2.5

3.1

0.24

0.22

g/l

1.43

649

Benign neoplasm: Skin of eyelid, including canthus

767

6713

1.16

3.60

2.3

2.2

0.22

0.21

g/l

3.02

725

6260

Pemphigus

203

2.02

3.59

3.0

2.2

0.22

g/l

0.02

193

Exposure to unspecified smoke, fire and flames

306

1.81

3.58

2.2

2.7

0.19

0.22

g/l

1.50

287

Other/unspecified synovitis and tenosynovitis

529

4502

1.19

3.57

2.5

2.3

0.21

g/l

0.15

500

4224

Degenerative diseases of the nervous system

1958

12942

1.10

3.55

1.8

2.1

0.19

g/l

0.22

1724

11933

Acute appendicitis, with complications

928

8227

1.14

3.54

2.3

0.21

g/l

0.02

855

7685

Sequelae of poliomyelitis

248

1.91

3.54

1.6

2.2

0.22

0.21

g/l

0.22

227

Pedestrian injured in collision with car, pick-up truck or van

113

794

1.48

3.53

2.1

2.3

0.22

0.21

g/l

0.85

103

744

Other contact dermatitis

349

2863

1.24

3.52

2.4

2.2

0.22

0.21

g/l

0.32

329

2690

Primary ovarian failure

500

1.60

3.51

2.5

2.2

0.23

g/l

0.25

478

Severe visual impairment, binocular

163

2.14

3.48

2.4

2.5

0.21

0.22

g/l

0.22

151

conjunctival haemorrhage

379

3147

1.23

3.46

2.5

2.2

0.21

g/l

1.12

352

2932

Other inflammation of vagina/vulva

144

1056

1.40

3.46

2.2

2.3

0.23

0.22

g/l

0.86

137

1001

Other disorders of Eustachian tube

142

1043

1.41

3.45

3.0

2.3

0.20

0.21

g/l

1.42

133

977

Blepharochalasis

1546

14115

1.11

3.45

2.0

2.2

0.21

0.20

g/l

5.67

1447

13174

Embedded teeth, including avohilmo

336

2749

1.24

3.43

3.2

2.6

0.22

0.23

g/l

0.53

316

2576

Other specified and unspecified strabismus

363

1.71

3.42

3.0

2.9

0.21

0.22

g/l

0.34

344

Carcinoma in situ, bladder

188

1445

1.35

3.42

1.8

2.3

0.21

0.20

g/l

0.88

173

1335

Hyphaema and other vascular disorders of iris and ciliary body

103

718

1.50

3.41

2.0

2.4

0.20

0.21

g/l

1.11

666

Pregnancy with abortive outcome

3213

15664

1.07

3.40

2.2

0.21

g/l

0.05

3030

14633

Contact with other hot metals

506

1.60

3.40

3.0

2.7

0.20

0.22

g/l

1.06

474

Enterobiasis

110

2.39

3.39

2.3

3.3

0.20

0.23

g/l

1.20

103

Covid-19 suspected case

935

8311

1.14

3.39

2.5

2.4

0.22

g/l

1.34

863

7788

Respiratory tuberculosis

240

1902

1.29

3.36

2.2

2.1

0.19

0.20

g/l

0.50

226

1753

Respiratory tuberculosis, confirmed and not-confirmed

240

1902

1.29

3.36

2.2

2.1

0.19

0.20

g/l

0.50

226

1753

Other specified/unspecified dorsopathies

160

1202

1.37

3.35

2.6

2.2

0.21

g/l

0.04

142

1130

Postpartum hemorraghe, all women as controls

718

7998

0.87

3.35

2.2

2.3

0.23

g/l

0.33

687

7567

Cervicocranial syndrome

496

4224

1.19

3.35

2.2

2.3

0.22

0.21

g/l

4.04

465

3963

Disorders of visual cortex

8.11

3.33

1.1

1.9

0.25

0.23

g/l

—

Chronic conjunctivitis

139

1026

1.40

3.29

2.2

2.5

0.22

0.21

g/l

1.19

127

964

Family history of certain disabilities and chronic diseases leading to disablement

180

1375

1.34

3.29

2.6

2.2

0.22

g/l

0.04

173

1301

Other disorders of pigmentation

214

1679

1.31

3.29

2.4

2.3

0.20

0.21

g/l

1.43

199

1580

Transient retinal artery occlusion

2.98

3.28

2.2

0.21

0.20

g/l

0.10

Multiple delivery

248

3090

0.79

3.27

2.0

2.4

0.22

g/l

0.28

234

2903

Chalazion

521

4466

1.18

3.26

2.3

0.22

0.21

g/l

1.16

483

4188

Triptan medication for migraine, min. 3 purchases

2624

18281

1.08

3.26

2.4

0.23

0.22

g/l

4.98

2478

17201

Aphakia

445

1.61

3.26

2.1

2.2

0.21

g/l

0.18

412

Dystonia

251

2010

1.28

3.25

2.2

2.4

0.21

g/l

0.25

231

1883

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

166

2.04

3.24

1.8

2.7

0.21

g/l

0.16

148

231

1821

1.29

3.24

2.0

0.19

0.20

g/l

0.08

208

1648

Cysts of oral region, not elsewhere classified

271

2191

1.27

3.22

2.2

2.3

0.22

g/l

0.43

252

2049

Mastocytosis

161

2.10

3.22

2.4

3.2

0.22

0.23

g/l

0.47

153

Helminthiases, including avohilmo

174

1331

1.34

3.21

2.7

0.21

0.22

g/l

0.55

164

1256

Chondrosarcoma, including Hilmo

106

2.35

3.20

1.8

2.3

0.19

0.21

g/l

0.90

Premature rupture of membranes

615

5039

0.86

3.17

2.3

0.23

g/l

0.25

586

4765

Open bite

213

1676

1.30

3.15

3.7

3.2

0.22

g/l

0.89

197

1597

Other and unspecified injuries of abdomen, lower back and pelvis

450

1.60

3.14

2.6

2.4

0.20

0.22

g/l

1.37

423

Causalgia

491

1.57

3.14

2.7

2.3

0.20

0.22

g/l

2.11

464

Chronic suppurative otitis media

291

2377

1.25

3.12

2.2

2.4

0.21

g/l

0.14

272

2214

Schizoid personality disorder

541

1.54

3.11

2.6

0.22

g/l

0.02

509

Epiphora

111

800

1.44

3.09

1.9

2.2

0.20

0.21

g/l

0.72

100

748

Atrioventricular septal defect

136

2.20

3.09

4.2

3.8

0.20

0.22

g/l

0.80

128

Frostbite

343

1.69

3.07

3.1

2.4

0.21

0.22

g/l

0.56

316

Maternal care for known or suspected malpresentation of fetus

498

4143

0.85

3.07

2.4

0.23

g/l

0.26

474

3932

Syndrome of inappropriate secretion of antidiuretic hormone

164

2.05

3.06

4.4

2.5

0.19

0.21

g/l

0.88

153

Carcinoma in situ of cervix uteri, exocervix

185

1.96

3.05

1.5

2.7

0.24

0.22

g/l

0.71

180

Whooping cough

142

2.09

3.04

2.4

2.5

0.23

0.24

g/l

0.13

134

Intestinal helminthiases, other/unspecified, including avohilmo

2.51

3.04

3.5

2.6

0.21

g/l

0.10

Sixth [abducent] nerve palsy

159

1215

1.35

3.03

2.3

0.21

g/l

0.03

142

1132

Other congenital malformations of circulatory system

122

896

1.41

3.03

2.6

2.5

0.22

0.21

g/l

0.07

113

844

Endometriosis of pelvic peritoneum

662

5274

1.15

3.01

2.4

2.2

0.23

0.22

g/l

2.53

631

4957

Pulmonary eosinophilia, not elsewhere classified

393

1.64

3.01

2.8

2.3

0.21

g/l

0.17

363

Contact with sharp object, undetermined intent

109

786

1.43

3.00

2.9

2.6

0.21

0.22

g/l

0.41

101

735

Benign neoplasm: Skin of trunk

197

1550

1.31

3.00

2.7

2.3

0.21

g/l

0.07

183

1449

Alzheimer’s disease (undefined)

224

0.35

3.00

1.5

1.9

0.18

0.17

g/l

—

194

Paralytic strabismus

330

2746

1.23

2.99

2.4

2.3

0.20

0.21

g/l

0.13

301

2562

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

2.90

2.99

3.1

2.2

0.21

g/l

0.13

Other/unspecified soft tissue disorders related to use, overuse and pressure

129

956

1.39

2.99

2.2

2.3

0.21

0.22

g/l

0.15

120

908

Meralgia paraesthetica

160

1226

1.34

2.99

2.3

0.22

0.21

g/l

0.92

145

1148

Acute inflammation of orbit

187

1.94

2.96

2.6

0.19

0.22

g/l

1.56

176

Anomalies of dental arch relationship, including avohilmo

879

7101

1.13

2.95

3.0

2.6

0.22

g/l

0.93

829

6688

Arnold-Chiari syndrome

239

1.81

2.93

2.3

3.2

0.21

0.23

g/l

0.49

229

Lichen sclerosus et atrophicus

535

4643

1.17

2.91

2.2

0.21

g/l

0.05

491

4347

Scarlet fever

166

1.98

2.91

5.1

2.6

0.23

g/l

0.14

161

Macular pucker

816

7286

1.14

2.91

2.3

2.2

0.20

g/l

0.52

751

6779

Localized scleroderma [morphea]

452

1.57

2.90

2.3

2.1

0.22

g/l

0.43

424

Contusion of ankle

173

1343

1.32

2.90

2.4

0.23

0.22

g/l

0.91

163

1269

Traction detachment of retina

256

1.78

2.89

2.5

2.3

0.19

0.22

g/l

0.97

235

Disorder of external ear, unspecified

155

1189

1.34

2.88

2.5

2.3

0.21

0.22

g/l

0.15

143

1111

Benign lipomatous neoplasm of other sites/unspecified

401

3409

1.20

2.87

2.0

2.2

0.22

0.20

g/l

2.34

375

3178

Disorders of orbit

196

1550

1.30

2.87

2.4

2.3

0.21

g/l

0.08

181

1454

Scissor bite

132

980

1.38

2.87

4.6

4.3

0.23

0.22

g/l

0.19

124

938

Acute appendicitis, no complications

2730

25495

1.07

2.86

2.4

0.22

g/l

4.65

2565

23901

Urethral stricture

263

2150

1.25

2.86

2.1

2.3

0.21

0.20

g/l

1.20

232

1994

Carcinoma in situ of oral cavity

2.63

2.85

1.6

2.8

0.23

0.21

g/l

0.32

Motorcycle rider injured in other and unspecified transport accidents

236

1906

1.26

2.84

2.4

2.6

0.22

0.23

g/l

0.48

223

1789

Tuberculosis

269

2205

1.24

2.83

2.2

2.1

0.19

0.20

g/l

0.33

253

2028

Stenosis and insufficiency of lacrimal passages

443

3801

1.19

2.83

2.4

2.2

0.21

g/l

0.04

401

3541

Achilles tendinitis

483

4170

1.18

2.82

2.4

0.22

0.21

g/l

1.21

464

3920

Trichomoniasis, including avohilmo

289

1.73

2.82

2.8

2.2

0.20

0.22

g/l

0.75

274

Contact with hot air and gases

198

1.89

2.82

1.9

2.6

0.18

0.22

g/l

2.50

180

Other and unspecified pemphigus

2.43

2.81

3.1

2.1

0.20

0.22

g/l

0.34

Injury of nerves at wrist and hand level

166

1289

1.32

2.81

2.2

2.4

0.23

0.22

g/l

0.78

159

1219

Vascular dementia (subcortical)

169

1318

1.32

2.79

1.6

2.0

0.19

g/l

0.64

156

1196

Benign neoplasm of other and unspecified intrathoracic organs

353

1.65

2.78

2.8

2.2

0.21

0.22

g/l

0.55

331

Fibrosarcoma

169

1.94

2.77

2.5

2.1

0.21

0.20

g/l

0.16

152

Female infertility

1165

6336

1.11

2.76

2.4

2.2

0.22

g/l

3.73

1102

5945

Inguinal or femoral hernia, bilateral

500

4338

1.17

2.76

2.4

2.3

0.21

0.20

g/l

1.17

459

4043

Severe visual impairment, monocular

338

1.66

2.75

2.3

0.21

g/l

0.11

317

Trichomoniasis

261

1.76

2.74

3.0

2.0

0.19

0.21

g/l

0.84

246

Mixed conductive and sensorineural hearing loss

590

5183

1.15

2.73

2.3

0.21

0.20

g/l

0.27

543

4839

Other congenital malformations of upper alimentary tract

254

1.78

2.73

2.5

2.8

0.21

g/l

0.06

239

Horner syndrome

411

1.59

2.72

2.7

2.6

0.23

0.22

g/l

1.00

384

Perioral dermatitis

682

1.43

2.70

3.1

2.4

0.23

0.22

g/l

0.69

645

Other protozoal intestinal diseases, including avohilmo

666

1.44

2.69

3.0

2.3

0.23

0.22

g/l

0.45

630

Retinal haemorrhage

121

907

1.38

2.68

2.7

2.2

0.21

0.20

g/l

0.13

116

837

Pseudomembranous colitis

208

1.82

2.68

2.0

2.2

0.24

0.22

g/l

1.24

191

Dysplasia of cervi uteri

962

6099

1.12

2.67

2.3

2.2

0.23

0.22

g/l

5.30

903

5710

Other menopausal disorders

1064

6536

0.90

2.66

2.0

2.2

0.23

0.21

g/l

12.85

1007

6109

Spinal enthesopathy

110

808

1.39

2.65

2.3

1.8

0.18

0.19

g/l

0.30

102

725

Tuberculosis of other organs

695

1.43

2.65

2.9

2.2

0.19

0.20

g/l

1.12

641

Abscess of external ear

373

1.59

2.61

2.4

0.22

g/l

0.23

351

Gestational [pregnancy-induced] hypertension

960

8670

1.11

2.60

2.1

2.3

0.22

g/l

0.39

912

8176

Benign neoplasm: Larynx

145

1122

1.33

2.58

2.7

2.3

0.20

0.21

g/l

0.49

137

1039

Benign neoplasm: Lower jaw bone

131

2.07

2.58

2.2

2.8

0.24

0.22

g/l

0.58

125

Diabetes mellitus in pregnancy

1165

6745

1.10

2.57

2.2

2.3

0.23

g/l

1.08

1097

6404

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

309

2592

1.21

2.55

2.0

2.1

0.21

0.20

g/l

0.76

284

2406

Contracture of joint

384

1.58

2.55

2.2

2.3

0.22

0.21

g/l

0.07

366

Thyroiditis

308

2589

1.21

2.55

2.2

2.3

0.22

0.21

g/l

0.50

300

2432

Pathological resorption of teeth

166

1309

1.30

2.54

3.4

2.4

0.21

g/l

0.04

156

1225

Hypermetropia

328

2771

1.20

2.53

2.8

0.22

0.21

g/l

0.19

310

2599

Congenital deformities of hip, including avohilmo

623

1.44

2.52

2.4

3.2

0.22

g/l

0.15

593

Burn and corrosion of head and neck

702

1.41

2.50

2.7

0.21

0.22

g/l

0.31

662

Tetralogy of Fallot, a congenital heart defect.

133

2.06

2.50

2.8

4.8

0.22

g/l

0.07

128

Other congenital malformations of brain

169

1.92

2.50

3.4

3.9

0.21

g/l

0.03

160

Trigeminal neuralgia

263

2183

1.23

2.50

2.2

0.23

0.21

g/l

2.64

246

2038

Other benign neoplasms of connective and other soft tissue

439

3806

1.17

2.49

2.1

2.3

0.21

g/l

0.24

402

3567

Postpartum hemorraghe, parous women as controls

718

6718

0.89

2.48

2.2

0.23

g/l

0.40

687

6390

Alzheimer’s disease (undefined), excluding more controls

199

0.38

2.48

1.5

2.0

0.18

g/l

—

180

Hereditary nephropathy, not elsewhere classified

2.36

2.47

4.1

2.6

0.20

0.22

g/l

0.42

Tuberculosis of other organs, strict, including avohilmo

108

807

1.38

2.46

2.8

2.2

0.19

0.20

g/l

0.58

100

742

Disorders of eyelid in diseases classified elsewhere

141

1094

1.32

2.46

2.0

2.3

0.21

g/l

0.22

133

1020

Other acquired deformities of musculoskeletal system and connective tissue

200

1619

1.26

2.45

2.0

2.3

0.20

0.21

g/l

1.07

185

1521

Thyrotoxicosis with toxic multinodular goitre

287

2410

1.22

2.45

2.1

2.2

0.21

g/l

0.02

267

2253

Muscle strain

141

1094

1.32

2.44

1.9

2.3

0.22

g/l

0.55

134

1037

LSIL lesion of the cervix uteri, vagina or vulva

532

4676

1.15

2.43

2.7

2.2

0.22

g/l

0.07

508

4408

Inguinal hernia, bilateral

489

4281

1.16

2.43

2.5

2.3

0.21

0.20

g/l

0.96

450

3990

Foreign body entering into or through eye or natural orifice

353

3016

1.19

2.43

2.3

2.5

0.22

g/l

0.51

330

2822

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

2.41

2.42

1.9

2.4

0.20

0.24

g/l

0.85

Injury of blood vessels at shoulder and upper arm level

2.87

2.42

2.8

0.21

0.22

g/l

0.23

Felty syndrome

171

1.89

2.41

3.0

2.3

0.21

g/l

0.07

158

Hypersomnia

439

1.52

2.40

1.6

2.6

0.22

g/l

0.06

416

Benign neoplasm: Conjunctiva

146

1143

1.31

2.40

2.4

0.21

g/l

0.24

138

1071

Other and unspecified disease of Bartholin gland

127

978

1.34

2.38

2.2

2.1

0.22

0.21

g/l

0.38

120

918

Pterygium

1101

0.71

2.37

2.0

2.4

0.21

0.20

g/l

0.12

1030

Type 1 diabetes, definitions combined

348

2966

1.18

2.33

2.9

0.19

0.23

g/l

21.51

315

2805

Coalworker pneumoconiosis

6.61

2.33

1.4

1.3

0.24

g/l

—

Other disorders of conjunctiva

676

6059

1.13

2.31

2.6

2.3

0.21

g/l

1.87

628

5660

Cerebral atherosclerosis

450

1.50

2.31

2.1

0.21

0.20

g/l

0.58

411

Early lumbar disc prolapse, operated

347

2970

1.18

2.29

2.3

2.4

0.24

0.23

g/l

2.56

332

2827

Accidental poisoning by and exposure to alcohol

484

1.47

2.28

3.2

2.5

0.21

0.22

g/l

0.54

445

Inflammatory diseases of prostate (prostatitis)

596

5310

1.14

2.27

2.3

2.5

0.22

0.21

g/l

2.59

551

4938

Tuberculosis of other organs, strict

104

785

1.37

2.25

2.9

2.2

0.19

0.20

g/l

0.97

720

Benign neoplasm of eye and adnexa

498

4394

1.15

2.24

2.3

0.21

g/l

0.33

467

4104

Mental and behavioural disorders associated with the puerperium

243

1.66

2.22

2.0

2.5

0.23

0.22

g/l

0.25

235

Maternal care for known or suspected abnormality of pelvic organs

792

5906

0.90

2.18

2.4

2.3

0.23

g/l

0.58

764

5585

Normal-pressure hydrocephalus

154

1916

0.79

2.18

1.7

2.1

0.21

0.20

g/l

1.34

135

1770

Dermatitis herpetiformis

601

1.41

2.17

2.5

2.4

0.21

g/l

0.20

560

Respiratory and cardiovascular disorders specific to the perinatal period

124

863

1.33

2.16

4.4

5.2

0.20

0.21

g/l

0.96

116

833

Benign neoplasm: Skin of scalp and neck

113

869

1.34

2.15

1.9

2.5

0.22

0.21

g/l

0.33

106

818

Macular hole

289

2463

1.20

2.15

2.1

0.21

0.20

g/l

0.31

260

2296

Alzheimer’s disease, strict definition

1109

9707

0.91

2.13

1.7

2.0

0.20

0.19

g/l

1.61

968

8909

Injury of muscle and tendon at wrist and hand level

609

5454

1.13

2.13

2.2

2.4

0.22

0.21

g/l

2.50

572

5118

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

126

1.96

2.12

3.0

2.8

0.19

0.20

g/l

0.44

115

Effects of other external causes

112

861

1.33

2.11

2.0

2.7

0.23

g/l

0.59

105

811

Other intracranial haemorrhages

148

1182

1.28

2.11

2.6

2.2

0.20

g/l

0.08

141

1096

Short stature starting before birth

165

1.86

2.10

2.8

5.6

0.21

g/l

0.22

158

Abnormal findings in cerebrospinal fluid

2.16

2.09

2.8

2.7

0.21

0.22

g/l

0.15

Benign neoplasm of thyroid gland

144

1149

1.29

2.07

2.3

2.2

0.22

0.21

g/l

0.87

129

1083

Amoebiasis

164

1.81

2.07

3.3

2.6

0.21

0.22

g/l

0.41

154

Contusion of toe(s) with damage to nail

362

1.52

2.07

1.9

2.7

0.22

g/l

0.15

337

Infections of genitourinary tract in pregnancy

350

3029

1.17

2.07

2.0

2.3

0.21

0.22

g/l

1.03

333

2861

Congenital malformations of eye, ear, face and neck

257

2171

1.20

2.07

2.6

2.8

0.22

g/l

0.45

250

2046

Scarlet fever, including avohilmo

225

1.67

2.06

4.6

3.4

0.22

0.23

g/l

0.09

219

Torticollis

470

1.45

2.05

2.1

2.6

0.24

0.22

g/l

1.20

444

Use of donepezil

877

9136

0.91

2.05

1.7

2.0

0.20

0.19

g/l

2.11

779

8350

Type 1 diabetes, strict (exclude DM2)

344

2966

1.17

2.04

2.8

3.0

0.19

0.23

g/l

21.87

311

2809

Female infertility, tubal origin

188

1544

1.24

2.04

2.3

2.4

0.22

g/l

0.33

181

1469

Lateral epicondylitis

591

5299

1.13

2.04

2.3

0.22

0.21

g/l

2.20

547

4994

Burns and corrosions of multiple body regions

307

1.57

2.03

2.2

2.6

0.20

0.22

g/l

0.90

285

Calcific tendinitis of shoulder

251

2121

1.20

2.03

2.0

2.2

0.22

0.21

g/l

1.26

241

2006

Disorders of optic chiasm

3.85

2.03

2.9

3.0

0.25

0.21

g/l

—

Congenital malformations of genital organs

348

2996

1.17

2.02

2.8

2.7

0.23

0.22

g/l

0.59

332

2832

Foreign body in respiratory tract

223

1867

1.22

2.02

2.6

2.4

0.22

0.21

g/l

0.98

206

1748

Disorders of synovium and tendon in diseases classified elsewhere

721

1.36

2.01

1.9

2.3

0.21

g/l

0.11

677

Pedestrian injured in collision with pedal cycle

132

1046

1.29

2.01

2.0

2.2

0.20

0.21

g/l

1.22

126

975

Benign neoplasm: Endocrine gland, other/unspecified

107

2.04

2.01

1.9

2.2

0.21

g/l

0.19

Non-small cell lung cancer, adenocarcinoma, helper endpoint

309

2664

1.18

1.99

2.2

0.20

g/l

0.29

284

2464

Blindness, monocular

300

1.57

1.99

1.8

2.1

0.22

g/l

0.16

286

MS-disease / Multiple Sclerosis

274

2335

1.19

1.99

2.3

0.22

g/l

0.26

262

2202

Other bursitis of knee

457

1.45

1.99

2.0

2.4

0.21

g/l

0.05

430

Early syphilis, including avohilmo

390

1.49

1.98

2.0

2.6

0.22

g/l

0.14

365

Retinal detachment with retinal break

615

5542

1.12

1.97

2.5

2.2

0.20

0.21

g/l

0.19

566

5162

Other peripheral vertigo

432

3819

1.15

1.94

2.0

2.2

0.22

0.21

g/l

1.75

401

3572

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

177

1457

1.24

1.94

2.4

2.3

0.22

0.21

g/l

1.83

170

1359

Overjet

115

900

1.30

1.88

4.2

4.4

0.23

0.22

g/l

0.44

108

868

Vitiligo

353

1.50

1.88

2.2

2.6

0.23

0.22

g/l

0.47

331

Third [oculomotor] nerve palsy

661

1.36

1.88

2.6

2.5

0.21

g/l

0.25

619

Injury of nerves at hip and thigh level

132

1.88

1.87

2.0

2.8

0.24

0.22

g/l

0.50

122

Family history of other conditions

386

1.46

1.86

3.0

2.3

0.24

0.23

g/l

0.50

367

Benign neoplasm: Penis

2.48

1.86

2.1

2.3

0.22

0.23

g/l

0.21

Toxic effect of alcohol

687

1.35

1.86

2.7

2.4

0.19

0.22

g/l

1.88

647

Gestational diabetes (for exclusion)

1309

8384

1.08

1.84

2.1

2.3

0.23

g/l

0.99

1233

7953

Photocontact dermatitis [berloque dermatitis]

2.60

1.84

2.6

0.20

0.22

g/l

0.28

Bicuspidal aortic valve syndrome

162

1330

1.24

1.84

2.7

2.6

0.20

0.22

g/l

1.94

156

1251

Benign neoplasm: Skin, unspecified

174

1439

1.23

1.83

2.3

2.2

0.20

0.21

g/l

1.14

165

1343

Other abnormal products of conception

1026

7284

0.92

1.83

2.3

0.23

g/l

0.64

973

6899

Carcinoma in situ of cervix uteri

336

2929

1.16

1.82

2.2

2.3

0.22

g/l

0.02

309

2761

HSIL lesion of the cervix uteri

639

5790

1.11

1.81

2.4

2.3

0.23

g/l

1.42

595

5490

Multiple superficial injuries of ankle and foot

2.97

1.81

1.9

2.7

0.20

0.23

g/l

—

Need for immunization against single bacterial diseases

112

1.98

1.81

3.8

4.6

0.23

0.22

g/l

0.31

103

Other helminthiases, including avohilmo

2.24

1.81

5.4

2.5

0.18

0.24

g/l

1.75

Iridocyclitis in diseases classified elsewhere

647

1.35

1.81

2.3

2.5

0.21

g/l

0.02

612

Glucosamine medication

2492

18931

1.06

1.80

2.0

2.2

0.20

g/l

0.53

2285

17569

Birth injury to scalp

3.93

1.80

5.7

0.21

0.19

g/l

—

Acné excoriée

3.24

1.80

1.4

2.0

0.25

0.22

g/l

—

Pseudosarcomatous fibromatosis

4.43

1.79

1.2

2.6

0.26

0.23

g/l

—

Other and unspecified syphilis

2.15

1.79

2.1

2.9

0.26

0.23

g/l

0.70

Other chromosome abnormalities, not elsewhere classified

197

1.70

1.79

3.5

4.4

0.21

0.20

g/l

0.51

190

Benign neoplasm: Skin of lower limb, including hip

122

975

1.28

1.78

2.4

2.3

0.23

0.21

g/l

1.70

114

918

Bacterial meningitis

142

1154

1.26

1.78

2.1

2.4

0.22

0.21

g/l

0.45

132

1085

Burn and corrosion confined to eye and adnexa

736

1.32

1.77

2.1

2.5

0.23

0.22

g/l

0.83

692

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

375

1.46

1.76

2.2

0.22

g/l

0.08

360

Separation of retinal layers (serosa)

182

1519

1.22

1.75

2.6

2.3

0.23

0.22

g/l

0.59

175

1422

Benign neoplasm: Skin of ear and external auricular canal

169

1401

1.23

1.75

2.0

2.2

0.21

0.20

g/l

0.01

159

1290

Subarachnoid haemorrhage

464

4149

1.13

1.75

2.2

0.21

0.20

g/l

0.12

431

3849

Tooth agenesis EXCLUDE clefts and syndromes

148

1207

1.25

1.75

3.6

0.22

g/l

0.00

138

1146

Endometriosis ASRM stages 3,4

949

8782

1.09

1.73

2.5

2.2

0.21

g/l

0.08

901

8225

Aggressive periodontitis

101

793

1.31

1.73

2.0

2.3

0.22

0.21

g/l

0.42

744

Atopic conjunctivitis

182

1521

1.22

1.72

2.3

2.5

0.22

g/l

0.09

168

1425

Membranous nephropathy

128

1.84

1.72

1.3

2.9

0.26

0.22

g/l

1.05

117

Melanocytic naevi, other sites/unspecified

355

3127

1.15

1.71

2.7

2.3

0.22

g/l

0.76

338

2944

Congenital ovarian cysts

145

1184

1.24

1.71

2.3

2.2

0.24

0.23

g/l

1.38

140

1124

Use of riluzole

136

1.82

1.71

2.7

2.6

0.24

0.21

g/l

1.81

126

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

437

1.42

1.70

2.2

0.21

0.22

g/l

0.35

416

Benign neoplasm of brain and other parts of central nervous system

281

2440

1.17

1.69

2.3

0.22

0.21

g/l

0.48

264

2279

Vibratory urticaria

3.52

1.68

1.0

3.6

0.27

0.23

g/l

—

All dysplastic lesions of the cervix uteri

935

8518

1.09

1.67

2.4

2.3

0.23

0.22

g/l

1.42

878

8068

Brain glioblastoma, helper endpoint

530

0.66

1.66

1.6

2.6

0.27

0.21

g/l

4.25

498

Early syphilis

355

1.46

1.65

2.0

2.7

0.22

g/l

0.13

332

Graves disease, strict definition

415

3700

1.13

1.65

2.2

2.3

0.21

0.22

g/l

0.46

387

3491

Sequelae of inflammatory diseases of the central nervous system

2.02

1.64

3.1

2.6

0.20

0.23

g/l

0.54

Other specified disorders of external ear

170

1424

1.22

1.62

2.2

2.3

0.20

0.21

g/l

0.84

159

1329

Other disorders of optic disc

433

1.41

1.62

1.7

2.6

0.23

0.22

g/l

0.18

416

Vertigo of central origin

572

1.35

1.61

2.4

2.2

0.20

g/l

0.02

533

Flatback syndrome

2.98

1.61

1.9

1.7

0.20

0.22

g/l

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

2.02

1.61

1.7

2.5

0.20

0.21

g/l

0.13

Contact with other specified venomous animals

209

1.61

2.7

2.9

0.26

0.22

g/l

2.22

195

Alzheimer’s disease (Early onset), excluding more controls

1167

0.78

1.61

1.6

2.1

0.20

0.19

g/l

0.34

1085

Neurofibromatosis, type 2

2.38

1.60

3.5

2.9

0.23

g/l

0.08

Maternal care for other known or suspected fetal problems

701

4800

0.91

1.59

2.5

2.4

0.23

g/l

0.46

658

4551

Medial epicondylitis

156

1299

1.22

1.57

2.1

2.2

0.23

0.22

g/l

1.38

148

1230

Endometriosis ASRM stages 1,2

679

6227

1.10

1.56

2.4

2.3

0.22

g/l

1.23

648

5862

Pedal cyclist injured in other and unspecified transport accidents

484

4371

1.12

1.55

2.5

2.4

0.21

0.22

g/l

0.46

440

4099

Female infertility, cervical, vaginal, other or unspecified origin

1045

6221

1.08

1.55

2.4

2.2

0.22

g/l

3.00

988

5838

Pedestrian injured in other and unspecified transport accidents

386

1.42

1.54

2.3

2.4

0.21

0.22

g/l

0.22

364

Deep bite

502

3988

1.12

1.53

3.4

3.0

0.22

g/l

1.02

485

3762

Viral conjunctivitis, including avohilmo

150

1248

1.22

1.52

2.2

2.3

0.22

g/l

0.14

139

1171

Benign neoplasm: Vagina

413

1.40

1.52

1.7

2.2

0.22

0.21

g/l

0.34

393

Eclampsia

2.26

1.51

1.8

2.4

0.22

0.23

g/l

0.16

Localized hypertrichosis

3.06

1.50

1.3

1.7

0.25

0.24

g/l

—

Acne conglobata

125

1.75

1.50

3.8

2.7

0.24

0.23

g/l

0.17

119

Enterobiasis, including avohilmo

621

1.31

1.49

2.2

3.3

0.22

g/l

0.32

585

Obstructive hydrocephalus

483

1.36

1.49

1.9

2.9

0.19

0.22

g/l

2.32

456

Other congenital malformations of skin

160

1344

1.21

1.48

2.4

2.6

0.22

g/l

0.77

150

1268

Other and unspecified mononeuropathies of upper limb

123

1008

1.24

1.48

2.4

0.22

0.21

g/l

0.15

118

948

Liveborn infants according to place of birth

275

1.48

1.46

3.8

5.4

0.20

0.21

g/l

0.73

263

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

342

3043

1.14

1.46

2.2

0.22

0.21

g/l

0.39

325

2865

Benign neoplasm of other and unspecified female genital organs

179

1523

1.20

1.45

2.2

2.1

0.22

0.21

g/l

0.28

164

1434

Other disorders affecting eyelid function

311

0.59

1.45

1.4

2.3

0.21

g/l

0.03

293

Parapsoriasis

626

1.31

1.44

2.4

0.22

0.21

g/l

0.04

589

Other/unspecified disorders of vestibular function

185

1580

1.19

1.44

2.2

2.3

0.22

0.20

g/l

1.68

173

1469

Endometriosis diagnosis and infertility diagnosis occurring together

369

3298

1.13

1.44

2.3

0.23

0.22

g/l

0.64

355

3131

Arteriovenous malformation of cerebral vessels

366

1.42

1.44

2.7

2.5

0.22

g/l

0.00

341

Other congenital malformations of integument

2.94

1.44

2.7

4.0

0.18

0.23

g/l

—

Toxic effect of other noxious substances eaten as food

112

1.80

1.43

4.0

2.6

0.22

g/l

0.02

101

Brachial plexus disorders

361

3226

1.13

1.42

2.3

0.23

0.22

g/l

0.90

338

3048

Use of antiglaucoma preparations and miotics

355

3173

1.13

1.42

1.9

2.1

0.20

g/l

0.09

331

2923

Other and/or unspecified nontoxic goitre

359

3212

1.13

1.41

2.1

2.2

0.21

g/l

1.05

345

3025

Transient global amnesia

349

3898

0.88

1.41

2.2

0.21

0.20

g/l

0.70

317

3656

Chondrosarcoma

2.03

1.40

1.7

2.4

0.19

0.21

g/l

0.75

Benign neoplasm: Connective and other soft tissue of pelvis

1.99

1.38

1.7

2.9

0.24

0.21

g/l

0.60

Other and unspecified syphilis, including avohilmo

1.83

1.38

2.0

2.5

0.26

0.23

g/l

0.92

Benign neoplasm: Spinal meninges

352

1.41

1.38

2.3

2.1

0.20

0.21

g/l

0.22

332

Benign mammary dysplasia

617

5680

1.10

1.37

2.0

2.1

0.22

0.21

g/l

3.94

587

5292

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

465

1.36

1.37

1.8

2.2

0.19

0.20

g/l

0.47

427

Linear scleroderma

2.78

1.36

4.0

3.5

0.25

0.20

g/l

—

Lichenoid drug reaction

1.93

1.36

3.1

2.5

0.19

0.21

g/l

0.56

LeFortI or BSSO operation

1186

0.80

1.36

2.1

2.5

0.23

g/l

0.22

1118

Classical phenylketonuria

3.22

1.36

2.0

2.9

0.22

0.20

g/l

—

Idiopathic hypoparathyroidism

1.91

1.35

2.2

3.2

0.21

g/l

0.05

Injury of muscle and tendon at lower leg level

666

6154

1.09

1.35

2.3

2.4

0.22

0.21

g/l

3.02

614

5767

Contraceptive management

1727

12680

0.95

1.35

2.5

0.23

0.22

g/l

3.30

1637

11905

Vascular dementia (other)

227

1.51

1.34

1.6

2.1

0.21

0.19

g/l

0.45

208

Sequelae of other and unspecified effects of external causes

178

1.59

1.34

5.0

2.6

0.25

0.23

g/l

0.77

167

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

352

3159

1.13

1.34

2.3

0.21

g/l

0.04

332

2964

Nutritional and metabolic disorders in diseases classified elsewhere

3.41

1.33

8.4

5.2

0.19

0.20

g/l

—

Other conjunctival vascular disorders and cysts

101

823

1.26

1.32

3.4

2.3

0.21

g/l

0.16

765

Mental and behavioural disorders of puerperium, not classified elsewhere

277

1.45

1.32

2.0

2.4

0.23

g/l

0.13

270

Dementia in Alzheimer disease

859

6702

1.08

1.32

1.6

2.0

0.19

g/l

0.02

738

6145

Findings of drugs and other substances, not normally found in blood

139

1.68

1.32

2.7

2.3

0.22

g/l

0.08

131

Other retinal artery occlusion

101

824

1.25

1.31

2.9

2.3

0.19

0.20

g/l

0.41

748

Vascular dementia (undefined)

168

1421

1.19

1.30

1.8

2.0

0.19

0.18

g/l

0.79

139

1289

Other disorders of male genital organs

167

1428

1.19

1.30

2.5

0.22

g/l

0.22

154

1327

Secondary systemic amyloidosis

1.84

1.29

2.8

2.3

0.21

g/l

0.05

Benign neoplasm: Skin of upper limb, including shoulder

682

1.28

2.9

2.4

0.22

0.21

g/l

0.22

636

Nontoxic multinodular goitre

911

8536

1.07

1.28

2.0

2.1

0.21

g/l

2.31

856

7989

Other bursitis, not elsewhere classified

288

1.43

1.28

2.1

2.4

0.22

0.21

g/l

0.46

271

Benign neoplasm: Connective and other soft tissue of thorax

132

1.67

1.27

3.0

2.6

0.21

0.22

g/l

0.10

122

Tick-borne viral encephalitis, including avohilmo

164

1.59

1.27

1.9

2.7

0.23

0.22

g/l

0.45

153

Viral infections of central nervous system, not elsewhere classified/unspecified

331

1.40

1.27

2.3

2.4

0.21

0.22

g/l

0.28

313

Typhoid and paratyphoid fevers, including avohilmo

197

1.54

1.26

3.0

2.4

0.20

0.22

g/l

1.21

184

Placental disorders

227

0.56

1.26

3.3

2.2

0.24

0.23

g/l

0.44

217

Progressive vascular leukoencephalopathy

184

1592

1.18

1.26

2.1

1.9

0.20

0.19

g/l

2.01

166

1462

Other congenital malformations of limb(s)

205

1.51

1.25

3.0

4.5

0.24

0.22

g/l

0.57

195

Disorder of thyroid, unspecified

410

1.35

1.25

2.0

2.2

0.23

0.21

g/l

0.83

393

Anoxic brain damage

454

1.34

1.25

3.1

2.5

0.21

0.20

g/l

0.11

414

Benign neoplasm: Skin of lip

428

1.35

1.24

2.1

2.2

0.21

0.22

g/l

0.39

398

Use of selegiline

147

1721

0.84

1.23

1.8

2.2

0.19

0.20

g/l

0.63

137

1600

Pedal cyclist injured in noncollision transport accidents

484

4435

1.10

1.22

2.6

2.4

0.21

0.22

g/l

1.29

454

4167

Myopia

510

4682

1.10

1.22

2.9

2.5

0.22

g/l

0.37

481

4398

Contact with machinery

470

4304

1.10

1.22

2.5

2.4

0.21

g/l

0.02

442

4000

Maternal care for known or suspected fetal abnormality and damage

446

4138

0.91

1.21

2.2

2.3

0.23

g/l

0.32

429

3927

Other endophthalmitis

158

1.59

1.21

2.3

2.2

0.21

g/l

0.05

145

Pedal cyclist injured in transport accident

1005

9472

1.07

1.19

2.5

2.4

0.21

0.22

g/l

0.79

931

8871

Traumatic secondary and recurrent haemorrhage

2.14

1.19

1.8

2.6

0.21

g/l

—

Benign neoplasm: Vulva

708

1.26

1.18

2.6

2.2

0.21

g/l

0.18

671

Yaws, including avohilmo

103

1.73

1.18

3.8

2.3

0.21

0.22

g/l

0.14

Rheumatic fever incl heart disease

120

1007

1.21

1.18

2.5

2.2

0.20

g/l

0.19

107

921

Benign lipomatous neoplasm

1409

13412

1.06

1.18

2.2

2.3

0.21

g/l

1.65

1329

12520

Spasmodic torticollis

130

1101

1.20

1.17

2.0

2.3

0.21

0.22

g/l

0.22

120

1039

Amoebiasis, including avohilmo

251

1.44

1.17

2.9

2.6

0.21

0.22

g/l

0.37

237

Spontaneous abortion

1817

12710

0.95

1.16

2.3

2.2

0.22

g/l

0.13

1723

11950

Erosion and ectropion of cervix uteri

119

1002

1.21

1.15

2.4

2.1

0.22

0.20

g/l

0.79

107

938

Melanoma in situ

204

1793

1.16

1.15

2.1

2.2

0.22

0.20

g/l

2.21

196

1663

Other disorders of thyroid

425

1.33

1.14

2.0

2.3

0.23

0.21

g/l

0.65

401

Benign neoplasm: Extrahepatic bile ducts

1.75

1.13

2.3

2.6

0.24

0.21

g/l

0.78

Other inherited muscular atrophy

2.09

1.13

1.8

2.9

0.20

0.21

g/l

—

Vascular syndromes of brain in cerebrovascular disorders

189

1654

1.16

1.13

2.0

2.2

0.20

g/l

0.61

179

1536

Ganglion

914

8610

1.07

1.11

2.0

2.3

0.22

0.21

g/l

2.22

857

8089

Benign neoplasm: Brain, supratentorial

498

1.30

1.11

3.3

2.6

0.22

g/l

0.35

470

Melanocytic naevi of lower limb, including hip

184

1611

1.16

1.09

2.9

2.3

0.23

0.21

g/l

1.75

178

1511

Vasomotor rhinitis (mode)

304

2745

1.12

1.09

2.1

2.3

0.22

0.21

g/l

1.81

285

2568

Ectopic pregnancy

671

6266

1.08

2.2

2.3

0.22

g/l

0.12

616

5900

Other, unspecified and serous retinal detachments

135

1160

1.18

1.05

2.5

2.2

0.20

0.21

g/l

0.26

129

1074

Delayed puberty

205

1.45

1.05

3.8

3.6

0.22

0.23

g/l

0.63

192

Femoral hernia

178

1561

1.16

1.04

2.3

2.1

0.20

g/l

0.09

157

1451

Osteogenesis imperfecta

1.92

1.04

2.7

5.9

0.24

0.22

g/l

0.32

Other acute disseminated demyelination

274

1.39

1.04

3.9

2.5

0.22

0.23

g/l

0.50

261

Anisometropia and aniseikonia

130

1115

1.18

1.03

2.6

0.20

0.21

g/l

0.61

119

1043

Mandibular prognathia AND surgery (LeFortI or BSSO)

133

0.51

1.03

3.1

2.9

0.19

0.23

g/l

—

124

Hypertrophy of bone

1.75

1.03

2.1

2.6

0.22

g/l

0.10

Type1 diabetes, definitions combined, early onset

175

1984

0.87

1.02

3.0

3.4

0.19

0.23

g/l

13.56

159

1889

Femoral hernia, unilateral

111

944

1.20

0.99

2.4

2.1

0.21

g/l

0.04

100

880

Inguinal of femoral hernia, unilateral

111

944

1.20

0.99

2.4

2.1

0.21

g/l

0.04

100

880

Inguinal hernia, unilateral

111

944

1.20

0.99

2.4

2.1

0.21

g/l

0.04

100

880

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2793

21000

1.04

0.99

2.4

2.3

0.22

0.21

g/l

5.24

2626

19681

Noonan syndrome

2.06

0.99

2.1

4.2

0.17

0.23

g/l

—

Inflammatory disease of cervix uteri

255

2296

1.12

0.99

2.4

2.1

0.21

g/l

0.27

242

2153

Other puerperal infections

221

1970

1.13

0.99

2.0

2.3

0.24

0.23

g/l

1.20

208

1861

Other noninflammatory disorders of cervix uteri

210

1872

1.14

0.98

2.3

2.2

0.21

0.20

g/l

1.02

198

1735

Alzheimer’s disease (Late onset)

1049

9082

0.95

0.98

1.6

2.0

0.20

0.19

g/l

2.31

912

8313

Other disorders of cornea

430

3974

1.09

0.96

2.5

2.2

0.22

0.21

g/l

0.57

402

3735

Hypersensitivity angiitis

168

1.49

0.96

2.1

2.5

0.22

g/l

0.11

154

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

437

1.29

0.96

2.4

0.22

g/l

0.03

408

Secondary lactase deficiency

2.31

0.95

2.8

2.7

0.24

g/l

—

Tick-borne viral encephalitis

143

1.53

0.95

1.8

2.7

0.23

0.22

g/l

0.31

133

Malignant neoplasm of penis

1.67

0.95

1.9

2.2

0.22

0.21

g/l

0.07

Female genital prolapse

1311

6958

1.05

0.95

2.1

0.22

0.21

g/l

3.24

1225

6477

Tinnitus

1127

10745

1.05

0.95

2.2

2.3

0.22

0.21

g/l

6.55

1059

10049

Endometriosis of rectovaginal septum and vagina

303

2760

1.11

0.94

2.1

0.22

0.21

g/l

1.44

286

2568

Congenital dislocation of hip, unilateral

229

1.40

0.92

2.2

3.7

0.23

0.22

g/l

0.44

220

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

2.01

0.92

1.5

2.1

0.21

0.22

g/l

—

Scleritis and episcleritis

246

2221

1.12

0.92

2.5

2.2

0.22

g/l

0.33

233

2099

Caught, crushed, jammed or pinched in or between objects

210

1882

1.13

0.90

2.8

2.6

0.22

g/l

0.04

197

1774

Complications of anaesthesia during pregnancy

1.95

0.90

1.8

2.6

0.23

g/l

—

Acute myringitis

221

1.40

0.90

2.9

3.0

0.21

0.22

g/l

0.37

210

Injury of muscle and tendon at forearm level

595

1.23

0.90

2.7

2.5

0.21

0.22

g/l

0.32

563

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

1.71

0.89

1.9

2.6

0.21

0.23

g/l

0.46

Other specified/unspecified disorders of ear

1.64

0.89

2.2

2.4

0.20

0.23

g/l

0.63

Use of galantamine

301

3289

0.91

0.89

1.7

2.0

0.20

0.19

g/l

0.77

276

3001

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

183

1630

1.14

0.89

1.9

2.3

0.21

0.22

g/l

0.33

159

1526

Left side

139

0.55

0.88

1.8

2.5

0.20

0.22

g/l

—

128

Lens-induced iridocyclitis

1.89

0.88

2.1

2.8

0.23

0.21

g/l

—

Failed induction of labour

170

1506

1.14

0.87

2.6

2.4

0.23

g/l

0.23

161

1422

Other congenital malformations of skin, including avohilmo

319

2926

1.10

0.87

2.4

0.23

0.22

g/l

1.83

303

2748

Benign neoplasm: Choroid

290

2652

1.10

0.87

2.4

2.2

0.21

g/l

0.09

273

2480

Hand

163

1.46

0.86

1.7

2.6

0.24

0.22

g/l

0.84

149

Conductive hearing loss, unspecified

347

3198

1.09

0.86

2.3

2.4

0.21

g/l

0.29

313

2997

Other parasitologically confirmed or unspecified malaria, including avohilmo

1.65

0.86

3.3

2.7

0.21

0.22

g/l

0.29

Unequal limb length (acquired)

197

1.40

0.85

2.6

2.8

0.23

g/l

0.22

184

Prepatellar bursitis

188

1683

1.13

0.85

2.3

0.22

0.21

g/l

0.56

174

1587

Respiratory tuberculosis, not confirmed

153

1353

1.14

0.84

2.1

0.20

g/l

0.08

144

1243

Respiratory tuberculosis, not confirmed, including avohilmo

155

1372

1.14

0.84

2.1

0.20

g/l

0.14

146

1261

Noise effects on inner ear

134

1523

0.87

0.83

2.2

2.4

0.19

0.21

g/l

2.31

127

1414

Benign neoplasm: Lip

712

1.20

0.82

2.1

2.4

0.22

0.21

g/l

0.51

663

Periodontal disease, other/unspecified

107

926

1.17

0.81

2.4

0.21

g/l

0.12

875

Melanoma in situ of other and unspecified parts of face

486

1.25

0.80

3.0

2.2

0.22

0.20

g/l

1.16

449

Central retinal artery occlusion

779

1.19

0.80

2.2

2.3

0.18

0.20

g/l

1.13

716

Benign neoplasm: Connective and other soft tissue of abdomen

1.62

0.80

2.6

2.4

0.21

0.22

g/l

0.25

Other benign neoplasm of uterus: Other parts/unspecified

179

1607

1.13

0.80

1.8

1.9

0.20

g/l

0.15

162

1478

Nasal polyp

865

8239

1.05

0.80

2.2

2.4

0.21

g/l

1.75

818

7699

Congenital malformations of larynx

116

1.55

0.80

2.5

4.6

0.18

0.20

g/l

0.69

111

Polypectomy (DHB20)

231

2537

0.90

0.79

2.1

2.4

0.22

0.21

g/l

0.48

216

2366

Disturbances of smell and taste

175

1569

1.13

0.79

2.3

0.23

0.21

g/l

2.43

164

1479

N06DA Anticholinesterases

1679

13400

0.96

0.79

1.7

2.1

0.20

0.19

g/l

1.73

1516

12304

Use of anticholinesterases

1679

13400

0.96

0.79

1.7

2.1

0.20

0.19

g/l

1.73

1516

12304

Chronic inflammatory disorders of orbit

1.68

0.79

2.0

2.6

0.21

0.22

g/l

0.14

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

458

1.24

0.78

2.3

2.1

0.19

g/l

0.27

413

Dislocation, sprain and strain of joints and ligaments of elbow

251

2292

1.10

0.78

2.9

2.6

0.22

g/l

0.26

228

2150

Other vitreous opacities

179

1608

1.13

0.78

2.3

0.20

0.21

g/l

0.79

161

1504

Other and unspecified disorders of vitreous body

2205

20924

1.03

0.78

2.3

2.2

0.22

0.21

g/l

6.48

2048

19578

Galactorrhea

271

1.32

0.77

2.2

2.4

0.24

0.23

g/l

0.44

261

LSIL lesion of the cervix uteri

382

3551

1.08

0.77

2.6

2.2

0.22

g/l

0.12

363

3360

Mandibular retrognathia

199

2193

0.90

0.77

2.8

3.0

0.23

0.22

g/l

0.37

189

2075

Other and unspecified postprocedural disorders of eye and adnexa

1.64

0.77

2.6

2.8

0.20

0.22

g/l

0.46

Dengue, including avohilmo

1.72

0.76

2.8

2.5

0.24

0.20

g/l

0.81

Benign neoplasm: Peripheral nerves and autonomic nervous system

562

1.22

0.76

1.9

2.3

0.21

g/l

0.22

526

Frostbite involving multiple body regions and unspecified frostbite

1.76

0.76

2.7

3.2

0.18

0.23

g/l

—

Early lumbar disc prolapse operation

362

3362

1.08

0.76

2.3

2.5

0.24

0.23

g/l

2.34

345

3181

Disorders of globe

103

896

1.17

0.75

2.6

2.1

0.20

0.21

g/l

0.82

831

Family history of other specific disorders

362

1.26

0.74

2.9

2.5

0.23

0.22

g/l

0.40

338

Prominent ears

211

1.35

0.74

3.7

3.6

0.22

0.23

g/l

0.42

199

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

2.09

0.74

2.0

3.5

0.21

0.23

g/l

—

Hair colour and hair shaft abnormalities

118

1.50

0.73

2.9

2.4

0.19

0.22

g/l

0.74

111

Dementia due to Parkinson's disease

111

974

1.16

0.73

1.7

2.2

0.20

0.19

g/l

0.25

888

Alzheimer disease, including avohilmo

1813

12948

0.97

0.72

1.7

2.1

0.20

0.19

g/l

0.49

1604

11934

Other benign neoplasms of uterus

227

2076

1.11

0.72

1.9

2.0

0.20

g/l

0.06

207

1923

Cervical polyps

412

3856

1.08

0.72

2.2

2.3

0.22

0.21

g/l

1.44

387

3610

Presbyopia

280

3030

0.92

0.71

2.4

2.3

0.22

g/l

0.67

263

2852

Explosion of other materials

1.55

0.70

2.6

2.2

0.23

0.24

g/l

0.09

Nontoxic single thyroid nodule

300

2780

1.09

0.70

2.1

2.2

0.22

0.21

g/l

0.90

283

2625

Hereditary corneal dystrophies

153

1375

1.13

0.70

2.3

2.2

0.21

g/l

0.33

144

1289

Lipoprotein deficiency

1.66

0.69

1.9

2.9

0.18

0.21

g/l

0.56

Fourth [trochlear] nerve palsy

791

1.17

0.69

2.3

2.4

0.20

0.21

g/l

0.59

743

Foreign body in ear

651

1.18

0.69

2.3

2.8

0.22

g/l

0.21

607

Occupational exposure to risk-factors

137

1224

1.13

0.69

2.3

2.4

0.20

0.21

g/l

0.71

129

1150

Other parasitologically confirmed or unspecified malaria

1.65

0.69

3.7

2.8

0.22

0.23

g/l

0.14

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.65

0.68

1.9

2.5

0.20

0.23

g/l

0.42

Melanocytic naevi of other and unspecified parts of face

226

2073

1.10

0.67

2.2

2.3

0.22

g/l

0.71

209

1948

Injury of muscle and tendon at hip and thigh level

429

4033

1.07

0.67

2.1

2.4

0.22

g/l

1.44

405

3794

Pneumoconiosis due to asbestos and other mineral fibres

671

1.18

0.67

2.3

2.1

0.18

0.19

g/l

0.93

606

Melanocytic naevi of lip

242

1.31

0.67

1.4

2.5

0.23

0.22

g/l

0.50

227

Other and unspecified hydrocephalus

616

1.19

0.67

1.9

2.4

0.21

g/l

0.14

576

Rheumatic valve diseases

700

1.17

0.66

2.7

2.2

0.19

0.20

g/l

0.50

635

Other appendicitis

340

3174

1.08

0.66

2.5

2.3

0.22

0.21

g/l

0.21

323

2975

Benign neoplasm: Central nervous system, other parts/unspecified

121

1.46

0.66

2.1

2.8

0.22

g/l

0.02

111

Unspecified pneumoconiosis

1.82

0.66

2.4

2.2

0.20

0.21

g/l

—

Endovascular or surgical operations to intracerebral aneurysms

251

2318

1.09

0.65

2.0

2.2

0.22

0.21

g/l

0.35

236

2173

Other obstructed labour

269

2497

1.08

0.62

2.0

2.2

0.22

g/l

0.24

248

2366

Lesion of plantar nerve

253

2345

1.09

0.62

2.0

2.2

0.22

0.21

g/l

1.62

233

2196

Abnormalities of forces of labour

312

3340

0.93

0.61

2.2

2.3

0.23

g/l

0.00

306

3167

Surgical ablation of atrial fibrillation

202

1.33

0.61

2.3

2.7

0.17

0.21

g/l

2.06

187

Cyst of Bartholin Gland

132

1187

1.12

0.60

2.1

0.22

g/l

0.14

124

1121

Eccrine sweat disorders

1.55

0.60

1.2

2.9

0.22

0.23

g/l

0.06

Migraine, single triptan purchase ok & required. ICD-code if available is included

3749

24888

1.02

0.60

2.4

0.23

0.22

g/l

10.50

3511

23384

Triptan medication for migraine, single purchase ok

3749

24888

1.02

0.60

2.4

0.23

0.22

g/l

10.50

3511

23384

Balanced rearrangements and structural markers, not elsewhere classified

1.51

0.60

2.4

3.0

0.24

0.22

g/l

0.51

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

1.55

0.60

1.9

2.6

0.15

0.20

g/l

—

Additional codes for the location of defect, injury or illness

238

2205

1.09

0.59

2.8

2.3

0.21

g/l

0.13

225

2067

Maternal care for known or suspected disproportion

110

1232

0.89

0.59

3.1

2.3

0.22

0.23

g/l

1.25

104

1180

Peripheral retinal degeneration

121

1086

1.13

0.59

2.0

2.3

0.20

0.21

g/l

1.10

113

1010

Other cestode infections

0.56

0.58

1.0

2.3

0.22

0.21

g/l

—

Gastric ulcer - Acute with haemorrhage, drug-induced

1.73

0.58

2.3

2.4

0.24

0.21

g/l

—

Deep endometriosis

351

3299

1.07

0.58

2.2

2.1

0.22

0.21

g/l

0.75

332

3098

Injury of muscle and tendon at ankle and foot level

822

1.14

0.58

1.9

2.4

0.23

0.22

g/l

1.25

779

Contact with nonpowered hand tool

163

1488

1.11

0.57

2.0

2.4

0.21

0.22

g/l

0.36

151

1395

Excessive earwax

3322

30664

0.98

0.56

2.2

2.4

0.21

g/l

3.86

3058

28569

Struck by thrown, projected or falling objec

172

1875

0.91

0.56

2.8

2.5

0.22

g/l

0.33

161

1758

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2102

15085

1.03

0.56

2.3

2.2

0.23

0.22

g/l

4.15

1990

14185

Cholera, including avohilmo

1.51

0.55

5.3

2.0

0.23

g/l

—

Multiple gestation

259

2776

0.93

0.55

2.3

0.23

g/l

0.20

249

2644

Choroidal haemorrhage and rupture

0.59

0.54

2.2

1.9

0.18

0.21

g/l

—

Other cestode infections, including avohilmo

0.60

0.54

1.0

2.2

0.24

0.21

g/l

—

Injury of blood vessels at lower leg level

144

1.36

0.53

2.7

2.6

0.19

0.21

g/l

0.55

135

Distal bite

151

1370

1.10

0.53

4.6

3.8

0.22

g/l

0.25

146

1304

Other congenital malformations of ear

297

1.23

0.52

3.4

0.23

g/l

0.01

283

Benign leiomyoma with endometriosis

672

6456

1.05

0.51

2.3

2.1

0.21

g/l

1.31

631

6024

Persons encountering health services in circumstances related to reproduction

2820

18521

1.02

0.51

2.6

0.23

0.22

g/l

4.59

2689

17394

Medullary carcinoma of thyroid gland, including Hilmo

1.61

0.50

3.0

2.5

0.23

0.19

g/l

—

L02BB Anti-androgens

354

3738

0.94

0.50

2.0

2.2

0.20

0.19

g/l

1.09

323

3439

Divergent concomitant strabismus

287

2700

1.07

0.49

2.3

2.4

0.22

g/l

0.03

274

2538

Congenital malformations of ovaries, fallopian tubes and broad ligaments

174

1607

1.09

0.49

2.2

0.23

0.22

g/l

1.11

169

1525

Lesion of sciatic nerve

173

1600

1.09

0.49

2.4

2.1

0.20

g/l

0.54

167

1477

Pneumoconiosis due to dust containing silica

1.42

0.48

3.0

1.9

0.18

0.20

g/l

0.36

Exposure to ignition of highly flammable material

129

1.35

0.48

2.1

3.1

0.21

0.23

g/l

0.45

121

Male infertility

152

1399

1.09

0.47

2.5

2.6

0.23

0.24

g/l

0.23

143

1301

Acromegaly and pituitary gigantism

201

1.27

0.47

2.2

2.5

0.20

0.22

g/l

0.79

187

Episcleritis

199

1855

1.08

0.46

2.5

2.3

0.22

g/l

0.17

189

1748

Pleural plaque without asbestos

150

1385

1.09

0.45

2.2

0.19

g/l

0.34

136

1268

Drug-induced interstitial lung disorders, unspecified

1.51

0.45

1.0

2.6

0.24

0.22

g/l

—

Occlusion and stenosis of arteries, not leading to stroke

433

1.17

0.45

2.2

0.21

0.20

g/l

0.42

395

Hereditary spastic paraplegia

1.68

0.44

2.0

4.2

0.20

0.22

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

571

5491

1.04

0.44

2.3

0.22

0.21

g/l

0.67

538

5150

Cicatricial alopecia [scarring hair loss]

267

1.22

0.44

2.2

2.3

0.20

0.22

g/l

0.92

252

Disorders of glossopharyngeal nerve

1.45

0.44

1.9

0.21

0.20

g/l

—

Benign neoplasm: Respiratory system, unspecified

1.45

0.44

1.3

2.2

0.19

0.22

g/l

—

Abrasion of teeth

1719

16819

1.02

0.43

2.3

0.22

0.21

g/l

6.21

1604

15775

Mumps, including avohilmo

852

1.11

0.43

1.8

2.4

0.21

0.22

g/l

0.75

801

Infections of breast associated with childbirth

952

0.90

0.42

1.9

2.2

0.22

0.23

g/l

0.48

909

Postpartum haemorrhage due to retained placenta

331

3481

0.95

0.42

2.3

2.2

0.23

g/l

0.22

315

3309

Glaucoma suspect

1828

17897

1.02

0.41

2.0

2.2

0.21

g/l

0.17

1667

16670

Cutaneous autosensitization

1.52

0.41

5.4

3.0

0.22

0.24

g/l

—

Cholesteatoma of middle ear

204

1915

1.07

0.41

2.1

2.3

0.20

g/l

0.29

191

1781

Complications predominantly related to the puerperium

905

9317

0.97

0.40

2.3

0.22

g/l

0.08

839

8808

Erythema in diseases classified elsewhere

1.37

0.39

1.8

2.5

0.26

0.22

g/l

—

Seropositive rheumatoid arthritis, strict definition

650

6287

1.04

0.39

2.2

0.20

0.21

g/l

1.62

592

5885

Other disorders of amniotic fluid and membranes

396

3991

0.96

0.39

2.0

2.3

0.23

g/l

0.29

385

3791

Benign neoplasm: Vertebral column

1.40

0.38

3.3

2.9

0.19

0.22

g/l

0.47

Injury of heart

1.32

0.38

2.9

2.6

0.19

0.21

g/l

—

Glaucoma, exfoliation

439

4567

0.96

0.38

1.8

2.0

0.20

0.19

g/l

0.70

396

4205

Twin gestation

253

2669

0.94

0.38

2.3

0.23

g/l

0.23

243

2542

Antepartum haemorrhage, not elsewhere classified

235

2484

0.94

0.38

2.0

2.4

0.23

g/l

0.04

224

2367

Benign neoplasm of male genital organs

745

1.11

0.38

3.1

2.6

0.21

0.20

g/l

0.18

682

Spirochaetal infections, other/unspecified, including avohilmo

1556

15885

0.98

0.38

2.4

2.3

0.23

0.21

g/l

12.25

1448

14877

Other infestations

0.64

0.37

1.2

3.1

0.20

0.21

g/l

—

Mumps

831

1.10

0.37

1.7

2.4

0.21

0.22

g/l

0.75

782

Crushing injury of wrist and hand

544

0.87

0.37

2.1

2.5

0.22

0.21

g/l

0.36

507

Other lesions of median nerve

107

986

1.09

0.37

1.9

2.1

0.19

0.20

g/l

0.78

100

915

Poor fetal growth

348

3328

1.05

0.36

2.5

2.3

0.23

g/l

0.42

321

3167

Other and unspecified corneal deformities and disorders

122

1131

1.09

0.36

2.5

2.3

0.22

0.21

g/l

0.20

113

1066

Use of rasagiline

104

959

1.10

0.36

2.1

2.3

0.20

0.21

g/l

0.08

886

Benign neoplasm: Lymph nodes

1.36

0.36

2.4

2.7

0.23

0.22

g/l

0.20

Vestibular neuronitis

375

3599

1.05

0.35

2.2

2.3

0.21

g/l

0.31

348

3372

Normotensive glaucoma

390

3747

1.05

0.35

1.9

2.1

0.20

g/l

0.45

351

3480

Lyme disease, including avohilmo

1546

15769

0.98

0.35

2.4

2.3

0.23

0.21

g/l

12.55

1438

14776

Lyme disease

1546

15769

0.98

0.35

2.4

2.3

0.23

0.21

g/l

12.55

1438

14776

Injury of blood vessels at forearm level

1.35

0.35

1.8

2.8

0.21

0.23

g/l

0.80

Operations 1 for CAVS

101

1.33

0.33

3.1

4.3

0.20

0.21

g/l

0.20

Unspecified maternal hypertension

274

0.83

0.33

2.0

2.3

0.23

g/l

0.09

261

Congenital malformations of posterior segment of eye

174

1.23

0.33

2.4

3.5

0.21

g/l

0.08

163

Other and unspecified iridocyclitis

185

1751

1.06

0.32

2.2

2.3

0.21

g/l

0.01

171

1636

Other bursal cyst

533

1.12

0.32

2.0

2.2

0.21

g/l

0.20

500

Mesial bite

296

1.16

0.31

3.0

3.8

0.23

g/l

0.02

281

Mononeuritis multiplex

1.33

0.31

3.2

2.1

0.19

0.21

g/l

0.45

Vitreous prolapse

102

1.31

0.31

2.9

2.3

0.20

0.21

g/l

0.15

Pregnancy examination and test

501

3208

0.97

0.31

2.2

2.4

0.23

g/l

0.67

474

3021

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

106

0.74

0.30

1.8

2.5

0.16

0.21

g/l

—

Unspecified abortion

168

1590

1.06

0.29

2.6

2.2

0.22

g/l

0.30

157

1505

Melanoma in situ of trunk

594

1.11

0.29

1.8

2.4

0.21

0.20

g/l

0.15

553

Carcinoma in situ of breast, other/unspecified

479

1.12

0.29

2.1

2.0

0.22

0.21

g/l

0.86

449

Inflammation of lacrimal passages (chronic)

517

1.11

0.29

2.2

2.1

0.22

0.20

g/l

0.48

479

Desensitization to allergens

168

1591

1.06

0.29

2.8

0.23

g/l

0.13

159

1504

Other spirochaetal diseases, including avohilmo

1583

16094

0.98

0.29

2.4

2.3

0.23

0.21

g/l

12.16

1474

15074

Other disorders following mastoidectomy

117

0.75

0.28

1.3

2.1

0.20

g/l

—

106

Pedestrian injured in collision with two- or three-wheeled motor vehicle

116

0.76

0.28

2.3

2.8

0.27

0.22

g/l

—

110

Fall on and from ladder

312

3003

1.04

0.28

2.3

2.4

0.21

g/l

0.18

288

2795

Disorders of lacrimal system and orbit in diseases classified elsewhere

816

1.09

0.28

2.4

2.1

0.21

g/l

0.14

767

Ménière disease

396

3831

1.04

0.28

2.0

2.2

0.22

0.21

g/l

1.93

367

3576

Use of rivastigmine

728

7089

1.03

0.27

1.7

2.0

0.20

0.19

g/l

2.71

660

6479

Rubella [German measles], including avohilmo

125

1178

1.07

0.27

3.1

2.6

0.21

0.22

g/l

1.45

117

1113

Other spirochaetal diseases

1567

15917

0.98

0.26

2.4

2.3

0.23

0.21

g/l

12.40

1459

14912

Glaucoma-related operations

224

2336

0.95

0.26

1.9

2.1

0.21

0.20

g/l

0.96

208

2163

Unattended death

311

1.14

0.26

2.2

2.4

0.19

0.21

g/l

0.42

287

Bicipital tendinitis

188

1797

1.05

0.25

2.0

2.3

0.21

g/l

0.09

179

1693

Traumatic amputation of wrist and hand

166

1582

1.05

0.25

2.7

2.4

0.21

g/l

0.03

161

1488

Use of memantine

1349

10679

1.02

0.25

1.6

2.0

0.20

0.19

g/l

1.54

1183

9783

Use of other anti-dementia drugs

1349

10679

1.02

0.25

1.6

2.0

0.20

0.19

g/l

1.54

1183

9783

Rubella [German measles]

124

1173

1.06

0.24

3.1

2.6

0.21

0.22

g/l

1.45

116

1108

Vertical strabismus

127

1203

1.06

0.24

2.0

2.4

0.22

0.21

g/l

0.12

117

1120

Other congenital infectious and parasitic diseases

0.00

0.24

0.0

6.3

—

0.23

—

Foreign body or object entering through skin

229

2202

1.04

0.24

2.3

2.4

0.22

g/l

0.09

210

2066

Maxillary hypoplasia

1.26

0.24

2.9

3.6

0.21

0.23

g/l

0.49

0.76

0.24

3.4

5.3

0.17

0.21

g/l

—

Changes in corneal membranes

125

1.22

0.23

2.2

2.1

0.24

0.23

g/l

0.22

120

Benign neoplasm: Skin of other and unspecified parts of face

437

4253

1.03

0.23

2.7

2.2

0.21

g/l

0.72

402

3969

Beningn neoplasm: Meninges, unspecified

516

1.09

0.23

2.2

2.1

0.22

0.21

g/l

0.22

486

Congenital malformation of vitreous humour

0.00

0.22

0.0

1.8

—

0.24

—

Heredofamilial amyloidosis, unspecified

0.00

0.22

0.0

2.9

—

0.16

—

Nontoxic goitre/thyroid nodule

1374

13542

1.02

0.22

2.1

2.2

0.21

g/l

2.05

1294

12625

Unspecified dementia

459

4012

1.03

0.22

1.9

2.0

0.18

0.19

g/l

0.72

395

3665

Typhus fever, including avohilmo

0.00

0.22

0.0

3.6

—

0.23

—

Benign neoplasm: Cranial nerves

109

1032

1.06

0.22

2.3

0.22

0.21

g/l

1.01

102

969

Abnormal spermatozoa

523

5353

0.97

0.22

2.2

2.4

0.20

g/l

0.27

477

4978

Venous complications and haemorrhoids in the puerperium

325

1.12

0.22

2.9

2.2

0.22

g/l

0.04

309

Graves ophthalmopathy, strict

741

1.07

0.21

2.5

2.1

0.21

0.22

g/l

0.02

695

Idiopathic progressive neuropathy

1.31

0.21

2.0

2.5

0.19

0.21

g/l

—

Failure in dosage during surgical and medical care

1.25

0.21

2.0

3.2

0.26

0.22

g/l

—

Congenital malformations of ear causing impairment of hearing

112

0.79

0.21

1.3

3.8

0.28

0.22

g/l

—

106

Labour and delivery complicated by umbilical cord complications

152

1455

1.05

0.20

2.5

2.3

0.23

0.22

g/l

0.28

144

1377

Type 1 diabetes, strict definition, subgroup 1

209

2010

1.04

0.20

2.6

3.1

0.19

0.23

g/l

18.53

187

1908

Generalized pustular psoriasis

118

1.21

0.20

3.2

2.7

0.23

0.21

g/l

0.19

111

Keratoconus

792

1.07

0.20

3.3

2.4

0.22

g/l

0.29

756

Primary open-angle glaucoma, strict

1271

12504

1.02

0.20

1.9

2.1

0.20

g/l

0.22

1167

11556

Foreign body on external eye

569

5809

0.98

0.19

2.6

2.5

0.22

g/l

0.72

533

5443

Cerebral arteritis

1.26

0.19

1.8

2.6

0.26

0.22

g/l

—

Alzheimer disease

1588

11488

0.99

0.19

1.6

2.0

0.19

g/l

0.55

1395

10562

Feeding problems of newborn

185

1.15

0.19

4.3

5.4

0.21

0.20

g/l

0.14

180

Contact with and exposure to communicable diseases

1150

11287

1.02

0.18

2.6

0.22

g/l

0.08

1070

10654

Pityriasis rubra pilaris

1.20

0.18

2.3

2.9

0.21

0.23

g/l

—

Use of levodopa decarboxylase inhibitor

621

6098

1.02

0.18

2.0

2.2

0.20

g/l

0.02

567

5647

Retinal breaks without detachment

702

7139

0.98

0.17

2.2

2.3

0.21

g/l

1.04

670

6685

Kissing spine

1.22

0.17

2.4

0.25

0.21

g/l

—

Inhalation of gastric contents

0.75

0.17

1.0

2.5

0.16

0.21

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

372

3634

1.03

0.17

2.5

2.3

0.21

g/l

0.11

354

3407

Discontinuity and dislocation of ear ossicles

173

0.86

0.17

2.6

2.5

0.20

0.22

g/l

0.64

157

Prolapse and hernia of ovary and fallopian tube

135

1391

0.96

0.17

2.2

1.9

0.20

0.19

g/l

1.11

116

1262

Lumbosacral root disorders, not elsewhere classified

398

1.09

0.17

2.0

2.3

0.20

0.22

g/l

0.64

373

Benign neoplasm: Ribs, sternum and clavicle

1.16

0.17

1.4

2.9

0.22

g/l

—

Testicular dysfunction, other/unspecified

162

0.85

0.17

1.7

2.9

0.21

0.24

g/l

0.63

151

Undefined dementia

464

4367

0.98

0.16

1.9

0.18

0.19

g/l

0.59

400

3947

Preterm labour and delivery

990

9765

1.01

0.16

2.3

0.22

g/l

0.74

930

9217

Accidental poisoning by and exposure to other gases and vapours

168

1.14

0.16

1.5

2.8

0.23

0.22

g/l

0.27

155

Other obstetric trauma

150

1447

1.04

0.16

2.6

2.3

0.23

g/l

0.32

143

1371

Other specified/unspecified hearing loss

374

3661

1.02

0.15

2.4

2.2

0.22

0.20

g/l

2.82

358

3407

Impacted maxillary molar

155

1604

0.96

0.15

3.2

2.7

0.23

g/l

0.17

148

1492

Use of ropinirole

142

1371

1.04

0.15

1.9

2.3

0.21

g/l

0.05

129

1279

Postpartum haemorrhage due to anatomy

252

2455

1.03

0.15

2.4

2.1

0.23

g/l

0.35

239

2335

Congenital hydrocephalus

0.77

0.15

2.4

3.0

0.22

0.24

g/l

—

Migraine with aura, drug-induced

316

0.91

0.14

2.4

0.21

0.23

g/l

0.69

301

Speech therapy

1198

11850

1.01

0.14

2.4

2.3

0.22

0.21

g/l

6.96

1101

11057

Otosclerosis

288

2947

0.97

0.14

2.3

2.2

0.21

g/l

0.14

274

2769

Retained placenta and membranes, without haemorrhage

441

4332

1.02

0.14

2.3

0.21

0.22

g/l

0.99

417

4087

Macular cyst

131

1266

1.04

0.14

2.3

2.2

0.21

0.20

g/l

0.74

120

1171

Acquired stenosis of external ear canal

354

1.08

0.14

2.7

2.5

0.22

0.21

g/l

0.40

326

Medical treatment for female infertility

638

6228

1.02

0.13

2.3

0.23

g/l

0.74

613

5912

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.19

0.13

3.1

2.7

0.19

0.21

g/l

0.35

Haemorrhage in early pregnancy

1045

10037

1.01

0.13

2.3

0.22

g/l

0.05

983

9481

Juvenile osteochondrosis

101

972

1.04

0.13

2.9

2.6

0.22

0.23

g/l

0.63

918

Type 1 diabetes, strict definition

219

2238

0.97

0.13

2.6

3.1

0.19

0.23

g/l

17.73

197

2130

Disorders of acoustic nerve

101

973

1.04

0.13

2.3

0.22

0.21

g/l

1.22

915

Malignant neoplasm of heart, mediastinum and pleura

326

1.08

0.12

2.3

2.2

0.18

0.19

g/l

0.91

297

Effects of air pressure and water pressure

152

1.13

0.12

4.1

2.8

0.22

0.23

g/l

0.22

143

Puerperal sepsis

476

4835

0.98

0.12

2.5

2.3

0.21

0.22

g/l

0.51

432

4568

Migraine, unspecified, drug-induced

210

1.10

0.12

3.4

2.5

0.20

0.23

g/l

0.77

199

Pedal cyclist injured in collision with motor vehicle

107

1033

1.04

0.12

2.1

2.3

0.22

g/l

0.01

100

968

Spermatocele

305

2992

1.02

0.12

2.3

2.4

0.21

0.20

g/l

0.92

284

2773

Primary angle-closure glaucoma

175

1707

1.03

0.11

1.8

2.2

0.20

g/l

0.36

162

1580

Graves ophthalmopathy

829

1.04

0.11

2.4

2.1

0.21

0.22

g/l

0.32

777

Parkinson's disease, including avohilmo

702

6941

1.01

0.11

1.9

2.2

0.20

g/l

0.09

645

6433

Embedded and impacted teeth

936

7520

1.01

0.11

3.0

2.6

0.23

g/l

0.10

886

7074

Unspecific neurodegenerative disorder

2162

14705

1.01

0.10

1.8

2.1

0.20

g/l

0.33

1915

13590

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

157

1532

1.03

0.10

2.0

2.3

0.22

g/l

0.16

145

1452

Obstructed labour due to maternal pelvic abnormality

596

5897

1.01

0.09

2.2

2.3

0.22

g/l

0.47

564

5566

Viral haemorrhagic fevers, not elsewhere classified/unspecified

289

2936

0.98

0.09

2.4

2.3

0.22

0.21

g/l

0.14

275

2755

Parkinson's disease, strict definition

626

6196

1.01

0.09

2.0

2.2

0.20

g/l

0.04

573

5739

Primary open-angle glaucoma

1557

14880

1.01

0.09

1.9

2.1

0.20

g/l

0.03

1422

13765

Other perinatal haematological disorders

0.78

0.08

3.6

7.3

0.20

0.21

g/l

—

Nontoxic diffuse goitre

115

1121

1.03

0.08

2.3

2.1

0.21

g/l

0.28

107

1058

Torsion of testis

548

1.04

0.08

2.4

2.9

0.21

0.23

g/l

1.08

507

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

126

1231

1.03

0.08

2.0

2.6

0.23

0.21

g/l

1.72

120

1161

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

251

2549

0.98

0.08

2.1

2.3

0.21

g/l

0.21

231

2381

Multiple system atrophy (rare forms of Parkinsonism)

1.06

0.07

2.5

3.1

0.22

0.20

g/l

—

Vascular dementia (sudden onset)

1.05

0.07

1.3

2.4

0.18

0.17

g/l

—

Fetus and newborn affected by other complications of labour and delivery

1.08

0.07

2.4

5.4

0.27

0.21

g/l

—

Myocardial infarction, unclassifiable

968

8589

1.01

0.07

2.0

2.1

0.19

g/l

0.52

881

7846

Cellulitis of external ear

394

1.04

0.06

2.1

2.7

0.22

g/l

0.19

373

Certain zoonotic bacterial diseases, including avohilmo

100

1022

0.98

0.06

2.6

2.3

0.20

0.21

g/l

0.54

953

Hydrocephalus

302

2987

1.01

0.06

2.0

2.2

0.21

0.20

g/l

0.56

274

2756

Corneal pigmentations and deposits

119

1.10

0.06

3.3

2.6

0.25

0.21

g/l

0.66

109

Non-small cell lung cancer, squamous, helper endpoint

178

1806

0.98

0.06

1.8

2.2

0.20

0.19

g/l

0.26

161

1659

Supervision of high-risk pregnancy

731

4364

1.01

0.05

2.2

2.3

0.23

g/l

0.10

691

4122

Impacted teeth

642

5544

0.99

0.05

3.0

2.8

0.23

g/l

0.32

612

5203

Brain glioblastoma

374

0.96

0.05

1.6

2.4

0.27

0.21

g/l

4.33

343

Suppurative otitis media, unspecified

777

0.98

0.05

2.4

2.6

0.21

g/l

0.01

723

Dentofacial anomalies [including malocclusion]

3424

26713

1.00

0.04

2.4

0.23

0.22

g/l

10.68

3216

25069

Villonodular synovitis (pigmented)

239

1.05

0.04

5.0

2.4

0.24

0.22

g/l

0.48

229

Parkinson's disease

669

6658

1.01

0.04

2.0

2.2

0.20

g/l

0.01

614

6174

Postmenopausal atrophic vaginitis

1188

6455

1.00

0.02

2.0

2.2

0.22

0.21

g/l

9.79

1123

6008

Injury of muscle and tendon at shoulder and upper arm level

1741

17377

1.00

0.02

2.2

2.4

0.21

g/l

1.74

1618

16236

Abnormal findings on antenatal screening of mother

196

1975

0.99

0.02

2.5

2.4

0.23

g/l

0.67

191

1881

Other facial nerve disorders

950

1.01

0.02

2.2

2.4

0.22

0.21

g/l

0.97

882

Non-allergic asthma

333

3314

1.00

0.01

2.5

2.4

0.22

0.21

g/l

1.02

306

3109

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

989

0.99

0.01

2.0

2.2

0.20

g/l

0.25

902

Benign neoplasm: Bones of skull and face

323

1.02

0.01

2.5

2.4

0.22

g/l

0.08

305

Use of levodopa decarbox-comt-inhibitor

122

1212

1.01

0.01

2.0

2.3

0.20

g/l

0.18

109

1118

Colour vision deficiencies

116

0.94

0.01

1.5

3.0

0.23

0.22

g/l

0.19

106

Other maternal disorders predominantly related to pregnancy

2402

15029

1.00

0.00

2.2

2.3

0.22

g/l

0.92

2248

14159

Transient synovitis

234

1.03

0.00

3.5

2.9

0.22

g/l

0.10

220

L02BX Other hormone antagonists and related agents

235

2351

1.00

0.00

2.0

2.3

0.20

g/l

0.13

217

2175

Use of fingolimod

208

1.01

0.00

1.9

2.6

0.25

0.23

g/l

0.55

199

Other specified/unspecified diseases of inner ear

146

1.03

0.00

1.4

2.4

0.21

g/l

0.01

132

Congenital ptosis

109

1.01

0.00

2.1

4.0

0.18

0.22

g/l

0.71

103

Down's syndrome

121

0.99

0.00

2.9

4.1

0.21

0.22

g/l

0.14

112

Lesion of medial popliteal nerve

119

1.01

0.00

1.2

2.3

0.20

0.22

g/l

0.48

112

Carcinoma in situ of uteri, other/unspecified

181

0.99

0.00

1.3

2.4

0.24

0.22

g/l

0.35

176

Congenital cataract

143

0.98

0.00

2.5

3.4

0.24

0.22

g/l

0.42

132

Other disorders of prostate

127

1267

1.00

0.00

1.9

2.5

0.20

g/l

0.34

116

1163

Melanocytic naevi of eyelid, including canthus

293

0.99

0.00

1.8

2.3

0.20

0.22

g/l

0.51

277

Maternal care for cervical incompetence

122

1225

1.00

0.00

2.9

2.2

0.22

0.21

g/l

0.07

115

1142

Other specified/unspecified disorders of tympanic membrane

135

1.04

0.00

2.4

2.7

0.17

0.22

g/l

1.82

129

Congenital ptosis, including avohilmo

132

0.98

0.00

2.1

3.8

0.19

0.22

g/l

0.87

124

Congenital lens malformations

152

0.99

0.00

2.5

3.3

0.23

0.22

g/l

0.33

141

Familial erythrocytosis

135

1.04

0.00

2.0

2.7

0.22

0.21

g/l

0.20

121

Other and unspecified water transport accidents

105

0.95

0.00

3.3

2.6

0.21

0.23

g/l

—

Bilateral

0.00

0.0

3.0

—

0.22

—

Malignant neoplasm of placenta

0.00

0.0

2.6

—

0.16

—

Nonscarring hair loss, unspecified, drug-induced

0.00

0.0

4.4

—

0.18

—

Monkeypox, including avohilmo

0.00

0.0

3.2

—

0.20

—

Traumatic shock

0.00

0.0

2.0

—

0.24

—

Dengue

0.00

0.0

3.8

—

0.20

—

Testicular hypofunction, drug-induced

0.00

0.0

1.2

—

0.24

—

Congenital retinoschisis

0.90

0.00

1.6

3.2

0.22

0.21

g/l

—

Cyst of iris, ciliary body and anterior chamber

1.02

0.00

3.6

2.5

0.25

0.22

g/l

—

Taeniasis, including avohilmo

0.00

-0.00

0.0

2.4

—

0.22

—

Meretoja disease

0.92

-0.00

1.6

2.1

0.21

0.22

g/l

—

Anencephaly and similar malformations

0.00

-0.00

0.0

3.0

—

0.21

—

Maple-syrup-urine disease

0.00

-0.00

0.0

1.6

—

0.23

—

Abnormalities of ear ossicles

1.02

-0.00

4.8

3.0

0.20

0.22

g/l

—

Melanoma in situ of scalp and neck

0.91

-0.00

2.4

2.7

0.26

0.21

g/l

—

Alcohol-induced pseudo-Cushing syndrome

0.00

-0.00

0.0

2.1

—

0.22

—

Radiological devices associated with adverse incidents

0.00

-0.00

0.0

4.6

—

0.21

—

Taeniasis

0.00

-0.00

0.0

2.6

—

0.21

—

Typhus fever

0.00

-0.00

0.0

3.9

—

0.23

—

Choroidal detachment

0.97

-0.00

1.3

2.4

0.20

g/l

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.91

-0.00

2.0

2.8

0.24

0.22

g/l

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

2.3

—

0.17

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

-0.00

0.0

2.3

—

0.23

—

Labyrinthine fistula

0.92

-0.00

1.4

2.6

0.24

0.22

g/l

—

Visual disturbances in diseases classified elsewhere

0.00

-0.00

0.0

1.9

—

0.22

—

Granuloma inguinale

0.00

-0.00

0.0

2.0

—

0.22

—

Other and unspecified disorders of lacrimal system

0.98

-0.00

2.0

0.18

0.22

g/l

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

-0.00

0.0

1.3

—

0.27

—

Secondary thrombocytopenia, drug-induced

0.00

-0.00

0.0

6.4

—

0.20

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

-0.00

0.0

4.8

—

0.23

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prealbumin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS